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The Use of Static Retinal Vessel Analysis in Optometric Practice




At present optometric examination of the retinal microcirculation consists of a subjective assessment of artery size
when compared to a neighbouring vein; the arterio-venous ratio (AVR). Despite it’s documented limitations, the
AVR still features in UK optometric clinical guidance. An objective method of recording the central retinal artery
and vein equivalent sizes (CRAE and CRVE) has been used for research purposes for two decades but has yet to be
validated in a clinical setting. A review of the present literature identified correlations between CRAE and CRVE
and three key cardiovascular pathologies; hypertension, diabetes mellitus and stroke. A methodological study was
undertaken to establish whether retinal photographs acquired in clinical practice yielded results with reproducib-
ility comparable with those in the literature. It was shown that calibre measurements do not fluctuate significantly
with the use of mydriatics, or subject to minor temporal fluctuations. When the technique was applied in clinical
practice, a cross-sectional cohort (n = 271) revealed vessel correlations with systemic biomarkers in agreement with
those identified in the literature review. CRAE was seen to be reduced in those with raised blood pressure, and
objective AVR was reduced in those with increased cardiovascular risk (QRISK). There did not appear to be signi-
ficant fluctuations in vessel measurements when the cohort was observed longitudinally across a period of 12 – 24
months, suggesting changes either too slow or too small to be detected at present; supporting theories of gradual
morphological changes. When considered as part of scope of primary care, improved cardiovascular assessment
through retinal vessel analysis (especially when supplemented with blood pressure and cardiovascular risk calcula-
tions) relieves pressure on GPs and identifies a significant number of previously undiagnosed and unmanaged cases
of cardiovascular disease. The results build a strong case for the incorporation of objective retinal vessel analysis
into routine optometric clinical guidelines.
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The eye is often referred to as a ‘window to the body’. This may be an overstatement, but it is a well-
documented fact that the eye, in particular the retina with it’s rich vascular tree, serves as the only
location where the microcirculation can be observed in vivo[1, 2]. Since the retinal vasculature is connec-
ted to the body’s macrocirculation, systemic changes both physiological and pathological can manifest
in the eye. Optometrists in primary care are well situated to screen patients on a routine, continual basis
for such changes. Of particular consideration are those conditions which directly affect the circulation;
i.e. cardiovascular disease.
1.2 Projected Impact of Cardiovascular Disease
Diabetes mellitus (DM), hypertension (HT) and stroke are three common, systemic cardiovascular con-
ditions intrinsically linked to one another. Prevalence amongst adults (16+) of the over-arching term ‘car-
diovascular disease’ (including stroke, angina, coronary heart disease, myocardial infarction) in England
for the year 2017 was calculated to be 13.5%, with numbers increasing in-line with age. Age-standardised
death rates from cardiovascular disease in the UK was 246 per 100,000 in the same year[3]. Aside from
1918, CVD has been the leading cause of death in America since 1900, with the incidence being higher
than the next four leading causes combined (cancer, chronic lower respiratory disease, accidents, DM)[4].
Diabetes mellitus (Types I and II) currently affects 3.8 million people in the UK alone, and prevalence is
expected to nearly double by 2035 (although it is thought that around half of the Type II DM diagnoses
could be avoided if childhood obesity is sufficiently curtailed)[5]. In the UK each week, there are 169 limb
amputations, 530 heart attacks and 680 strokes as a result of DM. In short, it is thought that more than
500 diabetics die prematurely per week[5]. Diabetes mellitus has been cited as an independent risk factor
for the development of cardiovascular disease and hypertension[6, 7]. Conversely hypertension and anti-
hypertensive medication are known to be a risk factor for DM[8, 9]. The increase in DM prevalence is set
to require a further 7% of the National Health Service (NHS) budget by 2036[10]. This poses serious finan-
cial implications since diabetic retinopathy complications alone in 2010/11 cost the NHS £57,741,842[10].
Spending on Type II DM alone has increased rapidly in the UK over recent years. Between 2012 and 2016,
there has been a 25% increase in spending on DM treatment; split between an increase in diagnoses
and the prescribed treatment. Expenditure for diabetic drugs in 2015/16 was £873,000,000[11]. Per year,
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total hospital costs are estimated to be £32bn; diabetes-related treatments made up 16.25% (£5.2bn) of
that budget[12]. Hypertension is equally prevalent, affecting more than 50% of those aged 65 and over
in the UK[13]. With an ageing population, incidence figures are set to rise for conditions such as DM,
hypertension and cardiovascular disease. Their complex inter-relationship will undoubtedly exacerbate
such figures. Clearly there will be a much greater need for prompt diagnosis and more efficient mon-
itoring of individuals in order to best allocate NHS services and treatment. Examination of the retinal
vasculature as a means of monitoring DM is relatively quick and cheap to perform. Current costs of the
retinopathy screening service are only predicted to rise by just over £1million over the next twenty years,
whereas diagnostic costs as a whole will rise by over £7.5million[10]. Optometrists have been identified as
a key component in diabetic patient care, in both detection and subsequent diagnosis of DM, but also
in monitoring for signs of progression in existing cases of DM[14]. More generally, multi-disciplinary
care can improve the efficiency healthcare with better patient outcomes (such as slowed rate of renal
function decline in chronic kidney disease[15]), although it has been identified that inter-professional
communication is key to keep informed about that patient’s well-being[16]. This would be especially per-
tinent in a community setting where primary healthcare providers may well be situated at different sites
(e.g. GP, nurse, pharmacist, optometrist). There is an increasing shift towards the use of practice nurses
and healthcare assistants (HCAs) in UK GP-based hypertension monitoring schemes[17]. In context to
cardiovascular disease, early detection of vascular changes through optometric examination can help
improve detection and diagnosis rates and initiate earlier interventions[18]. Changes to vascular mor-
phology in cardiovascular disease is well-known[2, 1, 19], but in order for this to be effectively monitored,
there needs to be an accurate and clinically appropriate method for recording them.
1.3 Overview: Hypertension
When the heart pumps, expelling oxygenated blood into the arterial system, the maximum pressure
that this travels at is referred to as the systolic blood pressure. When the heart relaxes, and there is
a surge of blood returning to the heart in the venous system, the blood is at its lowest pressure; the
diastolic pressure. The Seventh Joint National Committee on the Prevention, Detection, Evaluation
and Treatment of High Blood Pressure in the United States published a revised classification for blood
pressure and hypertension based on blood pressure readings alone (see Table 1)[20]. Whilst there has
since been an eighth JNC report, the classification criteria for hypertension remains unchanged[21]. The
diagnosis of hypertension is made when the average of two or more readings over two successive visits
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are repeatedly high[22]. The classification in the UK (see Table 2), outlined by the National Institute for
Health and Care Excellence; NICE, is the same as that published in the JNC report, with the addition
of a fifth category; ‘Severe hypertension’ (sometimes referred to as ‘malignant hypertension’, however for
consistency the NICE terminology will be used). To reflect changes observed throughout the day, the
European Society of Hypertension (ESH) and European Society of Cardiology (ESC) have also published
guidance on defining hypertension based on the setting of BP measurement (see Table 3). Ambulatory
blood pressure refers to the continuous monitoring of blood pressure over a given period, rather than
an isolated ‘window’ during the day.
Classification Systolic (mmHg) Diastolic (mmHg)
Normotension <120 and <80
Pre-hypertension 120-139 or 80-89
Stage 1 hypertension 140-159 or 90-99
Stage 2 hypertension ≥160 or ≥100
Table 1: Classification of blood pressure in persons aged 18 and over - JNC-7 Report (USA). [20]
Classification Systolic (mmHg) Diastolic (mmHg)
Normotension <120 and <80
Pre-hypertension 120-139 or 80-89
Stage 1 hypertension 140-159 or 90-99
Stage 2 hypertension 160-179 or 100-109
Severe hypertension ≥180 or ≥110
Table 2: Classification of blood pressure in persons aged 18 and over - NICE Guidelines (UK). [23]
Systolic (mmHg) Diastolic (mmHg)
Office BP ≥140 and/or ≥90
Ambulatory BP:
Daytime (awake) ≥135 and/or ≥85
Night-time (asleep) ≥120 and/or ≥70
24-hr ≥130 and/or ≥80
Home BP ≥135 and/or ≥85
Table 3: ESH/ESC hypertension definitions for office and out-of-office blood pressure readings. (Note
the definition for ‘Office BP’ is coincident with NICE and JNC definitions of ‘Stage I hypertension’) [24]
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Pre-hypertension as a category was created since those persons with blood pressure readings of 130-
139/80-89mmHg are twice as likely to develop hypertension as those with blood pressure below those
values[20]. This category is of particular relevance to the optometrist since accurate retinal vessel ana-
lysis with this group of patients has the potential to monitor and detect pathological changes sooner
or even before pathological damage has taken place; a previous study has shown that simply measur-
ing blood pressure alone in optometric practice identifies one in 8 ‘undiagnosed hypertensives’ (where
BP was >140/80mmHg)[18]. This statistic could be suggested to underestimate those at risk, since the
category of ‘pre-hypertension’ was not recognised by the study. By identifying those patients at partic-
ular risk of going on to develop hypertension, a thorough assessment of the vascular status and calibre
is of great importance. Patient education and notification of the GP or physician at this stage allows
for the early intervention and possible curtailing of any further increase in (and microvascular damage
arising from) blood pressure. Despite raised pressure being the driving force of hypertension, the ma-
jority of complications that arise are thrombotic (stroke, myocardial infarction) in origin, rather than
haemorrhagic (as one would expect with raised pressure)[25, 26]. This has been termed the “Thrombotic
(or Birmingham) Paradox” and is an important consideration when evaluating patient risk.
Despite it’s widespread prevalence, the aetiology and mechanism of hypertension is still not well
understood; even the action of the first-line recommended treatment (β-blockers) remains unknown[27].
There is a variety of factors known to influence hypertensive susceptibility; however the understanding of
genetic influence is currently limited[22]. Whilst it is known that blood pressure traits can run in families,
the specific genes dictating this have yet to be identified. In a theoretical population of normotensive
persons, the blood pressure would be normally distributed, thus the genetic influence to predispose
those subjects to fall either side of the peak of distribution needs to be explored[22]. There are a number
of factors known to be hypertensinogenic; obesity, insulin resistance, high alcohol intake, high salt intake
and low potassium and calcium intakes; and some of these factors can be additive (e.g. obesity and
alcohol intake combined carry a greater risk)[20, 22]. Environmental aspects such as stress and a sedentary
lifestyle are also associated with hypertension development[22].
Hypertension arises due to an imbalance between cardiac output (which generally remains unchanged)
and peripheral vascular resistance[28]. This manifests as constriction of small arterioles. Exactly when
these changes occur in the timeline of hypertension is still unknown, however it is believed that a struc-
tural change takes place prior to a clinical increase in blood pressure[29, 30]. Since small arterioles contain










Figure 1: Development of hypertension. An increase in calcium within the muscular tunic of the arteries
prompts inward muscular contraction and reduction of vessel lumen. Since the same volume of blood is
travelling through the vessel, this raises the pressure at which it is travelling, and promotes the cascade
of events associated with hypertensive damage (damage through increased sheer stress and vascular
resistance).
lular calcium, contracting the muscle which leads to an irreversible thickening of the vessel wall with a
reduction in vessel lumen and (in the case of retinal arteries) reduced visible blood column (see Figure 1).
This is in addition to the subsequent sequelae associated with hypertensive pathophysiology[28]. Regard-
less of the anatomical uncertainty, there is a long-standing and well-documented association between
increased blood pressure and narrow arteries[31, 32, 33, 34]. The arteries are known to stiffen with age as
well as decrease their lumenal diameter. This results in a pressure-load increase and a decreased ability
for vascular deformation to take place in an effort to absorb this increase in pressure (and thus raised
vascular resistance)[34]. Atherosclerosis is a common process with strong associations with hypertension
but remains a distinct pathophysiological entity. What begins as a ‘fatty streak’ within the intima and
inner media of larger artery walls gradually develops into a fibrous plaque which, as it increases in size,
protrudes into the lumen of the vessel; thus increasing blood turbulence and subsequent endothelial
damage. A resultant increase in blood pressure locally due to the constriction is worsened as the ath-
erosclerotic plaque increases in size (see Figure 2)[34]. As such, since the visible portion of the retinal







Figure 2: Development of atherosclerotic plaque. Gradual deposition of a ‘fatty streak’ restricts lumen
diameter, particularly once it begins to fibrose. This eventually leads to a focal rise in blood pressure,
itself producing further damage to the vessel wall.
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1.4 Overview: Diabetes Mellitus
Diabetesmellitus is a collection of pathologies, characterised by abnormal insulin function. Since insulin
is involved in the metabolism of sugars within the blood, the resultant hyperglycaemia in DM leads to
long-term damage and failure of particular organs; the kidneys, nervous system and heart as well as the
vascular network and the eyes (the latter being both highly innervated and vascularised)[36, 37]. Diabetes
mellitus is commonly referred to as either being type I (‘insulin-dependent’) or type II (‘non-insulin-
dependent’), however a number of further sub-types such as gestational and drug-induced diabetes mean
that the use of these two types in isolation is not strictly accurate. The terms ‘type I’ and ‘type II’ are
still extensively prevalent, even in research. Recently, emphasis has been placed on the identification
of pre-diabetes, particularly those patients with impaired glucose tolerance (IGT) and impaired fasting
glucose (IFG), both of which carry an increased risk of diabetogenesis and the development of other
cardiovascular conditions. The International Diabetes Federation held a Consensus Workshop and part
of their findings suggested considering both IGT and IFG as actual diseases instead of risk factors[37].
Diabetes mellitus is also known to accelerate the vascular ageing process, particularly the development
of atherosclerosis. Studies have shown that with both Type I and II DM free from other cardiovascular
pathologies, vascular stiffness is increased compared to normoglycaemics[7].
1.4.1 Type I diabetes mellitus
Prevalence of Type I diabetes mellitus is estimated to be 5-10% of diabetics[36]. The full aetiology of
Type I DM is still not fully understood, with aspects such as geographic prevalence variations (incidence
in Scandinavian countries is markedly higher than oriental countries) currently remaining unexplained
- although this does suggest a possible genetic element[38]. Whilst the exact trigger for diabetogen-
esis remains largely unclear, the subsequent pathological process is better understood; an autoimmune
destruction of the β-cells in the pancreas which produce insulin [36, 38]. This destruction, which can
take a variable time course, generally leads to an absolute deficiency of insulin, thus necessitating the
lifelong dependency on insulin therapy. Since it is effectively an autoimmune condition, co-morbidities
of pathologies such as thyroid dysfunction, myasethenia gravis and pernicious anaemia are common[36].
1.4.2 Type II diabetes mellitus
Type IIDM is considerablymore common, with prevalence being 90-95%of thosewith diabetesmellitus[39].
Just as with Type I DM, regional variations suggest a genetic element to DM development, however Type
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II DM shows a much greater association with environmental and lifestyle factors such as weight. Ap-
proximately 80% of persons with Type II DM are obese, which carries a certain level of resistance to
the action of insulin[36, 39]. The key difference between Type I and Type II is that in Type II there is no
pathological destruction of the insulin-producing β-cells in the pancreas; patients therefore have a re-
lative insulin deficiency, as opposed to an absolute deficiency[36]. Given the gradual decline in insulin
secretion, symptoms may take years to develop despite microvascular damage taking place.
1.4.2.1 Young-onset Type II diabetes mellitus Distinction should be made for the growing num-
ber of cases of Type II DM developing in younger persons and adolescents. Historically, the distinction
between Types I and II has largely revolved around age of onset, with Type II being classically referred
to as ‘age-onset’ DM. This is typified in study methodologies, where those wanting to make distinc-
tions between DM types will do so based on age of onset, even in the cases of those which are specific-
ally looking at a diabetic cohort (such as the Wisconsin Epidemiologic Study of Diabetic Retinopathy;
WESDR)[40, 41, 42, 43]. It has also been suggested that children diagnosed as diabetic may have been clas-
sified erroneously as Type I simply because of their age[44]. As rates of child and adolescent obesity
are rising, it is suggested that increased insulin resistance is developing in these individuals leading to
young-onset Type II DM[45, 46]. Whilst these may not be insulin-dependent, and therefore modifiable
lifestyle changes can be implemented in an attempt to improve patient health, it has been shown that
adolescents in the United States with Type II DM are losing on average 15 years from remaining life
expectancy when compared to similarly aged non-diabetic adolescents (and DM-related complications
developing by the age of 40)[47]. It has been suggested that young-onset Type II DM should be an addi-
tional cohort in studies of cardiovascular disease since they appear to undergo a more aggressive disease
process compared to older adults developing Type II DM[48].
1.4.3 Diagnosis
The American Diabetes Association (ADA) recommend that DM be diagnosed using one of three tests,
and a positive diagnosis only be given if the results are consistently high at a second visit[36]. The least
effective test is the casual plasma glucose (CPG) test. This is taken at any time of day, with no considera-
tion given to when the last meal was consumed. The traditionally used test is the fasting plasma glucose
(FPG) test, which requires the patient to not have eaten within the preceding 8 hours. The final method,
which has specific guidelines provided by the World Health Organisation (WHO), is useful for diagnosis
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of impaired glucose tolerance, but is time consuming and potentially problematic in a patient with DM,
since it involves the loading of a patient with a concentrated sugar solution. The oral glucose tolerance
test (OGTT) is performed 2 hours following the patient’s consumption of a solution containing 75g of an-
hydrous glucose dissolved in water. The results and their meanings are summarised in Table 4. The ADA
and WHO also recommend against the use of glycosylated haemoglobin (HbA1c) measurements in the
diagnosis of DM[36, 49], although the WHO have relaxed this stance more recently, advising that HbA1c
can be used provided there is no better alternative and a minimum of two readings are acquired[50]. The
UK’s NICE guidance for diabetes does not stipulate it’s own classification of diagnosis; simply referring
to those in need of diagnosis as ‘presenting with hyperglycaemia’ (and making reference to the WHO
criteria (summarised in Table 4))[51, 52].
Test Result Diagnosis
CPG ≥200 mg/dl (11.1 mmol/l) Diabetes
FPG
≤100 mg/dl (5.6 mmol/l) Healthy
100-125 mg/dl (5.6-6.9 mmol/l) IFG
≥126 mg/dl (7.0 mmol/l) Diabetes
OGTT
<140 mg/dl (7.8 mmol/l) Healthy
140-199 mg/dl (7.9-11.1 mmol/l) IGT
≥200 mg/dl (11.1 mmol/l) Diabetes
Table 4: A summary of diagnostic tests for diabetes mellitus. ‘CPG’ = Casual Plasma Glucose (reading
taken at any time), ‘FPG’ = Fasting Plasma Glucose (reading taken 8 hours following last meal), ‘OGTT’
= Oral Glucose Tolerance Test (reading taken 2 hours following patient loading of 75g anhydrous glucose
solution). ‘IFG’ = Impaired Fasting Glucose, ‘IGT’ = Impaired Glucose Tolerance.
1.4.4 Monitoring
In the UK, the NHS oversees a comprehensive programme to monitor diabetics following diagnosis.
An established retinopathy screening service involves patients having dilated fundus photographs taken
and sent to an analysis centre for grading by trained observers, to evaluate both risk of sight-threatening
diabetic retinopathy but also because the retina acts a surrogate for the rest of the circulatory system.
This is recommended to take place within 3 months of diagnosis[53]. Similar automatic enrolment into
a regular monitoring scheme is also in place for the diabetic foot[54], however NICE only recommend
offering screening for chronic kidney disease[55]. Principally, patients are educated and encouraged to
undertake home monitoring of blood glucose levels, especially when taking insulin. More recent treat-
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ments include insulin pumps which operate continuously to supply the required dosage. Stability of
blood glucose can be evaluated through the glycosylated haemoglobin (HbA1c) test, which provides
an accurate indication to blood glucose levels over the preceding 8-12 weeks (based on the lifespan of
erythrocytes (red blood cells))[56]. HbA1c is recorded in mmol/mol, however it was previously specified
in percentage (%), thus patients may be more familiar with one or other format. The WHO suggest an
HbA1c of 6.5% (48mmol/mol) as the cut-off for diabetic diagnosis. Diabetes UK suggest that when a
person with Type II DM (and not taking any treatment, i.e. ‘diet-controlled’) has an HbA1c which falls
below 6.5% (48mmol/mol) they are considered to be in remission[57]. Those at risk of Type II DM are
encouraged to aim for an HbA1c of ≥6.0% (42mmol/mol).
1.4.5 Systemic complications of diabetes mellitus
Diabetes mellitus affects both the micro- and macro-circulation throughout the body, and are sum-
marised in Figure 3. Kidney failure (nephropathy) is characterised by the presence of protein in urine
(proteinuria). The risk of this complication rises exponentially with duration of DM, and can lead to
premature death due to coronary heart disease (reiterating the complex interaction of cardiovascular
disease). Diabetic neuropathy is also a complication, where peripheral regions such as the hands and
feet are most at risk, and healing is also impaired[58]. This causes particular problems with the diabetic
foot due to a combination of poor circulation and reduced nerve sensitivity.
1.4.6 Ocular complications of diabetes mellitus
The retinal vasculature is one of the main sites of diabetic complications, and several countries including
the UK have a routine screening program to track the progress of the characteristic diabetic retinopathy
(DR) as a surrogate for diabetic control. Duration of DMbecomes an increasing risk factor for developing
retinopathy; type I DMposes the greatest riskwith 60%prevalence at 30 years duration ofDM[59]. Briefly,
the retinopathy consists of two stages; non-proliferative DR (NP-DR) and proliferative DR (P-DR).
1.4.6.1 Non-proliferative diabetic retinopathy The earliest stage of NP-DR consists of initial mi-
croaneurysms which are localised out-pouchings of the capillary wall. To the observer, these appear as
small dots and are the first sign that vessel permeability is compromised. This can be more pronounced
in cases of retinal haemorrhages, whereby the type of haemorrhage indicates it’s location within the ret-















Figure 3: Systemic complications of diabetes mellitus. These occur at various vascular (and nervous)
beds throughout the body with some being easier to image and monitor than others.
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retinally they arise from the venous end of capillaries and are more concentrated, thus appear as more
defined bleeds (dot and blot haemorrhages); and haemorrhages into the middle retinal layers signify
haemorrhagic retinal infarcts and appear as darker, deeper bleeds. Waxy, yellow lesions (exudates) and
neuronal debris / local infarcts (cotton-wool spots) can also be seen. All of these signs correspond to
‘mildDR’. In ‘moderate DR’, there is an increased number of the retinopathy signs, as well as venous bead-
ing and ‘generalised dilation’. This can be further classified as ‘severe’ and ‘very severe’, with the risk of the
DR progressing to proliferative increasing proportionally to the amount of retinopathy present. A subtle
dilation of the arteries is also suggested to be an early signifier of ischaemic dysfunction, progressing to
‘silver-wiring’ as a result of narrowing in cases of significant ischaemia[59].
1.4.6.2 Proliferative diabetic retinopathy The progression of retinopathy to P-DR signifies that
the retinal circulation has been compromised to such an extent that perfusion is severely impaired in at
least one quarter of the retina. The ocular response to this is to produce a network of new blood vessels
following the release of a stimulating hormone, vascular endothelial growth factor (VEGF). These vessels
can appear at the optic nerve, elsewhere on the retina, or extend as far forward as the iris. These vessels
are prone to leaking and haemorrhage and so complications such as vitreous haemorrhage are a major
concern.
Thus, depending on the stage of retinopathy, the alterations in vascular calibre are different, for both
the arteries and veins.
1.4.6.3 Diabetic macular oedema Another complication of diabetes and retinopathy is macular
oedema (DMO). DMO occurs as a result of capillary leakage and blood-retinal-barrier breakdown within
the macular region, although the detailed pathophysiology remains unclear[60]. It can also occur at any
point within the standard DR progression, and is assessed and graded separately to DR as a result[61].
Clinically, this accumulation of sub-retinal fluid disrupts vision, resulting in it being the major cause
of vision loss among diabetics[60]. Whilst arterial compliance (i.e. rigidity) was found to be reduced in
cases of DMO, there was no significant difference in measured vessel diameter[62]. DMO incidence is
reportedly variable depending on type and onset of DM; highest in late-onset, insulin-dependent (25.4%
over 10 years) and lowest amongst those who were late-onset, insulin-independent (13.9%)[63].
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1.5 Overview: Stroke
Stroke occurs when there is a disruption to the blood supply to the cerebral tissue, arising through either
blockage and reduction of cerebral blood flow (ischaemic stroke) or rupture of a cerebral blood vessel
due to localised blockage and subsequent build-up of pressure (haemorrhagic stroke) (see Figure 4). This
can occur at any time and it is estimated that every 40 seconds, someone in the United States suffers
a stroke. Of the 795,000 stroke cases annually, 610,000 are first-time incidents[64]. Unfortunately, only
half of those occur in hospital; highlighting that early detection of risk could prove vital in curtailing
such statistics[4]. There can be a number of causes for a stroke incident, and there are various systems
for classification; including the Lausanne Stroke Registry (LSR), Oxfordshire Community Stroke Project
(OSCP) and Trial of Org 101721 in Acute Stroke Treatment (TOAST). Each classification system (with
their own advantages and short-comings) makes use of a variety of diagnostic tests as well as clinical
findings. LSR, whilst being the first classification system proposed, features a large number of stroke
sub-types (7), increasing the chances of a patient falling into multiple categories[65]. Opting to focus
more on the clinical assessment of a stroke victim, the OSCP classification system has the advantage of
being applicable in the earliest stages of stroke, before such investigations as MRI and CT scanning have
been performed. Whilst inter-observer reliability has only been found to be moderate, the system lends
itself well to a clinical (rather than research) setting[66].
1.6 The Cardiovascular System: gross anatomy
The heart serves as a pump, sending blood throughout the body via a network of vessels. Arteries carry a
quarter of the total blood volume away from the heart under high pressure, considered a ‘pressure reser-
voir’. The blood then passes through a network of capillaries at target organs, whereby there is a transfer
of nutrients and waste products. Blood is then returned to the heart, under less pressure (and three
quarters of the total blood volume; a ‘volume reservoir’) in the veins[34]. To reflect these different roles,
arteries and veins have different anatomy, which is summarised in Figure 6. Blood passes through the
heart twice during circulation; once, where blood is pumped from the right ventricle to the lungs in or-
der to acquire fresh oxygen and deposit waste carbon dioxide, before returning to the more muscular left
ventricle whereby the blood is then pumped a second time into the systemic circulation[67]. The blood
vessels, as they get further from the heart, decrease in diameter individually, however their combined
diameter is actually increased compared to the originating aorta. This results in a net drop in pressure






Figure 4: Types of stroke. Note that both types involve a focal reduction in vessel lumen which either
prevents flow of blood (ischaemic stroke), or causes a rupture of the vessel wall (haemorrhagic stroke).
and velocity[34]. Arteries, by their nature and function, have a much more complex physiology than
veins. Blood destined for the ocular circulation passes out of the heart into the aorta, which measures
around 25mm in diameter[68]. In turn, it passes into the internal carotid arteries which run perpendic-
ularly upwards through the neck to supply the head. The first branch of the internal carotid artery is
the ophthalmic artery which provides blood to the eyeball, extraocular muscles and adnexa. Due to its
near right-angle branching from the internal carotid artery, stenosis is highly common in the ophthal-
mic artery[69]. One significant branch of the ophthalmic artery (though only carrying 20% of the overall
blood flow to the eye) is the central retinal artery (CRA). This pathway is summarised in Figure 5.
1.7 Vascular supply to the ocular circulation: The Central Retinal Artery
The CRA travels alongside the optic nerve before, 1.25cm posteriorly to the eyeball, penetrating the
optic nerve’s dura and arachnoid sheaths to travel alongside the nerve itself. The CRA, along with the
exiting central retinal vein (CRV), penetrate the eyeball at the laminar cribrosa. The anatomy of the CRA
and its branches is considered to be analogous to the cerebral vasculature, both through functionality
and post-mortem studies[70, 71]. Functionally, both vascular beds feed high-oxygen-demand structures
whilst also providing a tight barrier between the blood and its surrounding matter; the blood-retinal-

































Figure 5: Origins of the ocular blood supply. Note the gradual reduction in vessel diameter from the
aortic arch upwards to the ophthalmic artery and it’s subsidiary, the central retinal artery. Retinal vessel








Figure 6: Blood vessel anatomy. Arteries feature a much more prominent muscular tunica media com-
pared to veins of equivalent size. The relative lumen diameters partially explain why blood travels at
higher pressure in the arteries, since the volume of blood is contained within a smaller diameter ves-
sel. Stiffening of the muscular tunic will also cause further reduction of arterial lumen. The different
architecture of the vessel types reflects it’s function and is also the root of different vessel responses in
pathology.
fibrous and fibro-hyalinoid thickening in the cerebral arteries occurred simultaneously in the retinal
arteries[71]. The retinal circulation does differ however. Right-angle branchings, as observed on the
retina, are not found in the cerebral circulation, and whilst the cerebral circulation has an abundance
of collateral loops, the retinal arteries can be considered ‘end-arteries’ as there are no anastomoses[71, 72].
This puts the retina at greater risk of damage through occlusion. Irreparable damage is thought to
occur one hour post-occlusion[73]. There is a distinction in the anatomy between the pre- and post-
laminar portions of the CRA. Before the laminar cribrosa, the CRA consists of a single-layer endothelium,
internal elastic laminar, media (containing layers of smooth muscle), external elastic laminar (albeit ill-
defined) and a mostly collagen-based adventitia. Post-laminarly (i.e. intra-retinally) the CRA loses the
elastic laminar, one argument for the subsequent retinal branches to be considered arterioles instead
of arteries; and its media gets progressively thinner (due to a reduction in layers of smooth muscle).
Overall, the post-laminar CRA shrinks in both diameter and wall thickness, with its wall-to-lumen ratio
reducing from 1:4 to 1:10[74]. Although the wall naturally thickens with age, a post-laminar increase in
wall-to-lumen ratio has been shown to be indicative of increased cerebrovascular risk; further evidence
to support the proposed homogeneity with the cerebral vasculature[75]. Having pierced the posterior
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aspect of the globe, the CRA bifurcates into a superior and inferior branch, before further dividing to
serve the temporal and nasal aspects of each hemisphere. In the peripapillary region, the CRA has a
lumen of approximately 100µm and a wall of 15µm (by contrast, pre-laminar adult CRAs have a lumen
of approximately 200µm and a wall of 32µm, thickening with age by up to 5µm)[74]. The CRA branches
progressively lose their artery-like structure as they reach the peripheral retina. Smoothmuscle layers are
reduced from 5-7 at the optic disc to 1-2 layers in the periphery, making them more arteriolar in nature.
The designation of whether the retinal vessels are truly ‘arterial’ or ‘arteriolar’ is not definitive[74, 33]. It
is agreed that the CRA itself and the initial bifurcations close to the disc can be considered arteries.
This is supported by pathologic studies, since the retinal findings associated with cerebral changes were
restricted to the peripapillary region only[71]. Vessels more proximal to the ora serrata correlated much
less. It could therefore be argued that, rather than a clear divide, there is a progressive transition from
artery to arteriole. This is of particular importance when considering the action of pathologies upon
the retinal vasculature; changes detected in the peripapillary region may not be reflective of the outer
reaches of the retina. The ora serrata itself is avascular, and the peripheral retina approaching it has a
much lower metabolic demand; thus less blood is required which results in a reduced calibre[76]. Given
that the CRA contains smooth muscle, it is at risk of systemic pathologies affecting muscular arteries,
such as giant cell arteritis (GCA)[74]. The CRA is also accompanied by a sympathetic nerve plexus as
it approaches the eye, but does not enter it. This is a contrast to the choroidal blood supply (which
supplies the outer aspect of the retina). Sympathetically, the CRA is innervated by post-ganglionic nerves
originating in the superior cervical ganglion[73]. Once the CRA passes the lamina cribrosa and loses it’s
innervation, it becomes reliant upon autoregulation. Autoregulation ensures that within an optimum
perfusion pressure range flow remains constant[77]. As a result, retinal blood flow has been shown to
remain constant despite changes to mean blood pressure of up to 41% above baseline[78]. Oxygen levels
in the bloodstream are also affected by autoregulation, since both retinal arteries and veins have been
shown to constrict under hyperbaric conditions[79]. The precise mechanisms behind autoregulation are
unclear, however evidence suggests that there is input from various hormones (such as nitric oxide,
prostaglandins, endothelins and lactate) as well as metabolic feedback from the retina[19]. The arteries
themselves occupy the inner half of the retina, so supply of nutrients does not extend to the nuclei of the
photoreceptors (a task fulfilled by the choroidal vasculature)[69]. Retinal arteries are known to have an
increased reflex, the arteriolar light reflex, and this is a sign that has been used in the quantification of
pathological changes such as hypertensive retinopathy. The actual underlying physiological explanation
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for it’s appearance has been disputed; historically being attributed to sclerotic changes within the vessel
wall[33, 80]. Contemporary theories have suggested it occurs due to the convex and relatively slow-moving
blood column, enhancing the illuminating light into a significantly visible reflex[81, 82].
1.8 Vascular drainage from the ocular circulation: The Central Retinal Vein
Blood is transferred from the arterial arm to the venous drainage aspect via a network of capillaries.
These capillaries are much thinner vessels, with diameters between 3 and 6µm, and a much simpler
architecture. The retinal capillaries consist of an endothelium, which maintains the integrity of the
blood-retinal-barrier, intramural pericytes and a basement membrane[74]. Deoxygenated blood then
passes into the venous system to be removed from the eye. Commencing posterior to the ora serrata, the
retinal veins collect blood from capillary arcades, increasing towards the optic nerve head. The veins are
distributed in a similar branching pattern to the arteries[73]. As venous blood volume increases towards
the optic nerve, there is an increase in thewall and diameter of the vein branches, with a lumen of around
200µm prior to vein’s exit through the laminar cribrosa[74]. Upon leaving the orbit, the central retinal
vein (CRV) exits the optic nerve to drain into the superior ophthalmic vein. By exiting the optic nerve,
the CRV travels in the subarachnoid space (as well as the CRA), meaning it is exposed to the pressure of
cerebrospinal fluid (CSF)[73]. Whilst the CRA remains unaffected due to both it’s substantial vessel wall
and high arterial blood pressure within, the CRV is muchmore sensitive to changes in CSF. As intraocular
pressure (IOP), CRV pressure and CSF pressure are much closer to one another, spontaneous pulsation
of the CRV is often visible in healthy normal eyes[83]. Anatomically, the intra-retinal portion of the CRV
consists of an endothelium, a thin basement membrane, a media (with widely spaced pericytes) and the
adventitia (which accounts for two thirds of the vessel wall)[74]. Significantly, the wall lacks an internal
elastic laminar and smooth muscle, rendering it much less able to respond to changes in environment.
As such, the mechanisms behind changes in retinal venular calibre are much less understood[1, 19].
1.9 Subjective Retinal Vessel Calibre Assessment
Whilst it is, of course, critical to observe the retinal vasculature, it is of equal importance to be able
to record and quantify it; particularly in the case of follow-up and long-term monitoring. Inconsisten-
cies, inter- and intra-observer disagreement and learning effects are inherent problems of subjective
methods which can largely be mitigated by an objective approach. Until the advent of digital photo-
graphy, objective analysis of the retinal vasculature was a lengthy and clinically impractical process. For
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instance, when Parr and Spears developed their objective formulae, photographic negatives needed to
be mounted on a glass slide and viewed through an engineers’ measuring projector[84]. Alternatives in-
cluded a microscope and screw micrometer to measure each vessel individually. This meant there was a
greater emphasis on subjective analysis, which falls into two categories; subjective measuring and sub-
jective grading. Interestingly, subjective grading (often according to one of the earliest grading scales;
the Keith-Wagener-Barker classification) still features alongside direct ophthalmoscopy in clinical man-
agement guidelines of systemic hypertension[24, 20, 23].
1.9.1 Subjective Measuring
1.9.1.1 Arterio-Venous Ratio Since a graticule cannot be physically placed within the eye to obtain
a true measurement, any size measurements made subjectively within the eye need to use a landmark
as reference (for instance disc diameter). Whilst the disc diameter is a good static landmark, it’s size is
considerably greater than the blood vessels, making it unsuitable for measuring vessel calibre. Gowers
described a method for estimating the calibre of the retinal arteries as a ratio of the neighbouring veins,
now commonly referred to as the arteriole-venule ratio (AVR), in 1876[31]. He stated that in an eye free
from pathology the ratio was approximately two-thirds to three-quarters (or 2:3 to 3:4). The AVR is ad-
vantageous in that the objects being measured (i.e. arteries and veins) are both subject to the same dis-
tortive effects exhibited by the patient’s refractive error and therefore do not require correction factors.
This has even been demonstrated when examining photographs with modern objective formulae; where
individual artery and vein diameters were found to require a correction factor, the ratio of the two did
not[85]. It is also condenses both aspects of the circulation into a single value, allowing for quick assess-
ment in the consulting room. Subjectivity is a major limitation of the AVR; with a lack of agreement
between observers[86]. What is considered to be a ‘normal’ value differs between sources, and Gowers
initial description of a normal AVR of “ 23 to
3
4 ” is in itself a very broad range, although this is the most
commonly-referenced value in cases of ‘healthy normals’[87, 88, 31]. Both awide range of quoted ‘normative
values’ and reported considerable difficulties in selecting truly comparable vessels pose further issues to
the technique[87]. There is an implicit assumption with the AVR that venous calibre remains unchanged
with age or blood pressure, hence its utilisation as a static landmark for tracking arteriolar changes[89].
Various large-cohort studies have shown however, using more advanced methods, that changes to the
retinal venular calibre do occur during hypertension and other pathologies[1, 2, 90, 91, 92]. Furthermore,
patients suffering from co-morbid changes to both arms of the retinal circulatory system will confound
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the AVR further. Bi-directional calibre changes (such as an artery decrease and venous increase) will
result in an exaggerated change in AVR, whilst parallel changes (such as an increase in both artery and
venous calibre) will result in no net change to the recorded AVR. The AVR has likely remained a staple for
the optometrist due to its relatively simple premise and universal understanding. Optometrists in the
United Kingdom are primary care practitioners and so can sometimes be the first medical professionals
to detect a systemic pathology. There is an inference that AVR is a useful tool by its continued reference
in pathologic studies. The AVR’s value to the optometrist is made questionable by its marked absence
from various (cardiovascular) pathology textbooks; common disease reference and anatomy handbooks,
and more specialised retinal vascular publications, make no mention of the AVR[74, 93, 94, 95, 73, 96, 97]. This
continues through to optometric referral criteria and clinical decision making, neither of which are in-
fluenced by AVR. Even optometric practice guidelines in the United Kingdom remain vague with regards
to recording retinal vascular features such as AVR; principally, the only recommendation made by the
College of Optometrists is to record the AVR for each eye and “any unusual features”. Given it’s absence
from any referral or management guidelines, the clinical value of recording the AVR is debatable. Ex-
pressed as a ratio of one to another, calculating the widths of a retinal artery and it’s equivalent vein is
not as simple as the premise sounds. The key to an accurate AVR is the selection of vessels; particularly
that they are arise from the same number of divisions (e.g. third bifurcation). The location for vessel
selection varies between sources, with some optometric textbooks quoting a region between 1 and 2 disc
diameters from the disc margin[93]. The problems from not having a standardised location are likely
to be compounded by the fact that truly comparable vessels are not always neighbouring. They can
be difficult to detect and would require intensive scrutiny of fundus photographs. Stokoe and Turner
highlighted this problem and detailed no less than 11 separate problems with vessel selection (see Figure
7)[87].
1.9.1.2 Subjective-Objective Measuring Prior to the widespread use of fundus photography, vessel
measurement by means of traditional ophthalmoscopic techniques were explored. Such devices were
cumbersome and resulted in being a curiosity rather than a widely used instrument. Lobeck described
an instrument which employed the optical separation technique[98]. It’s mechanism is shown in Figure 8.
The optic disc is imaged through a bi-prism which is adjusted until the outer aspect of one hemisphere is
touching the inner aspect of the other, and the associated distance is read from a scale. The same method
is then applied to the vessel in question, and it’s diameter is calculated relative to the disc’s diameter. As
Lobeck states, this technique results in a measurement independent of refractive error. Mikuni adapted
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Figure 7: Issues associated with vessel selection in the subjective AVR. i – lower branch supplying upper
hemisphere; ii – no vessel pair; iii – unequal ratio of arteries to veins; iv – multiple branching makes
vessel selection difficult; v – one vessel doesn’t branch evenly; vi – both vessels don’t branch evenly; vii
– vessel trifurcates; viii – central retinal artery / vein may branch posterior to optic nerve head; ix –
superior and inferior vessel branch arise from common artery branch; x – unpaired arteries (not cilio-
retinal arteries) run horizontally; xi – numerous small branches with questionable significance.
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Figure 8: Lobeck’s optical separation method for vessel measurement. a) shows the disc and vessel
branches. b) shows the determination of the disc diameter by optical separation. c) shows the principle
being applied to a vessel for a comparative calibre measurement to be made, based on the disc diameter.
this concept several years later (see Figure 9) to describe an ocular with built-in arrowswhich are adjusted
to the diameter of the optic disc, and then the desired blood vessel[99]. Mikuni’s instrument was found
to have greater accuracy than Lobeck’s, however neither instrument reached widespread usage.
1.9.2 Subjective Grading
1.9.2.1 Keith-Wagener-BarkerClassification Since the blood vessels are known to change as part of
the pathologic process, vessel diameter changes were integrated into broader grading scales. The work
of Keith, Wagener and Barker (KWB) in their 1939 paper outlining a classification system for retinal
hypertensive changes is still used today[32, 100, 101, 102]. They proposed four stages of hypertension, graded
I to IV, which looks not just at a single factor (i.e. arteriolar narrowing), but the larger clinical picture
for that patient. The retinal details are described in Table 5.
Given that the KWB grading system was devised at a time when hypertension was not well under-
stood or easily treated, the spread of severity was much broader (3 year survival was 70% for Grade I but
only 6% for Grade IV)[32]. This means that when applying the KWB classification today, there will be a
much greater emphasis on the first two grades of the system. There are a number of other difficultieswith
the KWB classification. Whilst the authors acknowledge that grading numerically circumvents the use
of confusing descriptive terms, the broad nature to their classification criteria has resulted in alterations
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Figure 9: Mikuni’s adaptation of the Lobeck ocular for vessel measurement. a) shows the disc and vessel
branches. b) shows determination of the disc diameter by placing of the arrows at the disc margin. c)
shows the principle being applied to a vessel for a comparative measurement to be made, based on the
disc diameter.
Grade I Mild generalised arteriolarnarrowing
Grade II Definite focal narrowing and AVnipping
Grade III Grade II + retinal haemorrhages,cotton wool spots and exudates
Grade IV Grade III + papilloedema
Table 5: The Keith-Wagener-Barker (KWB) classification of arterial hypertension.
by subsequent users[33, 101]. Distinguishing the subtleties between Grades I and II can be challenging
for the observer[101]. Greater distinction between the mild presentations is of much more importance
today given the improvements in diagnosis and treatment of hypertension. Another limitation is that
the severity of retinopathy does not always correlate easily with the severity of the hypertension[101]. In-
deed, the original KWB classification neglects to outline a definitive method for separating the retinal
signs of Grade I and II (arguably the two most important grades of the classification today)[32, 103]. A later
study with more emphasis on those first two grades used the absence (Grade I) or presence (Grade II) of
arteriolar sclerosis[103]. What is important however, is that the classifications make reference to ‘arteri-
olar narrowing’ in very general terms. Whilst the AVR had been used for nearly 50 years by the time of
Keith, Wagener and Barker, it does not feature in their classification. Interestingly, a potential solution
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Grade I
Earliest increase in arteriolar
reflex with minimal AV
compression
Grade II More marked reflex increase andAV compression
Grade III Copper-wiring with advancedAV compression
Grade IV Silver-wiring
Table 6: Scheie’s modification to the original KWB classification.
to the problem of distinguishing between Grade I and II would undoubtedly involve measurement or
quantification of the arterial calibre. This was proposed by Wagener and colleagues in 1947, where they
suggested either using the AVR or comparing observed arterioles to ‘normal’ from memory[104]. Wa-
gener et al. do acknowledge the principle limitation of the AVR for quantifying arteriolar narrowing;
that there needs to be consideration for venular dilation, although give no remedial action besides using
intuition as to whether the arteries are narrower than normal. Studies into the KWB classification and
it’s usefulness in modern patient management have demonstrated these drawbacks[101, 105].
1.9.2.2 ScheieModification Scheie later refined the KWB classification in 1953[33]. The changes out-
lined in the original KWB classification give an indication of the severity of the hypertension, but not the
duration. Scheie argued that severity of arteriolar sclerosis is of equal importance, since this serves as
a reasonable index for the duration of the condition, and therefore proposed that in conjunction to the
KWB grading of hypertension, the patient should also be graded on arteriolar sclerosis. Scheie stressed
that since this can develop equally in mild hypertension over a number of years and acute malignant
hypertension over a much shorter period, the two values together give a more accurate picture. Scheie’s
modification (or rather, supplementation) to the KWB classification is shown below in Table 6.
Whilst grading allows for a more consistent and comprehensive picture to be built up of the retinal
status, condensing the entire retinal landscape (including its vasculature) into a single grade or number
is too general, and still remains a major drawback of this technique. Retinal changes can differ between
quadrants of the same retina, let alone between eyes. The classification systems are difficult to navigate,
and modifications are still common, meaning that comparisons between studies is difficult.
1.9.2.3 Neubauer Classification The subjective grading landscape changed little in the following
half-century, with the existing grading scales either having modifications applied or their applicability
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to clinic questioned. Scales such as the one proposed by Neubauer (see Table 7) aimed to refine the
classification initially outlined by Keith, Wagener and Barker[106]. Here, distinction is made between the
vessel wall changes (fundus hypertonicus) and the accompanying (‘classic’) signs of advanced hypertens-
ive retinopathy. Whilst this refinement would pose a cumbersome and time-consuming tool if applied
routinely in clinic, it does highlight two key points; firstly that different vessel types respond differently
to vascular pathology, and secondly that a more structured and systematic approach for examination of
those vessels (particularly splitting the vessel tree into arteries and veins) is required.
1.9.2.4 Dodson et al. Prognosis-based Classification Dodson and colleagues proposed a simple,
clinic-focussed grading system which was driven by overall prognosis[107]. Here the authors argue that a
simple scale is all that is required for clinical requirements; the ultimate focus being on the individual’s
prognosis. Their justification for the division between grades being that BP is universally correlated
with arterial narrowing, whilst the subsequent signs (including haemorrhages and cotton-wool spots)
are more indicative of advanced BP-related damage.
1.9.2.5 Mitchell andWongSimplifiedClassification Whilst the refinement proposed byNeubauer
resulted in a more detailed and comprehensive classification (with resulting impracticalities for clinic),
Mitchell and Wong’s refinement of the KWB classification (see Table 9) aims to distil the grading down
to more general grouping but with a greater emphasis on the cross-over with systemic cardiovascular
health[108]. Whilst it lacks the specificity required to track subtle changes between visits, it offers an ap-
proach with greater inter- and intra-grader reproducibility than it’s KWB forerunner[101]. Interestingly,
this study also highlighted (albeit with single observers) that an optometrist had a greater level of agree-
ment with the gold standard grader than the retina specialist ophthalmologist (kappa 0.784 vs. 0.683
respectively). As with all grading scales, the intended outcome dictates it’s suitability; the requirements
for individual one-off grading differ from long-term monitoring; the latter requiring a much greater level
of resolution to detect minor changes which may have little effect on broad classifications.
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Grade I } fundus hypertonicus (mild)
Grade II
Grade III } hypertensive retinopathy (severe)
Grade IV
Stage I
Optic disc Normal; mild hyperaemia
Major retinal vessels Normal; barely detectable light reflex changes
Arterioles Barely detectable narrowing
Precapillaries Normal
Capillaries Visible on optic disc
Venules Mild tortuosity (eventually)
Veins Mild enlargement (eventually)
Parenchyma Normal
Stage II
Optic disc Normal, mild hyperaemia
Major retinal vessels Obvious increased light reflex changes; obvious
narrowing of vessel wall ( focal irregularities)
Arterioles Obvious increased light reflex; obvious
narrowing of vessel wall ( focal / continuous
irregularities)
Precapillaries Narrowed; irregular light reflexes
Capillaries Few peripapillary loops
Venules Mild tortuosity
Veins Mild enlargement (eventually)
Parenchyma Mild haemorrhage; few cotton-wool spots
(eventually)
Stage III
Optic disc Often unclear margins; slightly prominent
(eventually)
Major retinal vessels Mild / severe narrowing and focal constriction;
irregular light reflexes
Arterioles Moderate / severe narrowing; irregular light
reflexes
Precapillaries Narrowed; visible alterations of vessel walls
Capillaries Ectatic (dilated / distended)
Venules Mild tortuosity
Veins Mild enlargement (eventually)
Parenchyma Focal / grouped haemorrhage; cotton-wool
spots; (pre-)thrombosis; capillary bleeding;
hard (circinate) exudates
Stage IV
Stage III + papilloedema; peripapillary
exudates; exudative retinal detachment
(eventually)
Table 7: Neubauer’s modification to the Keith-Wagener-Barker classification. Note that each stage is
sub-categorised by vessel type affected.
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Table 8: Dodson et al.’s prognosis-based classification.
Retinal Signs Systemic Associations
None No detectable signs None
Mild
Generalised / focal arteriolar
narrowing; AV nicking; copper
wiring










Malignant Moderate + papilloedema Strong association with death
Table 9: Mitchell and Wong’s simplified classification.
1.10 Objective Retinal Vessel Calibre Formulae
There have been many attempts to develop an objective method for recording vessel calibre since the
the invention of the ophthalmoscope[35]. Technological constraints were the main limitation and with
the advent of digital image analysis, there was a surge of literature highlighting a number of ways to
measure vessel calibre accurately[1, 35, 109, 110, 111]. The wide variety in vascular patterns with no common
landmark also hindered progress. As well as highlighting the difficulties in suitable vessel selection for
the AVR, Stokoe and Turner also showed the huge variety in vessel distribution amongst humans[87].
The central retinal artery branches differently in people, and whilst it has been argued that the overall
blood volume in the retina is the same for people[112], the way in which the vessels are distributed is not
so consistent[74, 73]. This relationship is analogous to the appearance of trees. Whilst the arrangement
of branches can differ significantly, the one biological constant true for all trees is that they originate
from a single trunk; this is also true for the central retinal artery (and vein); see Figure 10). Since the
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Figure 10: The variable branching pattern of trees is analogous to the retinal vasculature. Note the
varying appearance of the trees (top), but the commonality of a single trunk. The key to objective retinal
vessel analysis lies in taking measurements of the visible branches (dashed lines) and calculating the
dimensions of the parent trunk (or central retinal artery/vein) (solid line).
single-most constant feature of human retinal vasculature are these single parent vessels (central retinal
artery and vein), the logical solution for a population-wide measurement should focus on these vessels
(rather than their highly variable daughter vessels). The difficulty in this approach is the obscuration
of these vessels, since they invariably lie at, or posterior to, the lamina cribrosa and so aren’t not easily
viewed with standard diagnostic imaging equipment. The solution to deriving an objective formula
lies in exploring the relationship between the visible branches of the central retinal artery and vein (as
seen ophthalmoscopically) and the dimensions of their parent vessels. An effective objective method
therefore has two requirements; detailed, cost-effective image capture (i.e. digital fundus photography)
and a standardised routine for vessel calibre measurement (i.e. objective formulae).
1.10.1 Parr & Spears
A breakthrough in objective formulae resulted from the work of Parr and Spears in the early 1970’s[84, 112].
They used the basic relationship between the width of a parent trunk and it’s branches in what is termed
the branching coefficient, where W is the width of the parent trunk, w1 the wider branch width and w2
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the narrower branch width.
Branching coefficient =




The main issue with this calculation for the retinal vessels is that the central retinal artery (CRA)
is often obscured from view on ophthalmoscopy or fundus photography since it bifurcates posteriorly
to the laminar cribrosa. This means that the true width of the CRA (W) has to be estimated instead
(Ŵ). Parr and Spears discovered that there was an inverse relationship between the branch vessel width
asymmetry and the branching coefficient. They established a new relationship between Ŵ, w1 and w2
(with the use of several constants), in the form of a new equation[84]:
Ŵ =
√
0.87w 21 + 1.01w
2
2 − 0.22w1w2 − 10.76
The equation is used for each arterial branch of the CRA until the values are condensed down into a
single value; the central retinal artery equivalent (CRAE). Parr and Spears suggested that the vessel width
measurements should be taken at the point closest to the disc margin where the vessels were a) sharply
in focus and b) level with the retinal plane. As such, the objectivity of their formula is undermined by the
lack of standard location for measurement, as well as vessel inclusion and exclusion criteria; particularly
a minimum vessel width and number of vessels to be included in the formula.
1.10.2 Hubbard et al.
Hubbard et al. used the Parr-Spears equation in the Atherosclerosis Risk in Communities (ARIC) study
and made some improvements to the technique, as a way of addressing the shortcomings described
above[113]. Firstly they defined a specific region from which the measurements would be taken; an an-
nulus between ½ and 1 disc diameter away from the optic disc margin (see Figure 11). Because of the
laborious nature in selecting the correct vessels for the original Parr-Spears equation, Hubbard pro-
posed that the widest and narrowest arteries within the annulus be selected, regardless of whether they
were associated branch pairs. In the paper, an equivalent formula is also suggested for calculating the
central retinal vein equivalent (CRVE), thus giving two formulae:
(CRAE)AŴ =
√
0.87w 21 + 1.01w
2
2 − 0.22w1w2 − 10.76
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(CRV E) VŴ =
√
0.72w 21 + 0.91w
2
2 + 450.05
The generated CRAE and CRVE, as well as giving information specific to each arm of the retinal
circulation, can then be combined to produce an objective AVR (O-AVR). Whilst this analysis cannot
be performed as readily as an ophthalmoscopic examination, it clearly circumvents the major pitfalls
of the original subjective technique. Knudtson and colleagues reported that a drawback of the CRAE
and CRVE equations is that they allow for a variable number of vessels to be analysed[114]. The summary
values generated are likely to be affected by a higher number of vessels used in the calculation. Given
that the distribution of vessels is so variable between persons (as shown by Stokoe and Turner[87]), this
is clearly a source for error. Hubbard’s equations also rely heavily upon the inclusion of constants which
means that the equivalents calculated will be dependent upon the inputted unit (e.g. µm, pixels etc.).
The solution to this lay in rewriting the equations with a simplified approach.
1.10.3 Knudtson et al.
Knudtson et al. proposed to simply restrict themeasurements to the six largest arteries and veins that fell
within the measurement annulus. Knudtson also suggested taking the branching coefficients calculated
from the same dataset that Hubbard used to develop his formula and inserting these into the original
branching coefficient equation. These produced the refined equations:
AŴ = 0.88×
√





w 21 + w
2
2
These latest two equations mean that CRAE and CRVE can be determined with any given input-
ted units, plus the results are less susceptible to physiological differences in vascular tree distributions.
When compared, Knudtson et al. acknowledge that these new formulae result in statistically different
calibres from those derived through Parr-Hubbard formulae (CRAE was found to decrease on average by
-19.7µm whilst CRVE increased by +12.6µm[114]), and AVR was reported as being more in line with what is
‘expected’ at 0.69 (instead of 0.85 as calculated with Parr-Hubbard). A further study has demonstrated
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Figure 11: Measurement zone for objective vessel measurement. (½ - 1 disc diameter)
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that whilst absolute summary values for arteries and veins may be different, calculated AVR remains rel-
atively unchanged provided an equal number of vessels are selected (the authors noted a similar disparity
in AVR depending on formulae used)[115]. AVR has been reported elsewhere as being in the region of 0.73-
0.76 in healthy, non-hypertensive subjects using a different objective approach[116]. Since no single set of
formulae has been adopted as a ‘gold standard’ good practice would suggest recording which formulae
have been applied to derive objective measurements.
1.10.4 Future formulae
Since the objective formulae have been adapted already following Hubbard’s first iteration of them in
1999, it shows that the theory behind the technique is still undergoing evolution. As such, new or
refined formulae are to be expected in the coming years. Researchers from the Singapore Eye Study
have assessed how an extended zone (0.5-2.0 disc diameters) gives similar results to the original ARIC
annulus[117]. The authors state that since a larger section of the vessel is being sampled, the overall
measurement has a greater representation of vascular calibre (although it’s uptake in research has yet to
occur). Adjustments to the formulae themselves has also taken place. The arterial formula has already
been adapted further to account for asymmetrical vessel branching[118]. The authors suggest using a
linear regressionmodel to better account for asymmetrical branching in the arteries, whereas Knudtson’s
formulae was developed using an average branching coefficient. This suggests reworking the formula
individually for each patient, which is a time-consuming process when applied practically. Another
consideration for this approach is that vascular branching can change as a result of pathology (i.e. fractal
dimensions), so would impact this method[119]. The authors state that there was no such association
with the venous branching, which when their separate morphologies are considered, suggests that the
formulae may have to be evolved independently.
1.11 Study Hypotheses and Aims
Optometrists are in a unique position to routinely screen and monitor their patients for signs of both
local and systemic pathologies; examples of the latter often being able to manifest themselves with little
or no symptoms. At present, the NHS runs a ‘health check’ scheme based with local General Practi-
tioners (GPs). Running for those aged between 40 and 74, the scheme is designed to detect early signs
of stroke, kidney disease, heart disease, type II DM and dementia, and is eligible to those without a
pre-existing condition every 5 years. The test comprises of general health and family history questions,
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a blood test, and measurements of height, weight and blood pressure. The scheme is designed to allow
earlier intervention or management through lifestyle changes. All persons meeting the criteria are auto-
matically invited to attend these checks, although it is also possible to request a check[120]. In addition
to this 5-yearly scheme, regular examination by other healthcare practitioners (including optometrists)
has the potential to detect earlier signs of pathology and manage accordingly; particularly given the
increased frequency of appointments (generally every 1 - 2 years). In line with clinical guidelines laid
out by the College of Optometrists, an appropriate history and symptoms will include details surround-
ing any existing cardiovascular disease and/or risk factors such as family history and lifestyle (including
smoking status, alcohol intake etc.,). Also, an adequate examination of the ocular structures will include
observation and interpretation of the retinal vasculature (albeit with subjective means). As more opto-
metric practices become equipped with fundus cameras and Optical Coherence Tomographers (OCTs),
and more emphasis is placed upon inter-professional co-operation of patient welfare, added to the over-
burdened healthcare system and spiralling incidence rates of (co-morbid) cardiovascular disease, it is
hypothesised that an attempt should be made to move away from subjective grading of the retinal vas-
culature by optometrists. This would be in favour of an objective assessment, producing values which
can be integrated with other CVD metrics such as blood pressure and risk calculation in an attempt
to improve sensitivity and specificity of cardiovascular disease detection. Since a standardised object-
ive approach of retinal vessel analysis exists in the research community, it will be evaluated whether
this method can make the transition into clinical practice. This thesis will ask the following questions,
whilst making continued reference to three leading forms of CVD; hypertension, diabetes mellitus and
cardiovascular disease risk / stroke:
1. What are the current associations between objective retinal vessel calibre and CVD reported in the
literature?
2. What is the protocol for using objective retinal vessel analysis in clinical practice? How repeatable
is it?
3. Are the same cross-sectional associations found in a clinical practice as in the literature?
4. How effective/useful is objective retinal vessel analysis in long-term / inter-eye examination period
follow-up of patients?
5. Can objective retinal vessel analysis be used in multi-disciplinary patient healthcare?
48
2 Associations of Retinal Vessel Calibre with Cardiovascular Dis-
ease: A Systematic Literature Review
2.1 Introduction
Since the ARIC study first published the use of objective vessel formulae, there has been a wealth of lit-
erature produced on the subject[113]. The use of the Parr-Hubbard, and latterly Knudtson, formulae has
all but become the gold standard in measuring retinal vessel calibre, and it is this source which will be
used in the subsequent practice-based study. Since objective analysis has not been used in UK optomet-
ric practice, and there is no research documenting its use, it would be difficult to determine a positive
result from using the technology with no real benchmark in practice. Thus, to best demonstrate the
efficacy of objective analysis in an optometric practice, the results obtained in practice will be compared
to those established in the scientific literature. This requires a systematic literature review examining
the findings of large, population-based studies investigating retinal vascular calibre and three key car-
diovascular pathologies; diabetes mellitus, hypertension and stroke, asking the specific question: how
do retinal vessel calibres correlate with these conditions? It can then be demonstrated whether results
obtained in ‘sub-optimal’ conditions (i.e. routine optometric practice) reflect those found in a controlled
research setting. The literature review, therefore, is key to establishing the benchmarks in static retinal
vessel analysis.
2.2 Methods
A systematic search was performed using the academic journal search engines PubMed, ScienceDirect
and Google Scholar for publications dating between December 1999 and August 2019. The searches
aimed to locate papers which investigated associations between retinal vessel calibre and cardiovas-
cular disease. The electronic search produced initial results which were then evaluated manually to
discover those which met the inclusion criteria. Search terms included; “retina*”, “vasc*”, “calib*”, “ves-




Only large cohort studies were included, and their methodology had to include retinal photography,
either on (digitised) photographic negatives or digital images. Since there are no specific criteria that
stipulate when a cohort study can be considered ‘large’, an arbitrary defining value of n = >100 was set
for inclusion. Only papers citing the objective Parr-Hubbard formulae or the Knudtson refinements
were included. Since Hubbard et al. published their formulae in December 1999, this provided the
earliest time frame for the literature search. Papers which used either formulae but only presented data
in the form of AVR were still included (though any inferences to artery calibre changes were noted).
Only papers reporting associations with blood pressure (BP) / HT, DM and stroke were included as were
papers looking at a variety of cardiovascular diseases or pathologies, but still had specific results for any
of these three conditions. Papers located through references within sources used were also included.
2.2.2 Exclusion criteria
Papers referencing further modifications or refinements of the Parr-Hubbard/Knudtson formulae were
discounted since there is not currently widespread uptake; any potential co-founding effects on results
are, as yet, undetermined. Papers referencing retinal vessel calibre but pre-dating the work of Hubbard
et al. were discounted for the same reason. Individual case studies were not included. Similarly, cohort
studies with a sample size smaller than 100 persons were also discounted. Results from meta-analyses
were not included.
2.2.3 Study Selection & Data Processing
Study selection and data processing was undertaken according to the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) Statement[121]. Initial search terms generated a high
volume of results, which required refinement and filtering. This was initially performed based upon
article title. In cases were the title alone did not indicate whether vascular calibre was included in the
methodology, a review of the abstract took place. For those remaining papers, a review of the full-
text was then performed to identify whether the methodology was correct, and published results were




Following a systematic review of the journal search engines and applying the above criteria, a total of
48 papers were included in the subsequent review (the selection process is summarised in Figure 12).
Manual exclusion of papers (n = 21) was principally due to non-standardised methods being applied to
quantify retinal vessel calibre (such as length-to-diameter ratios, subjective grading of arteriolar nar-
rowing or modified Parr-Hubbard / Knudtson formulae), but also included insufficient methodological
information (analysis technique, imaging details) and small sample sizes (i.e. <100). Five studies using
pooled data or meta-analyses were also excluded. The main details for each of the studies, including
country of origin, date and at what stage the ophthalmological focus was incorporated, are summarised
in Table 10. Associations between each of the three cardiovascular conditions are also tabulated below;
for hypertension (Tables 11 and 12), diabetes mellitus (Tables 13, 14, 15 and 16) and stroke (Tables 17 and
18). The results for DM were categorised into sub-groups. Firstly, showing the association between
retinal vessel calibre and incident diabetes / impaired fasting glucose (Table 13). Secondly, the asso-
ciation between retinal vessel calibre in cases of existing diabetes mellitus and progression of diabetic
retinopathy (Table 14); and finally the association between retinal vessel calibre and systemic diabetic
complications in cases of existing diabetes mellitus (Tables 15 and 16).
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* Search terms included: “retina*”, “vasc*”, “calib*”, “vessel”, “diamet*”, “microvasc*”, “hypertens*”, “blood
pressure”, “diabetes”, “diabetic”, “type 1”, “type 2”, “stroke”, “cerebrovasc*” and “cardiovascular”
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.4.1 Association of blood pressure and retinal vessel calibre
Retinal arterial narrowing with increasing BP has been well documented over the past 150 years, and
is arguably the best-understood relationship between retinal blood vessels and a pathology. Prior to
objective assessment, methods for evaluating the retinal blood vessels employed varying degrees of sub-
jectivity, yet still managed to report significant reductions in arterial calibre in cases of HT. This inverse
relationship is also clearly demonstrated with the objective formulae. A strong inverse relationship
between BP and CRAE is shown, with no effects seen with CRVE, in Tables 11 and 12. In this partic-
ular instance, the inverse relationship between BP and CRAE could explain the similar finding with
decreased AVR as Gowers first proposed; however the AVR does not make explicit whether there has
been a narrowing of the retinal arteries or a dilation of the retinal veins[31]. To demonstrate that the
inverse relationship exists across ethnicities, data from several studies around the world were combined
into a meta-analysis[162] . Although each study confirmed the association individually, the meta-analysis
showed that this finding is independent of ethnicity, reporting an overall CRAE decrease of 3.07μm per
10mmHg increase in mean arterial BP. As a general rule, direct comparisons between studies is difficult
for three reasons. Firstly, different methodologies were employed across the studies. Some groups opted
for dilated, stereoscopic photographs (Beaver Dam Eye Study (BDES), Blue Mountains Eye Study (BMES)
and Rotterdam Study (Rotterdam)), dilated fundus photographs (Singapore–Malay Eye Study (SiMES)),
whereas others used dark-adapted, non-mydriatic fundus photography (ARIC, Cardiovascular Health
Study (CHS), Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO), Funagata
Study (Funagata), the Multi-Ethnic Study of Atherosclerosis (MESA) and Thessaloniki studies). The ef-
fect of illumination on the definition of the vessel profiles through these different approaches, and how
it may affect subsequent measurements, has not been investigated. Similarly, BP was measured differ-
ently across the studies. ARIC and MESA, both studies with a focus on CVD, took three readings and
averaged the final two (and also the Thessaloniki study)[135, 131, 113]; BDES, CHS, FLEMENGHO, Rotterdam
and SiMES all took two readings with a 5-minute interval [154, 125, 128, 132, 134], whereas BMES and Funagata
both took a single BP reading [124, 129]. The fewer readings taken increases the chances that individual
subjects may be misclassified, particularly in the cases of single BP readings. Subsequent vessel analysis
also differed between reports. There is equal preference between the studies using both Parr–Hubbard
(ARIC, BDES, BMES, CHS, Funagata and Thessaloniki) and Knudtson (BDES, FLEMENGHO, Funagata,
MESA, Rotterdam and SiMES) formulae. The Rotterdam study added Littmann’s correction factor into
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their analysis – thus their findings are corrected for magnification errors – whereas the remaining stud-
ies did not. Correction formulae are aimed at mitigating the magnification errors that can arise from
including a variety of refractive errors in the dataset. The two correction formulae featured in the liter-
ature reviewed here are the Bengtsson and Littmann formulae. Both formulae were developed for use
with specific camera models, as camera optics differ between manufacturers and models. As explained
in Chapter 3.1.2 (Correction factors), telecentric cameras have an extended depth of field, meaning that
objects at various distances are equally focused on the photographic plane. As such, perspective of depth
is lost. This can be achieved by a number of optical arrangements within a camera system, hence why
the formulae are specific for a certain camera type. Incorrect application of the formulae (for instance,
when a different imaging system is used) has the potential to attenuate otherwise significant findings.
Littmann’s formula was written specifically for a Zeiss Oberkochen camera. The stereo camera used by
the Rotterdam study, although not explicitly named, was not the same camera used by Littmann, thus
the constants within the formula will potentially be meaningless. Also, whilst the majority of refractive
details required for the formula were collected in the methodology, recording of axial length, a key as-
pect of ocular magnification and requirement for the Littmann formula, is not mentioned[163, 164]. The
second consideration to be made when comparing the studies directly is the different environments and
times in which the studies were undertaken. As shown in Tables 11 and 12, the investigations took place
across the globe across a 20-year period, so external factors such as treatment and diagnosis approaches,
as well as genetic predispositions to CVD, must be considered. A final point is the variety of endpoints
reported. There is a clear association between increasing BP and decreasing CRAE; however, the ex-
tent to which these two are linked varies across studies. Those which use a decreased AVR as a sign
of generalised arteriolar narrowing are of particular concern since, as explained previously, an AVR de-
crease does not specify whether the change in vessel calibre has arisen from the arteries or veins. Given
the increasing evidence documenting changes in venular calibre, this is particularly problematic[1]. Per-
haps of most use to the optometrist are the findings reported by the authors of the reports for BMES,
FLEMENGHO, Funagata, MESA, Rotterdam and SiMES. Here, reductions in CRAE in relation to a fixed
increase in BP (10mmHg) are given (and shown in Table 19). This is of particular interest since the defin-
ition of a ‘normal’ or ‘pathologic’ vessel calibre is practically impossible given the wide range of variables
to be considered (age, gender, ethnicity, co-morbidity, etc.). Despite no ‘normative range’ existing, the
results from the Thessaloniki study should be approached with caution since they differ hugely from
those quoted in other studies, possibly suggesting an error in either methodology or reporting (mean
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Table 19: Summary of CRAE changes relative to a +10mmHg increase in blood pressure. (*Meta-analysis
combining data from BMES, Funagata, MESA and Rotterdam studies)
non-hypertensive CRAE and CRVE are given as 91.44μm and 118.88μm respectively)[135]. Difficulty in
defining a ‘normal’ vessel calibre is similar to there being no single ‘normal’ cup-to-disc ratio when ex-
amining the optic nerve head. Similarly to cup-to-disc ratio, vessel diameter changes for an individual
between examinations are far more clinically relevant. In addition, such a value would carry greater
clinical significance with the patient’s BP readings from each examination.
2.4.2 Association of diabetes mellitus and retinal vessel calibre
Diabetes mellitus has several subcategories, each characterised by abnormal or total absence of insulin
function, resulting in a range of signs and symptoms. The classification of DM based on blood serum
glucose levels is widely accepted (see Table 4)[36], although the literature quotes DM status as either
present or absent, rather than on a continuous scale of blood serum glucose, such as with BP. As such,
correlations with DM and retinal vascular calibre are generally quoted in probability scores such as odds
ratio (OR), hazard ratio (HR) and risk ratio (RR). Such ratios are important to clinicians assessing the ret-
inal vasculature. Since retinal vessel calibre could be used to aid diagnosis and management in patients
as well as ongoing monitoring of existing conditions, knowing the likelihood of a particular pathology
being associated with a calibre change is very useful. The associations between retinal vascular calibre
and DM can be broadly split into two categories. The first category encompasses the link between ret-
inal vessel calibre and the future development of DM (or incident DM), whereas the secondly category
includes retinal vessel calibre, existing DM and the complications thereof (including DR, nephropathy,
neuropathy and other cardiovascular events). The exact physiological processes behind diabetic vascu-
lar changes are not fully understood and often contradictory, and this is reflected by an inconsistency
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in the findings of the included literature[1].
2.4.2.1 Incident diabetes The less well-defined correlation between retinal vascular calibre and DM
extends to its development (or diabetogenesis). Both arms of the circulation appear to be implicated,
which further demonstrates the importance of considering artery and vein calibres separately. It has
previously been demonstrated that, with increased levels of glycaemia, vasoregulatory responses are di-
minished, and as such an increase in vascular calibre would be expected in cases of incipient DM [165].
Despite this, the ARIC study reports a reduction in CRAE with incident DM [136]. However, since ARIC’s
findings are inferred through a significant reduction in AVR, and venous calibre changes have since been
partially associated with DM development, the findings should be taken with caution. Perhaps of signi-
ficance is the fact that venous calibre changes only became significant when measurements were correc-
ted for refractive error (BMES and Rotterdam) [140, 90]. Whilst the BMES study used the telecentric Zeiss
FF3 camera (for which the Bengtsson correction formulae were developed) in their methodology, the
camera used in the Rotterdam study, as explained previously, was potentially not the Zeiss Oberkochen
telecentric camera to which the Littmann formula exclusively applies.
The time course of diabetogenesis must also be considered when evaluating the literature. All stud-
ies including incident DM used only the baseline photograph for calibre measurements, despite some
studies (BDES and BMES) taking photographs at each visit. The conclusions drawn from a single data
point when remarking on a change over time (i.e. the development of DM) carry limited weight, since
causality cannot be proven. The significant calibre associations with incident DM may reflect true, pre-
diabetic changes in the vascular architecture, or they may simply signify a natural predisposition to the
condition. This is especially true of those studies which had a follow-up greater than 5 years (Australian
Diabetes, Obesity and Lifestyle Study (AusDiab), BDES, BMES and Rotterdam [137, 138, 90, 140]), where the
time span between baseline retinal photography and diagnosis of DM is greater. By excluding poten-
tially confounding results; ARIC for only inferring a reduction in CRAE, and Rotterdam for potentially
misapplying a correction formula; three papers remain citing a reduction in CRAE as being indicative of
incident DM (AusDiab, BDES, MESA), with only one showing an increase in CRVE (BMES). The findings
of MESA were only significant in the Caucasian population, and since the cohorts for the other stud-
ies were also predominantly Caucasian, the possibility of an ethnic influence cannot be discounted[139].
Disagreement between studies demonstrates both the need for consistency in methodology (whether
or not to apply a correction formula) and further study into the longitudinal monitoring of cohorts for
individual changes. This would have the potential to answer the cause-or-effect question with regard to
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where retinal vessel calibre changes fall within the process of diabetogenesis.
Detection of incident diabetes by the optometrist is difficult without blood samples, and the findings
from studies are not as unequivocal as with BP. Here, an awareness of risk factors and family history be-
comes very important in conjunction with a thorough evaluation of the retina; not just the vasculature.
Understanding that vessel changes for incident diabetes predominantly involve arterial narrowing aids
differential diagnosis, particularly in cases where BP may remain unchanged from previous examina-
tions. Importantly, though, venular changes should not be ignored, and patients should be monitored
and referred accordingly (particularly if they are symptomatic).
2.4.2.2 Existing diabetes mellitus and diabetic retinopathy status The non-linearity between
retinal vessel calibre and DM is less pronounced when connected with DR status. Of the six studies
included, five reported an increase in CRVE with worsening DR status, with none reporting a contra-
dictory decrease. CRAE is less clear cut, with four studies reporting an increase in calibre, and a decrease
only in one. Interestingly, it is the Wisconsin Epidemiological Study of Diabetic Retinopathy (WESDR)
study which reports both a decrease (cross-sectionally[43]) and increase (longitudinally[42]) in CRAE with
increasing RR of DR progression; where the methodology and cohort remain the same. It is therefore
reasonable to suggest that vessels are changing throughout the course of DM, although in this particular
case the WESDR authors fail to quote individual long-term changes in CRVE and worsening DR and so
a single time point for a patient will yield different results when compared to a full time course. For
example it has been shown that, in acute instances of induced hyperglycaemia where retinal arterial cal-
ibre remains static, venular calibre decreases [166]. Whilst this only demonstrates short-term changes in
vascular architecture, these may contribute to long-term effects. From the data included it can be sug-
gested that CRVE increases are correlated with worsening DR, and CRAE increases are also a likely sign
of this. The follow-up study for SiMES (SiMES-2) reported a similar increase in CRAE when subjects were
stratified by DR category. For those considered to have vision-threatening DR (VTDR), CRAE increases
per SD (+11.4μm) were associated with a Risk Ratio of 2.22%; referable DR a Risk Ratio of 1.67% and stat-
istically insignificant correlations below that[143]. No such correlations were observed for CRVE amongst
the same cohort. Changes seen in DM and DR are numerically larger and thus more pronounced than
in HT. BMES state an increase in CRVE of 40.8μm between no DR and severe non-proliferative DR [41].
Such values are of greater significance since the ability to detect these clinically is much more feasible,
whilst others, such as WESDR, which reported an increase in CRVE of 1.07μm per increasing level of
DR, are so small that such an ability to detect these vessel changes clinically is arguably impossible[43].
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Whilst such values may shed light upon the underlying physiology of diabetic progression, their use in
informing clinical decision making is likely to be much less significant.
Interestingly, the Westmead Children’s Hospital (Westmead) study highlighted a statistical differ-
ence in the correlation between increasing CRAE and DR progression between males and females[40].
Although there was no statistical interaction based on gender (p ≤ 0.10), incident DR HRs were 4.39 in
females and 2.44 in males. The cohort was evenly split between males and females (45.6% males); how-
ever there is evidence which suggests females are at higher risk of developing microvascular disease [167].
A direct comparison with the findings of the Westmead study should be performed with caution, since
the average age is considerably younger than the other studies in Table 14 (13.5 years old, compared to
58.07 years (AusDiab), ≥49 years (BMES), 45–84 years (MESA), 29 years (WESDR)), and so age-related,
physiological changes to the vascular tree need to be considered. There is an established DR screening
programme in theUK available to thosewith DM,whereby signs of DR (microaneurysms, haemorrhages,
exudates, etc.) are a method for evaluating stability of the condition as a whole. Retinal vascular calibre
is not yet incorporated into this scheme. Both the presence and progression of DR act as a good surrogate
for the state of DM as a whole. Studies into the prevalence of DR have reported that diabetogenesis can
occur up to 12 years prior to formal diagnosis and/or presence of DR [168]. This reiterates the long-term
effects of DM upon the vascular system. One issue with the literature in Table 14 is the indiscriminate
grouping of both Type I and Type II DM into the same dataset. The authors of the AusDiab study state
that unpublished data showed no significant difference when Type I and II diabetics were compared and
thus the two sets were amalgamated [141]. Similarly, the MESA study made no distinction between the
two types [142]. Whilst the WESDR and Westmead studies both specifically used Type I diabetics only,
based on age of diagnosis (≤30 and 10–12 years old, respectively), the authors of BMES used only those
with Type II DM. Again, BMES based the status of Type II on the age of participants (≥49 years old);
whether those with long-standing Type I DM from childhood were excluded is not made clear. Whilst
there does not seem to be any difference between the two subtypes (for instance, both WESDR (Type
I only) and BMES (Type II only) found a significant increase in both CRAE and CRVE with worsening
stages of DR), the underlying physiology of the two conditions may differ, particularly since Type I DM
onset is predominantly in younger years. Duration of the condition is therefore an important consid-
eration, particularly in older cohorts. Similarly, time of recruitment could also have an influence on
the results. As Nguyen et al. report, to make a direct comparison between two studies such as MESA
and WESDR is potentially confounded by the fact that recruitment and data collection took place 20
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years apart. Treatment regimes and medications, diagnostic techniques and general awareness will have
altered in the intervening years, and this could impact upon how well controlled the DM is. The studies
included focus predominantly upon the earlier stages of DR. BMES, for instance, reports differences in
vessel calibre between no DR and severe non-proliferative DR (i.e. prior to any damaging ischaemia
taking place). Whilst these findings are still sizeable (CRVE increased by +40.8μm), the understanding
of more advanced DR and how vessel calibre changes correlate with this remain less well documented.
Patients with established DM will often have regular DR screening, but this does not mean that a
thorough inspection of the retina and its vasculature is not warranted at routine eye examinations. Un-
fortunately, since both CRAE and CRVE have been shown to increase with worsening DR, these changes
could be lost when performing an AVR. Having accurate measurements for each arm of the circulation
separately is of much greater clinical value, and can only be produced with objective analysis. Given
that DM itself is a significant risk factor for developing HT and CVD, continual monitoring of the retinal
vascular system and systemic BP will ensure that health changes can be detected as soon as possible.
Patient education is also key with regard to the DR screening programme, particularly since other CVD
could manifest in the eye involving parameters not currently measured by the DR screening service, and
so regular eye examinations are still very important.
2.4.2.3 Existing diabetes mellitus and systemic complications Diabetic complications target a
multitude of systemic organs making direct comparison of these problematic. However it can be con-
sidered that the systemic complications arise through a common causality – worsening or progressing
DM. The Fyn County study demonstrated a decrease in CRAE and increased OR of nephropathy or mac-
rovascular disease [146]. This finding was also reported by the Danish Cohort of Pediatric Diabetes 1987
(DCPD1987) study, Pittsburgh Epidemiology of Diabetes Complications (PEDCS) study and WESDR;
all of which correlate a reduction in CRAE with peripheral neuropathy, coronary artery disease and
proteinuria[144, 149, 151, 43]. Additionally, the Diabetes Management Project (DMP) reported a correlation
between reduced CRAE (by unspecified SD increments) with a 66% increased risk of erectile dysfunction
amongst Type II DM males[145]. These reductions in CRAE are most likely attributable to the underly-
ing microvascular pathology (arteriosclerosis) or increased peripheral resistance to blood flow, of which
having DM makes the individual more susceptible, rather than a direct measure of the DM itself. These
findings help to support the theory of an interrelationship between CVD, and that having one (e.g. DM)
puts the patient at greater risk of co-morbidity (e.g. coronary artery disease). DCPD1987, Fyn County
and EDC present their findings in the form of ratios, which are of much greater use to the clinician
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when evaluating the progressive changes of an individual. For instance (as shown by the Fyn County
study), knowing that a 17.4μm reduction in CRAE carries an OR of 2.17 and 3.17 for nephropathy and
macrovascular disease respectively helps to inform and direct patient management. In this case, the
patient is three times more likely to have macrovascular disease compared to a normoglycaemic pa-
tient, potentially warranting further medical investigation. This approach was taken further by Broe et
al., who stratified results by +/-10μm changes in calibre. They also attempted to define cut-off values
of absolute risk, based on Area Under Curve (AUC) calculations, however significance was lost through
small sample sizes[144]. A drive towards clinically relevant cut-off values and risk-based ratios lend them-
selves well into a clinical practice setting. The findings of the Multi-Ethnic Asian Population (MEAP)
study found less significant calibre changes associated with increasing levels of fasting plasma glucose
[147]. The CRAE increase with increasing fasting plasma glucose lost significance when corrected for
CRVE. Venular increase was more statistically significant; however, after similar correction for CRAE,
an increase of +0.51μm per unit increase in fasting plasma glucose is very small, arguably falling below
levels of clinical significance. The stronger findings amongst the Indian population within the study
could possibly be attributed to regional differences in diagnosis and management of DM. Ethnic vari-
ations must be considered, since increased levels of retinal pigmentation will make vessel edge detection
more difficult. It has been shown, however, that iris colour has a greater association with levels of ret-
inal pigmentation than ethnicity [169]. Ethnic variation is highlighted in the MESA study, where the
increase in CRAE amongst diabetics was only reported in the Caucasian cohort, whilst the increase in
CRVE was only amongst the Hispanic and Chinese populations [142]. Genetic variance and susceptibility
are possibilities, as well as environmental factors such as diagnosis and treatment strategies. Although
MESA took place entirely within the USA, different socio-economic groups could still impact upon res-
ults. The New Jersey 725 Study, which had an African American cohort found similar correlations to
those reported elsewhere with Caucasian-based cohorts; namely a decrease in CRAE and an increase in
CRVE. In this case, baseline CRAE was found to be decreased in those with a 6-year incidence of CVD
or Lower Extremity Arterial Disease (LEAD), even when corrected for DR classification, thus suggesting
a vessel change independent of other local changes. CRAE was also reduced for subjects with a 6-year
all-cause mortality when corrected for Mean Arterial Blood Pressure (MABP). Conversely, significantly
larger CRVE at baseline was associated with a 6-year incidence of hypertension (30.3μm) when corrected
for DR classification, and all-cause mortality (31.3μm) when corrected for MABP. These findings suggest
that some of the microvascular changes occur irrespective of ethnicity. Increased RRs of both protein-
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uria and long-term risk of stroke mortality were both associated with increases in CRVE by the WESDR
studies [151, 150]. Whilst increases in CRVE are well associated with numerous aspects of DM (and associ-
ated systemic complications), the underlying mechanisms are still unclear[144, 145, 147, 142, 151, 150]. Dilation
of the retinal veins has been theorised to result from hypoxia and subsequent lactic acidosis [151]. Sim-
ilarly, signs of inflammation through the presence of leukocytes and C-reactive proteins [117, 132, 170] and
endothelial dysfunction [171, 172, 173] have been attributed to the abnormal vascular reactivity. All of these
potential causes for changes in CRVE, whilst visualised and measured at the level of the retina, are almost
certainly taking place in organs throughout the body, hence the correlation between CRVE changes and
increased risk of developing micro- and macrovascular complications. It must also be noted, however,
that it has been demonstrated that venular diameter decreases in episodes of acute hyperglycaemia[166].
Different outcomes between studies make it difficult to give a single sign to look for when relat-
ing retinal vessel calibre to systemic changes resulting from DM. This is confounded by the number of
various endpoints covered by systemic changes, including nephropathy, neuropathy, proteinuria, mac-
rovascular disease, limb amputation and death. As with the other aspects of DM, the awareness that
both arterial and venular calibre can alter following a change in DM status is important. Effective mon-
itoring for patients can be performed on an individual basis, recording BP at each examination as well
as obtaining objective measurements of vessel diameters so that both arterial and venular aspects of the
circulation can be considered and monitored over time in isolation. Focus on risk and odds ratios plus
absolute AUC-derived cut-offs highlight the potential clinical applications of vessel calibre inmonitoring
patients.
2.4.3 Association of stroke and retinal vessel calibre
There is a growing number of papers citing correlations between stroke risk and/or incidence and retinal
vascular calibre. This area is in continued need of further research given the strong anatomical links
between the retinal and cerebral vasculatures (and the comparative ease of imaging the former). In brief,
both vascular beds are responsible for supplying high oxygen demand tissue whilst maintaining a strong
barrier between the blood and its surrounding matter (the blood–retinal and blood–brain barriers).
Anatomically, the two systems share many parallels (as explained in Chapter 1.7. Vascular supply to the
ocular circulation: The Central Retinal Artery)[70]. Post-mortem studies of cerebral haemorrhage and
infarction have revealed that the fibrous and fibro-hyalinoid thickening that occurred in the cerebral
arteries was also evident in the retinal arteries [71]. Given the considerable ease and lower cost of retinal
70
photography compared to magnetic resonance imaging, its use in clinical practice is of great significance
in the detection and prediction of potential cerebrovascular incidents. The data included in Tables 17
and 18 do not reveal a significant trend at first, however consideration of the development of the analysis
technique aids the interpretation of findings. Interestingly, there was the greatest number of manually
excluded papers for this category, particularly those reporting pooled data and meta-analyses.
Earlier studies, particularly the ARIC, BDES, BMES, CHS and WESDR studies, all make reference
to the AVR only, or used changes in AVR as a surrogate for arterial narrowing, reflecting the infancy
of objective retinal vessel analysis at this time [156, 153, 155, 161, 152, 92, 154]. Such measures and assumptions of
venular calibre stasis imply a greater emphasis on, or interest in, the arterial arm of the circulation at a
time when understanding of venular changes was limited. Therefore, any venular changes are likely to
have been missed in these analyses or could result in spurious AVR-related findings. Changes in CRVE,
particularly increases, were generally found when correction was made for refraction. In this partic-
ular instance, however, the ambiguity over the measurements taken and type of camera used means
the use of the correction factor has the potential to attenuate findings. Despite these potential lim-
itations, the Rotterdam study demonstrates a strong association between the retinal veins and stroke
[160, 159, 158]. Whilst there is a significant reduction in CRAE associated with a 12% increased risk of stroke
and intracerebral haemorrhage[158], there is a much stronger correlation between increasing CRVE and
stroke. In fact, Wieberdink et al. reported a 2.5-times increased risk of anticoagulant-related (suggesting
an already compromised cardiovascular system) cerebral haemorrhage, with just a +14.4μm increase in
CRVE amongst the Rotterdam cohort[159]. More recently, Fani et al. associated increases in both CRAE
and CRVE with global reduced brain perfusion and TIA, although interestingly there was no such correl-
ation with ischaemic stroke[160]. This could suggest that dilated vessels pose a greater risk of transient,
rather than permanent, ischaemia. Similarly, the findings of Lindley et al. found the retinal microvascu-
lar changes to be different depending on stroke type; in this case a significantly wider CRVE and reduced
AVR was observed in patients suffering from lacunar stroke when compared to other stroke types[157].
Lacunar stroke occurs when there is an occlusion to a single perforating artery supplying the deep tis-
sue within the brain, and is of particular interest when comparing to the retinal circulation as it affects
the smaller arteries of the brain (40–200μm), making them closely related to those of the superficial
retina; in structure, function and even their diameters. This study also noted that findings were more
pronounced when diabetic patients were excluded from the analysis (odds ratio of CRVE being in the
uppermost quintile in patients with lacunar stroke compared to other stroke types was 1.35 for the whole
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cohort, compared to 2.22 for the non-diabetic sample (66.84% of the whole cohort)), suggesting a dis-
tinct vascular change. Again, the exact mechanisms of such changes are not well understood, but since
multivariate analysis accounted for other CVD risk factors, a true relationship between venular dilation
and stroke is highly likely; larger vessel calibres could reflect maximal dilation leaving no autoregulat-
ory reserve which would normally be employed to increase arterial flow during periods of low perfusion.
These findings demonstrate that further research needs to be directed towards the underlying physiology
of the various subtypes of stroke, but also shows that the retinal vasculature has the potential to play a
key role in this avenue of investigation.
A subsequent meta-analysis has combined the data of both the BDES and BMES studies included
here in an attempt to explore whether a larger dataset would reveal any links[174]. Separately, the studies
revealed few significant data relating to vessel calibre and stroke. When the data were pooled however,
there was a slight increase in HRs for stroke deaths; 1.09 per standard deviation increase in CRVE. Unfor-
tunately, this does not account for non-fatal strokes, the incidence of which could be higher and of equal
clinical value. The authors report that, when the data were stratified by age, significance was attenuated
in the >70-years-old cohort, suggesting an age-related interaction with vessel calibres.
Given the similar anatomical structure shared by the retinal and cerebral vascular beds, optometry
has the potential to enhance screening and monitoring in cerebrovascular pathologies like stroke. It
appears that there is growing evidence to demonstrate that venular changes are of equal (if not greater)
significance when screening for signs of stroke. Consideration must be given to the complex interaction
of cardiovascular diseases, and further work is needed to explore whether retinal arterial narrowing
is truly part of stroke pathophysiology, or an interaction of hypertensive changes which pre-dispose
the patient to future incidence of stroke. This is similarly demonstrated by the findings of Lindley et
al., when diabetic patients were excluded from analysis; demonstrating that there appears to be some
overlap between the conditions and their effects on the retinal circulation.
Optometrists should appreciate that signs indicative of stroke may possibly manifest visibly in the
retinal vasculature. Routine BP measuring, as well as an up-to-date general health and medication list,
all help to highlight cardiovascular risk factors, particularly since a +14.4μm increase in CRVE has been
associated with a 2.5-times increased risk of stroke amongst those taking anticoagulants. Regular ret-
inal imaging of patients is very important, especially if objective retinal vessel measurements are being
recorded, since these allow for much smaller changes in calibre to be detected in individual vessels. The
associations of retinal vessels and stroke show, just as with DM, that the retinal veins should be con-
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sidered with equal importance as the retinal arteries. Since stroke is a single event but multi-factorial in
it’s origins, the use of cardiovascular risk calculations may well be of additional use to identify those at
risk patients.
2.4.4 Conclusions
There are several advantages to having a range of large cohort studies performed in this area. Firstly,
and most obviously, is that the large samples have the ability to reflect trends and associations across
a population, with a higher level of statistical certainty. The collective findings are able to greatly im-
prove our understanding of the physiology of the retinal vasculature and how it responds to pathology.
Secondly, the methodologies employed provide a detailed insight into the general health of the studied
cohorts. Having a wide range of blood tests and other investigations performed greatly supports the
independent associations between the pathologies and changes in retinal vessel calibre. By following up
subjects also helps inform our longer-term understanding of pathological processes, and identifies the
risks of developing particular conditions or complications. Thirdly, the global spread of studies shows
that these findings are not confined to a particular ethnicity or environment. This is particularly true of
the association with hypertension.
There are, however, a number of disadvantages that also need to be considered. Importantly, whilst
values of vessel calibre have been defined which are statistically significant, what values can we deem
to be clinically significant? These are in fact two separate values; whilst changes in the region of 2-5μm
are deemed a significant change in response to a +10mmHg increase in blood pressure, is the method
of objective analysis currently sensitive enough to reliably and repeatedly detect this level of change?
If the margin of error for repeated measures is even similar to these values, then any statistically sig-
nificant change will be lost in the margin for error of the measurement. As such, further research is
required into the actual measurements that are taken to demonstrate that current methods are sens-
itive enough to repeatedly detect such changes. Secondly, the extent of co-morbidity also needs to be
fully evaluated. Given the inter-relationship of conditions such as HT, DM and stroke, the pathological
processes involved in one are undoubtedly likely to affect another, in which case this interaction needs
to be fully explored. Finally, the question of cause or effect needs to be answered. Whilst it is unques-
tionable that retinal vessel calibres change in association with pathology; whether this occurs as a result
of the pathology, or is actually part of the initial cause of the pathology is not fully understood. The
number of excluded meta-analyses due to differing methodologies demonstrates a significant need for
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greater standardisation with the technique to allow for truly comparable findings. The results of the
above studies tell us a great deal about these associations, but actual individual changes over time need
much more attention in future studies. We know that arterial calibre is reduced in hypertensives, but
for an individual does this occur prior to the pressure raising, or as a result of it? Do the vessels of that
individual stabilise with medical treatment, do they continue to constrict or do they return to their ori-
ginal calibre? Whilst we know the answers in a statistical sense for the general population, we still do
not have much evidence on the subject for an individual over time.
The present literature review has also highlighted the need to evaluate the entire cardiovascular pro-
file of a patient. With the interaction between the three pathologies evaluated here, this is undoubtedly
increased when considering a wider variety of cardiovascular diseases. Evaluating a patient’s retinal ves-
sel calibre will need to be supported by an assessment and (quantification) of their overall cardiovascular
health; especially since the technology needs to be used in a predictive rather than retrospective manner.
The variety of findings (decreased CRAE, increased CRVE, decreased AVR etc.,) also suggests that in the
first instance, retinal vessel calibres should be used to simply identify the risk of general cardiovascular
disease, rather than pinpoint the specific condition, allowing for earlier intervention and management.
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3 Materials & Methods
3.1 Image Acquisition
3.1.1 Fundus photography
Whilst images have been acquired of the living human fundus from as early as 1886, it has taken ad-
vances in both optics and image capture methods to make the fundus camera a near-routine instrument
in the optometric practice[175]. The underlying optics of fundus photography is highly complex, and spe-
cific lens systems are not covered in detail by any fundus camera manufacturers for obvious reasons.
Principally however, all fundus cameras consist of a dual-lens system; an initial ophthalmoscope lens
which produces an aerial image of the retina, and a secondary conventional, camera-based lens array
which captures this aerial image (either on photographic film or CCD chip and digitized)[176]. Imaging
the human eye is fraught with problems; the retina is a curved surface and so is not easily imaged on a
flat plane without exposing the image to a large amount of aberrations, both through the imaging system
and the eye itself. The optics of the eye, which contains a number of refractive surfaces and interfaces,
introduces further reflections, aberrations and other image degradations which must be corrected for in
order to produce a high resolution image. As shown by Figure 13 on the following page, a pupil aperture
within the camera prevents excess light being focussed and allows for coincident focus. The curvature of
the fundus can be corrected by using a field lens; a construction of ancillary lenses which aim to focus all
light bundles (which will originate from different points on the curved fundus) onto a single, flat plane.
The resulting aerial image of the fundus can then be focussed onto the camera diaphragm by a second-
ary series of lenses; the photographic apparatus. This ‘flattening’ of the image whilst still retaining focus
is a form of telecentricity; an approach which, whilst ensuring consistent levels of image focus, intro-
duces it’s own series of problems which are considered below in Chapter 3.1.2 Correction factors. The
advent of digital photography in the 1990s meant that fundus cameras could be used more routinely and
efficiently in optometric practice. The time required to get images developed (which meant problems
with imaging were not immediately apparent to the photographer), the issues with storage and recall of
photographic prints and the associated costs were greatly mitigated by digitizing the process[177].
Fundus photography is now widespread in UK optometric practice. The availability of cameras and
particularly the improvement in optics to allow for clear image acquisition in the undilated eye have
meant that the procedure is fast becoming a routine element of the eye exam. It’s ease of use to ob-









Figure 13: Ray diagram illustrating the ophthalmoscope portion of a fundus camera. If all light leaving
the eye through an 8mm pupil is captured, there is no single point of focus; instead producing waists
of light rays. A pupil within the camera reduces the light-ray bundle, resulting in a sharp aerial image
which can then be focussed onto the camera diaphragm by a secondary lens array.
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hospital eye departments delegating the duty to non-qualified ancillary staff[178]. Whilst large cohort
studies predominantly use single photographs in their analysis (see Chapter 2 (Associations of Retinal
Vessel Calibre with Cardiovascular Disease: A Systematic Literature Review) for more detail), optomet-
rists have the major advantage that they have an individual catalogue of photographs for each patient,
spaced over time. Whilst objective analysis is not currently performed by UK optometrists, successful
implementation of the technique would mean that historic photographs for a patient could also be ana-
lysed. Modern non-mydriatic fundus cameras save digital files for photographs, and both full colour and
red free photographs are required for successful objective analysis. In order to preserve as much image
data as possible, photographs need to be saved in the largest (preferably uncompressed) file type, such
as Tagged Image File Format (TIFF), since the compression associated with smaller file sizes causes a
loss of resolution and data.
3.1.2 Correction factors
Whilst the fundus allows for an in vivo examination of the vascular system (particularly for taking meas-
urements), there needs to be consideration for the eye’s optics. Primarily, the measurements made of
the vessels are being made indirectly. This is because a graticule cannot be placed within the eye and
so measurements from a fundus photograph are made from an image on a single plane. This presents
a number of optical influences upon the produced image. Firstly, the object being imaged (the retinal
surface) is a concave surface, presented on a flat plane (either photographic film, or more recently digital
imaging), so is susceptible to optical aberrations. The image is also larger than the object (and depend-
ing upon digital image file format, can be enlarged to a considerable degree). This means any optical
imperfections in the system will be magnified and exaggerated. The dimensions of the eye being imaged
are also important. Axial length and refractive error can both manipulate the final image. Refractive er-
ror (and so indirectly axial length) has been of particular focus for the development of correction factors
in an attempt to standardise analysis of images. Two formulae receive most prominence in the liter-
ature; the work of Bengtsson[179] and Littmann[180]. Both formulae, however, are only applicable if the
photograph is taken on a telecentric fundus camera. In short, telecentric camera systems use an array
of lenses to enhance the depth of focus, resulting in a range of depths being in focus simultaneously[181].
The principle of telecentricity is shown in Figure 14.
This is particularly important for a retinal photograph as it is a concave surface being imaged. An ex-





Figure 14: Telecentric image focus. a) shows a telecentric image, with both objects equally in focus. b)
and c) show how conventional cameras are only able to focus one object at a time. Note that depth
information is lost with a telecentric image.
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and centre of the cup are equally in focus despite being at different distances from the camera. This ba-
sic optical problem can be combatted by various lens setups within the imaging system, with telecentric
lenses being just one example. As such, for the Bengtsson or Littmann factors to be used correctly, it
first must be confirmed that the camera used is indeed telecentric, and that the use of any constants
apply specifically to the individual camera model. If not, any ‘corrections’ will potentially attenuate
findings. The Rotterdam study is one such large-scale study investigating vessel calibre to acknowledge
the potential need to use correction factors to their data[140, 133, 182, 158]. Unfortunately their camera (an
unspecified Topcon stereo-fundus camera) was potentially not telecentric in design. The authors of the
Rotterdam papers reference Littmann’s original paper outlining his formula, however it is not directly
stated in the original Littmann paper that there is the inherent need for the system being used to be
telecentric. The Rotterdam study did not use a Zeiss Oberkochen camera like the one used by Littmann
and as such, the constant value given by Littmann (which is specific for the Oberkochen camera alone)
will be meaningless when applying it to the stereo-images acquired for the Rotterdam study. This has
the potential to attenuate any significant findings. The Blue Mountains Eye Study however, did use a
telecentric Zeiss FF3 fundus camera for their imaging[85], and so the use of a telecentric-specific formula
(Bengtsson) is justified (despite their showing refraction had no effect on the measured outcome).
The large population-based studies make reference to the use of correction factors in their analyses,
and this is indeed necessary when comparing data across a population to find a common outcome. How
relevant this is for use in everyday optometric practice is debatable. This would depend upon what the
vessel measurements would be used for. If an individual’s CRAE and CRVE were measured and were to
be compared against a pre-defined ‘normal’ then correction for ametropia would be required. However,
CRAE and CRVE is more likely to be used to monitor an individual patient case in optometric practice.
Just as optic nerve head analyses can be used to monitor for signs of incipient glaucomatous optic neuro-
pathy, a comparison of individual data against a ‘normal’ population is of limited use. Greater insight
for the clinical management of a patient will be in the long-term individual changes in vessel calibre.
Since the range for clinical ‘normal’ is so widespread, individual changes in vessel calibre (which may be
clinically significant) may still fall within what is considered ‘normal’. Taking the studies linking vessel
calibre and hypertension as an example, those providing ‘normal’ data as a comparison (i.e. normotens-
ive subjects), the combined normative data covers a range of 53.9μm[133, 122, 124]. ‘Normal’ therefore covers
a wide range, and since the same studies quote clinically significant changes in vessel calibre as values
less than 10μm, this can be problematic.
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When interpreting the results for an individual over time, there is much less need for correction
factors since the magnification effects will be less changeable. There are of course instances when this
will not be the case, particularly with laser refractive surgery and intraocular lens implants. In both
cases there will be considerable changes to the optical parameters of the eye, and as such a conversion
for ‘before’ and ‘after’ may indeed be necessary. Since the formulae require such measurements as axial
length (not routinely recorded by optometrists), the practical execution of these corrections in practice
may still only be a theoretical consideration.
3.1.3 Fundus photography protocol for current study
For the following studies, a Topcon OCT Maestro was used for data collection:
• Chapter 4. Repeatability and Variability in Objective Static Retinal Vessel Calibre Measurement
(page 100)
• Chapter 5. Correlations Between Retinal Blood Vessel Calibre and Cardiovascular Metrics Ob-
served in Optometric Practice (page 116)
• Chapter 6. Longitudinal Changes in Retinal Blood Vessel Calibre Observed Between Routine Op-
tometric Eye Examinations (page 140)
The Maestro is able to take 45º colour photographs under non-mydriatic conditions, also taking simul-
taneous OCT scans. Full-size colour and red-free optic nerve head-centred photographs were exported
as TIFF files; the largest, uncompressed format available. Since photographs were exported and analysed
at a later date, patients could not be recalled for dilation, thus giving a reliable indication of what image
quality could be analysed. Topcon recommend a pupil size of 2.50mm or greater[183]. Patients had their
pupils measured prior to imaging to ensure that their pupils were of adequate size. Those with smaller
pupils were offered the opportunity to rebook and receive pharmacological dilation.
Patients were seated in a room and dark adapted for a minimum of five minutes prior to the images
being taken. Images were taken according to the instructed procedure in the equipment’s documenta-
tion and any settings changed as suggested (i.e. small pupil function enabled when prompted). Patients
were encouraged to keep their eyes closed for several minutes in between image capture of each eye.
Photographs were reviewed for general quality at the time of acquisition, and if they were deemed too




Selection of blood vessels from a 2D image can be achieved through a number of computational al-
gorithms, and the process is not restricted to determination of vessel calibres only; branching patterns
and angles, fractal dimensions and vessel tortuosity all utilise vessel segmentation algorithms. The
method of vessel selection can vary between programs, but retinal vessel-based algorithms have been
broadly categorised into one of six categories; pattern recognition, matched filtering, vessel tracking,
mathematical morphology, multiscale approaches and model-based approaches[184]. Vessel segmenta-
tion and selection from images is not confined to ophthalmology, and so algorithms and approaches
have a number of applications with both 2- and 3-dimensional images[185]. Selection of retinal blood
vessel edges poses additional issues over simply skeletonising the vessel tree. An ‘optimally’ illumin-
ated retinal blood vessel will have a Gaussian function cross-sectional intensity profile. For retinal veins,
there is a more obvious hue and contrast change with the surrounding retinal tissue. However this is
less apparent with the arteries, and is further confounded by an often prominent central reflex, result-
ing in a double-Gaussian profile. There is no one cut-off point for identifying the edge as a point on the
Gaussian function, rather it is often defined as occurring at the local gradient maximum or minimum;
i.e. the point of maximal contrast on the function[186]. Cross-sectional intensity profiles are illustrated
in Figure 15.
As an experimental variable it is a theoretical consideration when interpreting findings, however it
is a factor controlled by the software designers.
3.2.2 Software available
As uptake of objective analysis has increased in research, a number of software platforms have emerged
which allow users to analyse retinal photographs and extract such details as vessel calibre. The software
packages vary in terms of analysis features and output as well as accessibility. On a basic level, it is pos-
sible to use freeware image editors such as ImageJ. Here, images can be imported and custom algorithms
applied to extract vessel widths, and the approach has very good agreementwith existing semi-automatic
analysis software (Spearman correlation 0.90)[187]. Whilst this approach is cost effective, both it’s lim-
ited capacity and laborious nature make it an impractical option for mass screening. There are also more














Figure 15: Cross-sectional vessel intensity profiles. Artery profile is shown in red (note the double-
Gaussian peak corresponding to the arteriolar light reflex), and vein profile is shown in blue. Intensity
profiles (solid lines) traverse the vessel perpendicular to it’s centreline (dotted line).
are VAMPIRE (Vessel Assessment and Measurement Platform for Images of the REtina), ARIA (Auto-
mated Retinal Image Analyser), QUARTZ (Quantitative Analysis of Retinal Vessel Topology and Size),
VesselFinder and RISA (Retinal Image multiScale Analysis)[188, 186, 189, 190, 191]. RISA and VesselFinder have
both been trialled in studies into retinopathy of prematurity. The authors of VesselFinder report that the
algorithm responsible for determining vessel diameter produces only an average width measurement,
rather than a collection of measurements along the vessel length. Whilst the authors of ARIA cite this as
a potential issue, measurements taken for determining CRAE and CRVE only require an average calibre
for each branch which is then fed into the objective formulae. The advantage of all of these packages
is that they are freely available to download, and so the costs incurred to the optometrist are relatively
low. A downside to these packages are their (current) lack of widespread use, so their reliability and
reproducibility have not yet fully been explored.
The final group of software packages are the commercially available platforms. IVAN (Interactive
Vessel ANalysis) and RA (Retinal Analysis), both based in Wisconsin, US and SIVA (Singapore ‘I’ Vessel
Assessment), based in Singapore, are the three software platforms most commonly referred to with the
large cohort studies. Whilst images can be sent to the centre in Wisconsin for analysis, it is possible to
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purchase a license for SIVA. Such software, given it’s extensive coverage in the academic literature, has
the advantage of being internationally recognised and it’s reliability much more robust. Other organisa-
tions offer software for purchase (to be used in clinical practice or research), and these include Imedos’
VesselMap (Imedos Systems, Jena, Germany) and vito’s iFlexis (Belgium).
Whilst vessel selection algorithms may differ, the general principle for establishing vessel calibre
remains constant and is summarised in Figure 16. A section of vessel is selected (within themeasurement
annulus; see Figure 11) and the software then takes multiple edge-to-edge pixel measurements along the
section which can then be converted into µm if required. A limiting factor is therefore, especially with
digital image acquisition, the pixel resolution of the imaging system (see Figure 17). From this, an average
width is generated for the vessel section and this value is then used in subsequent analyses. A worked
example in Figure 18 shows how a number of vessel width measurements produce an average with a
very low standard deviation (1.08µm) and coefficient of variation (1%). Software has internal criteria
regarding the minimum length of vessel that can be used, although it is not vital that the entire width
of the annulus is selected. It is worth noting that whilst this approach helps to quantify vessel calibre
(and therefore phenomena such as GAN) it does not account for local changes, such as Focal Arterial
Narrowing (FAN).
There is currently limited evidence comparing the outcome fromdifferentmeasurement programmes.
A detailed study by Yip et al. concluded that the measurements from three leading platforms (SIVA,
IVAN and RA (Retinal Analysis)), whilst they differed in their absolute measurements of vessel calibre,
all retained the same systemic associations (including age, blood pressure, BMI, cholesterol and glucose
levels)[192]. This finding was echoed by McGrory et al. who evaluated a wider range of vascular para-
meters (vessel calibre, tortuosity and fractal dimension), but suggest there is less agreement between
software measurements and systemic associations[193]. It should be noted that the more general meas-
ures with clinical applications such as blood pressure and glucose levels, produced the same associ-
ations regardless of software. The implication being that more detailed measures (such as c-reactive
protein, interleukin-6 and carotid intima-media thickness) require further investigation into software-
dependent bias, with more general measures producing repeatable results.
3.2.3 Image analysis protocol for current study
As a commercially available platform but which has also been referenced in the literature, VesselMap







Figure 16: Vessel selection and measurement. Once a section of vessel has been marked, multiple edge-
to-edge pixel measurements are taken, converted into micrometres (µm) and averaged to give a single




Figure 17: Image resolution as a limiting factor for determination of vessel edge. Splitting an image down
into a grid pattern (for illustrative purposes larger than actual pixel size), the sampling of the vessel edge


















Figure 18: Worked example of vessel width measurements. For a section of vessel, a number of widths
have been taken (inmicrometres; µm) and themean, standard deviation (SD) and coefficient of variation
(CoV) calculated and shown.
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academic literature at the time of study design and would therefore have required an extensive repeat-
ability study prior to it’s application. Exported images (in TIFF format) were imported into VesselMap.
Only red-free images were analysed. Colour photographs were used for reference to ensure arteries and
veins were selected correctly. Having set the designated grading area (see Figure 11), arteries and veins
were selected. In order to facilitate future comparisons of individual vessels, a clockwise protocol was
adopted, selecting the first artery and vein above the 9 o’clock position on the photograph, and working
around from that vessel. Prior to vessel selection, a visual inspection to ensure the correct number of
paired vessels could be selected was performed (i.e. to not end up with an unequal number of arteries
and veins selected). The individual vessel calibres and a reference screenshot of the selected vessels were
then exported for statistical analysis. Contrast enhancement was only used when a vessel was visible on
the photograph but could not be selected by the software. In such cases, a note was made in the results
that contrast enhancement had been employed.
3.2.4 VesselMap protocol
Retinal vessel analysis as performed in VesselMap is a straightforward process. First, the patient details
(name, date of birth and eye(s) imaged) are entered into the system and, if an external imaging system
is used, the photographs imported into patient record. In order for analysis to be performed, the image
must be imported in it’s red-free format to allow maximal contrast of the vessel edge. As part of this,
properties of the image itself are also input; including the camera used and the size of image in degrees.
Next, the image is opened in the analysis tab. At this point, the software will internally flag up images
which are deemed not suitable for grading (if the contrast is too high or too low). The grader is prompted
here whether they wish to proceed anyway as it is possible to adjust brightness and contrast of the image
within VesselMap, as well as select vessels manually.
The first step of analysis is the placement of the optic disc zone over the patient’s optic nerve head
(although the software automatically positions the zone over the disc, meaning the grader has to simply
check that it is correctly positioned). Since VesselMap employs the original Parr-Hubbard formulae,
an optic disc zone of a fixed diameter equivalent to 1850µm as specified in the original paper[113]. In
subjects with a larger visible disc, the zone is placed as close to the geometric centre of the disc as
possible (similarly if the disc is actually smaller than the 1850µm ring). This differs from other analysis
packages which require plotting of the disc margin manually (either on a point by point basis or an
adjustable circle). Whilst this latter approach reflects an individualised, relative measurement (i.e. the
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zone equates to the individual’s own disc diameter), the original Parr-Hubbard approach ensures a more
standardised location and lacks the need to subjectively define where the disc margin lies (a particular
issue in those with indistinct margins). This is of particular benefit in subsequent analyses of the same
person, as the measurement zone needs to be consistent across images.
Once the disc zone is placed, the measurement annulus automatically positions itself and the grader
is then prompted to select all arteries within that zone. This is done by simply clicking on any part of
the vessel which travels through the measurement zone and it is not possible to select vessels which
fall outside of this. Edge detection algorithms then select the whole vessel as it runs across the meas-
urement zone. The Parr-Hubbard (and Knudtson) formulae are derived from the trunk vessel rather
than branches, therefore if a vessel branches within the annulus, only the trunk should be selected. The
exception to this is given as if the trunk extends only briefly into the measurement zone; in which case
the two daughter branches should be selected instead. The selected vessel then appears in the data table
next to the image, with a unique vessel number and it’s measured calibre (in µm). Assessing the selected
vessel, the grader has several options:
a) The vessel has been correctly selected and measures more than 40µm: no action required.
b) The vessel has been correctly selected but measures less than 40µm: vessel deselected and not
included in analysis.
c) The vessel has been correctly selected but extends beyond a branching within the measurement zone:
region of vessel selected needs to be reduced to a point before vessel branching.
d) The vessel selection extends onto the retina (often an underlying choroidal vessel): vessel needs
reselecting, or vessel edge needs to be defined manually.
e) The vessel has not been selected (generally due to poor contrast with neighbouring retina): vessel
edge needs to be defined manually.
Manual selection of the vessel involves a calliper being placed at one edge of the vessel (the software
automatically zooms in to give a much better assessment of the vessel boundary) and dragged across the
width of the vessel. Following this, the software will either use this measurement singly, or it will try to
employ edge detection either side of the calliper to select a section of vessel. All of the arteries within the
annulus are selected and once this has been completed, all of the veins can then be selected in the same
fashion. The software colour codes selected vessels to aid identification (red for arteries, blue for veins,
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and grey for vessels where type is unclear). Once all of the arteries and veins are selected, the grader can
select the option to calculate AVR and the formulae are run on the vessels selected. An AVR is overlaid
onto the image, and the tabulated vessel measurements (numbered and identified as either arteries or
veins) can then be exported into spreadsheet software for analysis, including the calculated CRAE and
CRVE measurements. Reports can also be generated at this point to plot changes and correlate with
normative data (as shown in Appendix 6. VesselMap Report).When subsequent visits are to be analysed,
the software prompts the grader to use the previous selection, and will both automatically position the
measurement zone and reselect the same vessels. This then allows for comparative measurements to be
acquired and greatly reduces the analysis time.
In total, from the moment of image import to the generation of summary measurements, the analysis
of an image takes in the region of 2-3 minutes, depending on the complexity of the vessel arrangement
(particular care has to be taken on tortuous and crossing vessels) and the contrast and reflex of the
vessels. This contrasts to the original ARIC approach which cites analysis of an image can take approx-
imately 10-15 minutes per eye[113]. Similarly, the iFlexis platform (which employs the Knudtson formulae
instead) allows for quick analysis and is perhaps better suited to batch analysis. Here, the grader imports
a spreadsheet populated with patient names and the file extensions of the images they wish to use. The
images are imported in full colour and the software again automatically places the optic nerve head ring.
Here, however, the grader will check the positioning in each image, but can also adjust the size of the
ring to reflect different sizes of optic nerve heads. The measurement zone then corresponds to the indi-
vidual’s optic nerve head diameter, rather than the fixed value as specified by ARIC. iFlexis has a greater
level of automation as it then pre-selects the vessels and defines them as arteries or veins. The grader
simply has to check each image a second time to verify that all vessels have been selected and correctly
identified by type. Whilst all vessels are selected, by definition the Knudtson formulae only makes use of
the 6 largest vessel measurements, but this can be based numerically rather than subjectively choosing
the six largest. Using a full colour image allows for an easier identification of arteries and veins, but also
potentially retains maximum image resolution too (since red-free images tend to simply have extracted
the red channel, thus removing 1/3 of the image). Whilst iFlexis requires a double-pass check on the part
of the grader (first for disc position and size, second for vessel selection), both are confirmatory checks
on automated selection and so allow for large batches of images to be measured in a shorter period of
time (per image is in the region of 1-2 minutes).
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3.3 Sample size and patient recruitment
Determination of an adequate number of subjects required to make statistically robust conclusions is an
important consideration. This is particularly relevant if conclusions are to be made against previously
reported findings and comparisons made. As much as the research question may be to establish whether
a particular reported finding was similarly observed in optometric practice, it is of equal importance to
establish whether the cohort study possessed the robustness to significantly demonstrate this.
To determine a sample size, several key factors have to be considered[194]:
• Statistical power: the ability of a test to detect a true / positive difference against a control or null
hypothesis; a true positive. This is generally given as 80%; which is to say that the test is accurate
in four of 5 cases.
• Statistical significance: this is essentially the opposite of power in that it is the level at which
a true / positive difference is reported when no such difference exists; a false negative. Reported
as the ‘p value’, these are generally set at 5% (p = 0.05) as ‘significant’ or 1% (p = 0.01) as ‘highly
significant’.
• Prevalence rate: this is sometimes referred to as the ‘underlying population event rate’, and is
not determined by convention as with the previous two factors. Generally, prevalence is determ-
ined through the findings of previous studies but care must be taken as differences in samples
or methodologies may mean that the two are not directly comparable. Some studies will re-run
calculations throughout a study to ensure that changes in event rate are considered.
• Expected effect size: this is the amount that the study sample is expected to differ from the
control or null hypothesis. This factor has a great impact on the calculated sample size as there is
an inverse relationship between them; the smaller the effect size, the larger the sample required
to detect it.








• Zαis related to statistical significance and whether the effect is expected to be one- or two-tailed
[this value is obtained from pre-calculated tables].
• Z1-βis calculated based on the statistical power [this value is obtained from pre-calculated tables].
• σ is prevalence rate as determined through previous studies and work [this is calculated from the
estimated standard deviation of measurement(s) taken]
• Δ is the expected effect size in decimal form [this too is derived from previous work, however
consideration must be given for differences in samples used].
3.3.1 Sample size for the present studies
As the present studies are observational, it becomes problematic to determine an adequate sample size.
This is further compounded by the wealth of evidence to demonstrate that vessel calibre changes are
multifactorial, and even with three discrete pathologies it is difficult to determine clear-cut correla-
tions. A further issue is the disparity between clinical and statistical significance. For instance, the
literature review has demonstrated that vessel calibre changes specifically in relation to +10mmHg in-
creases in blood pressure are within the region of 3-5µm; yet the sensitivity of measurements may not
be of sufficient detail or accuracy to record this.
Whereas correlations for HT are perhaps more straightforward, with arterial calibre and blood pres-
sure as the two measurements, other conditions such as DM and stroke have a number of metrics con-
tributing to their development, and as such would require a multitude of sample size calculations to
factor these in. With respect to an observational study, it is not possible to foresee all possible co-
morbidities and influences upon vessel calibre which renders determination of sample size difficult.
The potential disadvantages of a lack of sample size calculation should not be discounted however,
and need to be borne in mind when interpreting findings from such these studies. Since no previous
studies have been undertaken in UK optometric practice, any findings of statistical significance can
first be compared with previously established correlations (as reported in the Chapter 2. Associations of
Retinal Vessel Calibre with Cardiovascular Disease: A Systematic Literature Review) to look for signs of
general agreement, but they will also highlight areas of further study to be undertaken within similar
conditions. Narrowing down the scope of study will then make calculation of sample size more feasible
and carry greater insight.
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3.3.2 Patient recruitment
The sample enrolled in the present studies were recruited from a single, independent practice based
in Leicestershire (Davis Optometrists, Market Harborough). Patients were initially notified of the pro-
spective study upon point of appointment booking, as the practice adopts a pre-arranged appointment
system. The study was mentioned and additional information was given if required. Upon arrival for
the appointment, patients were given a further opportunity to raise questions with the principle invest-
igator (CF). Informed consent was then given prior to the examination taking place, but patients were
advised that their routine examination would take place regardless of consent being given. Consent was
reaffirmed at any subsequent examination, and patients were allowed to withdraw themselves from the
study at any time.
The restricted locality and ethnicity (Market Harborough is a predominantly Caucasian neighbour-
hood) is advantageous in that it reflects the geographic variance in health as calculated by the QRISK
algorithms. It does, however, potentially limit the nationwide applicability of findings since it is restric-
ted to a single locality with a predominant ethnicity.
3.4 Additional ocular parameters
3.4.1 Tonometry
Fluid dynamics have demonstrated that there is a correlation between the intraocular pressure (IOP)
and rate of ocular blood flow (OBF) within the eye[196]. There is also longitudinal evidence which sug-
gests that decreases in both CRAE and CRVE is associated with increased risk of developing glaucoma
over a 10-year period (77% per -15.1µm for CRAE and 33% per -22.4µm for CRVE)[197]. This suggests initial
vascular changes prior to clinical detection of glaucoma, since a cross-sectional correlation has been es-
tablished previously[198, 199]. Considered the ‘gold standard’ in IOP measurement, contact tonometry in-
volves physical applanation of the corneawith a gradually increasingweight until it is coincidentwith the
outward pressure from within the eye. This requires the additional use of a single-use applanator head,
topical anaesthetic and staining agent (sodium fluorescein); all additional costs for the practitioner. Ad-
ditionally, the technique is not always possible on patients unable to be seated at a slit lamp; however
a hand-held equivalent (Perkins tonometer) is available which correlates strongly with Goldmann [200].
Non-contact tonometry (NCT) is a widely used surrogate for contact (Goldmann) tonometry in opto-
metric practice, with 78% of optometrists using it as their primary source of intraocular pressure meas-
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urement (whilst only 16% use contact tonometry as their routine method), and 68% of pressure-related
glaucoma referrals contain NCT-derived measurements[201, 202, 203]. In short, the technique involves a
measured impulse of air being directed towards the cornea whilst an illumination system produces an
image upon the cornea. As the pressure increases to an extent which distorts the cornea, this reflected
image is changed on the photodetector array within the instrument. At this point of distortion, the in-
strument samples the pressure of air being released by the instrument and determines the intraocular
pressure[204]. Despite the most recent update of the NICE Guidelines for glaucoma referral stipulating
that IOP must be measured with applanation tonometry, the correlations between non-contact tono-
metry and applanation tonometry are very high[205]. Corneal thickness and curvature is known to affect
both methods, however NCT has been shown to yield higher results compared to applanation tonometry
in patients with increased corneal thickness[206, 207].
3.4.1.1 Tonometry protocol for current study Intraocular pressurewas recorded as a routine aspect
of the eye examination. Non-contact tonometry was performed with a calibrated Keeler Pulsair 3000 in
reduced room illumination and the patient seated. Three readings were taken of each eye and averaged
for subsequent analysis. In cases of IOP reading above 24mmHg repeatedly, patients were re-assessed
with Goldmann applanation tonometry (and referred according to NICE guidelines if pressure was found
to be continually high[205]). Corneal thickness was not measured during the study.
3.4.2 Refraction
Associations with particular groups based on refractive status (e.g. myopia) have been explored pre-
viously, although have not always shown a significant association[208, 209]. Correction for magnifica-
tion aberrations induced by refractive error is theoretically possible (see above; Section 3.1.2 (Correction
factors)), however is not always possible due to the imaging system being used and the availability of
additional ocular measurements.
3.4.2.1 Refraction protocol for current study A complete subjective refraction was completed on
all participants. This was recorded for each visit in terms of a sphero-cylindrical prescription which was





The measurement of blood pressure is key to monitoring cardiovascular health, and is a measurement
easily performed in the consulting room. Whilst the mercury sphygmomanometer is still considered the
gold standard (despite being outnumbered in UK GP practices by their digital equivalent 4:1[210]) it’s use
is being phased out under an EUdirective surrounding their containingmercury[211]. Also the practicality
of performing this technique quickly and repeatedly on all or most patients seen in practice is problem-
atic and time consuming. As such, simpler devices such as oscillometric (digital) sphygmomanometers
provide a method of quick and (generally) reliable assessment of blood pressure, including over other
devices such as aneroid sphygmomanometers[212, 210]. Briefly, an aneroid sphygmomanometer amplifies
the pressure changes in the constricted blood vessel bymeans of a series of gears connected to an external
dial showing the pressure reading, whereas an oscillometric device contains a transducer which detects
the pressure wave within the compressed vessel and uses an internal algorithm to determine the points
relating to cardiac systole and diastole, thus negating the input of an observer[213]. Guidelines relating
to accurate, diagnostic determination of blood pressure recommend measuring pressure in the brachial
artery of the upper arm, although it is possible to determine blood pressure from other locations[23].
Inter-arm differences in systemic blood pressure are widely acknowledged but not fully appreciated in
clinical practice[214, 215, 216, 217]. A recent UK-based study reports a ‘significant improvement’ in that 52%
of practices interviewed measure inter-arm difference as part of hypertension diagnosis[17]. Of particular
note is that the origins of the inter-arm differences are relatively unknown; it is not merely a case of the
left arm being closer to the heart. Neither the NICE or JNC guidelines for hypertension specify an arm to
record blood pressure from, however NICE and AHA both advise that when formally diagnosing hyper-
tension, blood pressure readings should be obtained from both arms[23, 218, 219, 212]. A recent, UK-based
study of blood pressure measurements taken in primary care identified that significant inter-arm dif-
ferences occur in a minority of patients, although incidence increases in the presence of cardiovascular
pathology[220].
3.5.1.1 Sphygmomanometry protocol for current study In accordance to guidelines, blood pres-
sure was recorded following more than five minutes of being seated. To ensure a maximum period of rest
had been attained, the blood pressure readings were taken at the end of the eye examination. This also
ensured that a good patient rapport had been established and all other tests had been completed which
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may cause the participant undue stress or apprehension (particularly non-contact tonometry). Patients
were instructed not to talk whilst the measurements were being taken. Three readings were obtained;
each interspersed with a minute interval, on a digital oscillometric sphygmomanometer (A&D Medical
UA-767). Arm selection was governed by the configuration of the consulting room, with the sphygmo-
manometer positioned to the right of the patient, however in line with NICE and JNC guidelines, this
was not deemed a critical factor. The first reading was discounted and an average of the second and
third readings was used in subsequent analysis (in line with other cardiovascular studies).
3.5.2 Pulse Oximetry
Pulse oximetry (PO) is a quick, non-invasive test that can easily be performed in practice with relatively
little training. An awareness of the instrument, its methods and its drawbacks is a vital part of using
the instrument effectively in practice. The pulse oximeter is a simpler version of the laboratory-based
multi-wavelength co-oximeter, often considered the ‘gold standard’ for oximetry measurements[221]. A
blood gas analyser requires actual blood samples to determine oxygenation levels, so the pulse oximeter
is advantageous in that it provides a non-invasive instantaneous reading[222]. A pulse oximeter uses light
of known wavelengths to penetrate through a cutaneous vascular bed such as the earlobe or finger in
order to give the level of oxygen saturation in the bloodstream. In-depth discussions on the theory be-
hind pulse oximetry have been published elsewhere[221, 222]. Essentially, light (typically in the red/near-
infra-red portion of the spectrum) is transmitted at two wavelengths, designed to be at the peak of the
absorption spectrum for either oxyhaemoglobin (O2Hb) or reduced (deoxy-) haemoglobin (Hb). The
wavelengths – generally 660nm (where Hb absorbs light approximately ten times more than O2Hb) and
940nm (where O2Hb absorbs more than Hb) – have the added benefit that they are able to penetrate
tissues deeper than other parts of the visual spectrum. A comparison of the transmission data for the
two wavelengths can then be used, by route of a ratio between the signals, to determine a level of oxygen
saturation, or the functional saturation. The pulse oximeter is limited in it’s ability to give precise levels
of oxygen saturation because of it’s method of sampling. The co-oximeter as well as measuring levels
of O2Hb and Hb also measures two other substances; carboxyhaemoglobin (COHb) and methaemo-
globin (MetHb), giving fractional saturation. In a young, healthy, non-smoking individual, the levels
of both COHb and Hb are minimal (less than 1%), hence the pulse oximeter works as a good screening
instrument; operating on the assumption that of the four components, only O2Hb and Hb are present
in significant levels. However, both COHb and MetHb interfere with the readings generated by a pulse
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oximeter as they also interact with the transmitted light wavelengths. This means that in case where
there is excessive COHb (particularly in heavy smokers) or MetHb (through pharmaceuticals such as
anaesthetics or nitrates), the reading generated by a pulse oximeter may not be a true reflection of the
levels of oxygen in the bloodstream. COHb absorbs light from the 660nm source similarly to O2Hb and
so if present in supra-normal concentrations in the bloodstream, can lead to an over-estimation of oxy-
gen saturation on the pulse oximeter. MetHb has a similar absorbance of 660nm to Hb, but crucially it
also causes a greater impedance of the 940nm source. This has an additive effect at driving the overall
ratio of signals between the two sources towards one, thus giving an under-estimation of the oxygen
saturation level.
Other artefacts present in the bloodstream can also influence pulse oximetry readings. Patients with
hyperbilirubinaemia will have higher levels of COHb due to an increase in carbon monoxide produced by
the breakdown of haemoglobin. Intravenous dyes can also reduce oximetry measurements. Methylene
blue can reduce levels to as low as 1%, though dyes encountered in optometry are much less (indocyanine
green) or even negligible (fluorescein)[221].
In an optometric setting however, where the oximeter would simply be an auxiliary measurement,
these drawbacks and limitations are of limited significance, but an awareness of the potential pitfalls is
undoubtedly necessary, particularly in key patient groups, e.g. heavy smokers. The pulse oximeter is
standardised to a calibration curve developed using a cohort of young, healthy adults. Because studies
cannot ethically induce extreme levels of hypoxia onto participants, this calibration curve is extrapolated,
meaning that it’s efficacy with very low levels of oxygen saturation will be less (and indeed reports have
shown that with low levels of oxygen saturation, the pulse oximetry levels show significant bias). Of
note for clinical practice is that patients encountered routinely by optometrists are from all age ranges,
with many suffering a variety of pathologies. This can be considered to be a drawback of the pulse
oximeter, since measurements of an elderly patient will not equate to those of the young calibration
cohort. However, the measurements (when taken on a routine basis) will be an individual measure and
whilst comparisons across the patient base will not be possible, comparisons for an individual patient
may highlight changes to the cardiovascular system between examinations.
Many modern pulse oximeters also feature a plethysmograph, which monitors the change in volume
of the area being measured to provide a surrogate measure of beats per minute. This measure gives a
good indication of a patient’s pulse, however if systemic blood pressure is being measured in the con-
sulting room, then this measure, which is known to have a number of confounding variables, is not of
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vital importance[221].
3.5.2.1 Pulse Oximetry protocol for current study Since there are no guidelines for the recording
of fingertip pulse oximetry, a routine was standardised for the present study. A digital finger-tip pulse
oximeter (RisingMed RPO-8B) was applied to the right index finger (or nearest available digit) for a
minimum of 30 seconds, or until both the oximetry and pulse rate readings stabilised. Patients were
encouraged to rest their hand on the desk and refrain from talking as the measurement was taken. The
measurement was taken in ambient room lighting.
3.5.3 Cardiovascular Risk Calculators
The Mayo Clinic has released an online risk calculator which requires simple health and lifestyle metrics
to be entered in order to produce a quantifiable risk ‘score’ of developing cardiovascular disease. The
calculator is based on an amalgamation of algorithms from a range of Framingham-based calculators;
Framingham Heart Study Cardiovascular Disease 10-Year BMI-Based Risk Score Calculator, Framing-
ham Heart Study General Cardiovascular Disease 30-Year Lipid-Based and BMI-Based Calculators, and
ACC/AHA Pooled Cohort Equations CV Risk Calculator. Since the baseline Framingham Study was run
in the United States between 1968 and 1975, it is perhaps not surprising that it’s calculations have been
shown to over-estimate risk in European populations[223, 224]. To address this, a UK-based calculator,
QRISK, was devised based on contemporary data obtained nationwide through GP surgeries to reflect
the varying regional and ethnic pathology incidences[225]. This was expanded to include a number of
additional risk factors including Type II diabetes mellitus, treated hypertension, rheumatoid arthritis,
renal disease and atrial fibrillation[226]. Risk stratification in a sample cohort (also of UK-based data)
resulted in 41.1% of Framingham-derived ‘high-risk’ subjects being down-classified to ‘low-risk’, with a
subsequent 10-year observed risk of 16.6%, reflecting increased classification accuracy . This has resul-
ted in its incorporation into NICE Guidelines as a clinical tool[227, 23]. A newer iteration of the calculator
(QRISK3) was released in 2018, however NICE guidelines have yet to be updated to incorporate this. The
updated algorithm incorporates more condition-specific parameters which correlate with an increased
CVD risk including; migraine, systemic lupus erythematosus (SLE), use of atypical antipsychotic and
corticosteroids, severe mental illness and erectile dysfunction[228]. The new calculator also requires the
standard deviation of two or more blood pressure readings to reflect blood pressure variability.
A more specific risk calculator for risk of progression of diabetic retinopathy (the RetinaRisk Calcu-
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lator) can also be applied to those participants with existing diabetes mellitus. The RetinaRisk app is
a smartphone-based system which allows for practitioners to individually stratify patients‘ risk of de-
veloping sight-threatening diabetic retinopathy[229]. ‘Sight-threatening’ DR was defined as proliferative
retinopathy and/or clinically significant macular oedema. The algorithm has been validated against
cohorts across Europe showing a similar level of accuracy and reduction in recommended visits for
controlled cases when compared to fixed-interval annual screening[230, 231, 232]. When re-calibrated to
quantify risk based on the ‘at risk’ categories in the UK’s grading system for DR, the calculator offered a
40% reduction in screening frequency compared to fixed-interval annual screening, posing a significant
cost-saving potential[233]. Integration of risk calculators into optometric practice simply requires adding
the necessary questions into routine history and symptom taking at the beginning of an eye examination.
3.5.3.1 Cardiovascular Risk Calculator protocol for current study In order to fulfil the criteria
of the risk calculator, the specific data required was built into an extended history and symptoms with
participating patients. The questions were not always optimum for an ophthalmological focus. For
instance, questions pertaining to recent cigarette smoking ask if more than 100 cigarettes have been
smoked in the last year, whereas it will be within a shorter time-period that cigarette smoke and nicotine
will affect retinal vessel calibre (less than 24 hours). However, since the calculator is designed to quantify
risk of cardiovascular disease, the questions were asked as stated in the calculator itself. These are shown





















Figure 19: A flow-chart of methods for patient enrolment.
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4 Repeatability and Variability in Objective Static Retinal Vessel
Calibre Measurement
4.1 Introduction
A photograph captures the retinal vascular tree at a single point in time, with measurements taken only
applicable to that particular moment. Before cross-sectional or longitudinal correlations between vessel
calibre and ocular and systemic parameters can be explored, the validity of individual measurements
needs to be determined. The cardiovascular system is dynamic, with pulse waves travelling through-
out the body following cardiac systole. Indeed, spontaneous pulsation of the central retinal vein is
often directly observable on ophthalmoscopy; a physiologically normal sign in approximately 90% of
patients[83, 234]. The muscular anatomy of the arterial system particularly, as outlined in Chapter 1.6
(The Cardiovascular System: gross anatomy) on page 28, goes some way in maintaining the pressure
wave that propagates in the ventricles of the heart. The comparative lack of muscular tunic in the venu-
lar system means it is less adept at responding to significant pressure changes and predominantly relies
on autoregulatory vasodilation (through mediators such as nitric oxide and prostaglandins). These dis-
tinct anatomies mean that vessel diameters are not absolute and raise the question whether a single
photograph can be affected by this. The cardiac pulse cycle and associated changes therefore become
a consideration when measuring retinal blood vessel calibre statically (i.e. through photographic ana-
lysis). Previous studies, through various setups with fundus cameras attached to electrocardiograms
(ECGs), demonstrate that it is possible to photographically measure significant changes in vessel dia-
meters through the cardiac cycle[235, 236]. Chen et al. suggest three factors which can cause transient
changes in retinal vessel diameter[235];
• pulsatility (due to direct changes in blood pressure through the cardiac cycle);
• autoregulation (a chemically-mediated change in vessel diameter in response tomore pronounced
/ prolonged periods of pressure changes to ensure constant rates of perfusion);
• vasomotion (oscillative changes in vessel diameter that occurs independently from changes in
blood pressure or the cardiac cycle).
Whilst their studies took place prior to the advent of the objective technique being employed here (and
the authors do not elucidate howmeasurementswere accurately obtained in μm) the percentage changes
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in vessel diameter across the cardiac cycle offer confirmation that the vessel diameter does alter in line
with stages of the cardiac cycle. When a similar study was run by Knudtson et al. in 2004, they observed
that only large venules (most likely due to their size and significant contrast to surrounding retina) had
a significant change in diameter when linked with pulse cycle[236]. However, it should be noted that in
this particular study, images were captured on a Canon D-30 digital camera, with a resolution of only
3.0 mega-pixels (MP). Given that vessels of approximately 75μm were being evaluated, camera resol-
ution has the potential to significantly limit quality and accuracy of such measurements. Pauli et al.
demonstrated that compared to a 7MP reference image to a 3MP and 5MP version, there was an ap-
parent ‘narrowing’ of vessels with decreasing image resolution[237]. For CRAE this was seen as a change
from -1.57µm to -2.77µm. A larger variation was seen in CRVE, with a 5MP image underestimating vessel
calibre by -1.93µm, raising to -4.89µm in a 3MP image. Compensation for cardiac cycle has also been
demonstrated in cases of externally induced diameter change (e.g. isometric exercise, O2 inhalation),
although it was shown that if the effect on vessel diameter was significant enough, such as in the case
of 60% O2 inhalation, it was significant even when cardiac cycle was not compensated for[238]. Few
studies have addressed the question of room illumination on vessel diameter measurements, and those
which have tend to focus on the alteration in calibre measurements as subjects are exposed to sudden
changes in ambient lighting (e.g. from dark to bright illumination). Of those studies, there appears to
be a mild reduction in venular calibre when subjects are dark adapted (in the order of 1.5-2.8%)[239, 240].
Volumetrically this will have an increased effect on blood flow (the primary driving force for the change,
responding to increased O2demand), however if conditions for imaging subjects are kept constant, this
effect should be distributed evenly across a cohort. Ambient illumination, as well as directly affecting
diameters, also impacts on pupil size, itself another variable in determining image quality. There is lim-
ited evidence around the impact of pupil size on retinal vessel measurements, however studies involving
the grading of diabetic retinopathy (DR) have been more extensive. Gradability is the ability to detect
signs of DR, which includes small signs such as microaneurysms. Gradability can, therefore, be taken
as a reasonable surrogate for ability to objectively analyse an image; i.e. vessel calibre measurements.
It has been shown that there is a clear correlation between mydriasis and a greatly reduced number of
ungradable images. Up to one quarter of images taken in non-mydriatic conditions were classified as
ungradable, which reduced to less than 5% with the use of pharmacological dilation[241, 242]. Both of
these studies reported that media opacity (i.e. cataract) was the leading cause of ungradable images
when acquired under mydriasis (78% had early-moderate cataracts[241]), and subjects over the age of 40
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years have been reported to be increasingly less likely to produce gradable images when not dilated[243].
A number of variables were identified which could impact on retinal vessel measurements and are
summarised in Figure 20. Firstly, to reflect standard UK practice whereby patients are not routinely
dilated, the use of non-mydriatic photography needs to be compared with dilated images from the same
subjects. If non-mydriatic imaging is to be used and compared with the findings of large cohort studies
which employed pharmacological dilation, there needs to be no significant difference in vessel meas-
urements for both conditions. Secondly, to determine if a single image is sufficient, or whether multiple
images need to be acquired for an individual. This relates to the dynamic nature of the microcircula-
tion and ultimately depends upon the sensitivity of the measurements; is the current approach of static
retinal vessel analysis accurate enough to detect minor fluctuations in vessel diameter arising from the
cardiac pulse cycle? For a single image to be sufficient, there needs to be minimal variation in vessel
calibre across a sequence of images taken in quick succession. An eye examination considers the ocu-
lar state at that particular visit, and is making assumptions that there has been little or no change in
the time preceding and following the appointment. The third variable to consider is how stable vessel
calibre measurements are over short periods of time; do they change day-to-day? For static retinal ves-
sel analysis to be utilised in clinical practice, the measurements need to be consistent over short time
scales (in order to then identify clinically significant changes between examinations). This means that
there should be no statistically significant difference in measured vessel calibre for an individual over
an interval of several days.
As well as image acquisition, the image analysis process also produces a number of potential vari-
ables. The selection of vessels themselves, influenced by the internal edge detection algorithmwithin the
software, needs to be independently verified to demonstrate that it is capable of repeatedly producing
the same measurement from the same selected vessels. Additionally, the formulae used to transform the
individual vessel measurements into CRAE and CRVE values have been previously shown to influence
the outcome value[115, 114]. Whether this is also the case in a clinic setting needs to be determined, as
different software platforms employ the different algorithms. Finally, the grader themselves could po-
tentially introduce variability to the measurements produced. Experienced graders are often employed
in studies, whereas this may not be the case in practice (particularly in the early days of application,
where the primary clinician will also be inexperienced). How sensitive, therefore, is objective vessel
analysis to grader experience? These three image analysis variables can be investigated by using a single
image but analysing it multiple times; any significant differences highlighting variables which will need
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Figure 20: A summary of the potential variables encountered during image acquisition and analysis
(Clockwise from top: i) effect of pupil dilation: undilated vs. pharmacologically dilated; 2) cardiac pulse
cylce and small-scale temporal variations; 3) moderate temporal variations; 4) image anaylsis: software-
related intra-image variability, formulae used and inter-observer agreement).
accounting for in future work.
4.2 Methods
All participants were enrolled from the prospective cohort study (see Chapter 5. Correlations Between
Retinal BloodVessel Calibre andCardiovascularMetricsObserved inOptometric Practice) andhad provided
signed consent. The methodology study was covered by the over-arching ethics application which was
approved by Aston University (see Appendix Appendix 1. Ethical Approval) and conformed to the tenets
of the Declaration of Helsinki.
Participants had blood pressure and non-contact tonometry performed prior to assessment. All sub-
jects had a thorough eye examination before participation to exclude underlying ocular pathology.
4.2.1 Effect of dilation
Each subject was seated in the dark for 5 minutes in order to achieve maximal natural pupil dilation.
Pre-mydriatic pupil diameters were all larger than the minimum specified by the camera (2.50mm[183]);
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subjects’ pupils having been measured prior to imaging. Subjects with a pre-mydriatic pupil size less
than 2.50mm in either eye were excluded from the study.
4.2.2 Sequential imaging
Ten, 45º disc-centred full-colour fundus images of the right eye were captured with a Topcon 3D Maestro
(Visit 1). The images were acquired in rapid succession (although each individual photograph had to be
manually captured). In cases where the pupil diameter was small, a pause of up to 30-seconds was
employed to allow some recovery dilation. After the images were acquired, 0.5% Tropicamide (Bausch
& Lomb) was instilled into the right eye. Following full pharmacological mydriasis, subjects were then
re-imaged. A further 10 disc-centred photographs were taken. For each subject, a total of 20 images were
captured; 10 undilated, and 10 dilated.
4.2.3 Repeated imaging
The procedure of non-mydriatic imaging followed by dilated imaging was repeated one week later (Visit
2), at the same time of day as Visit 1. Following completion of imaging, a total of 40 images were acquired
for each subject; 20 from Visit 1 and 20 from Visit 2.
4.2.4 Image analysis
All images were exported both in full-colour (for vessel identification) and red-free (for analysis) in the
maximum uncompressed file format size (Tagged Image File Format; TIFF). These were then imported
into VesselMap v3.0 (Imedos Systems, Jena) and objective analysis was performed on all of the images
acquired. Initial grading was performed by an experienced grader (CF), having trained on a sample bank
of >150 unrelated images. To explore variability in image analysis, the sharpest dilated and undilated im-
age of the sequences from Visit 1 were selected; reflecting a practice-based scenario. In order to evaluate
inter-grader experience and variability, a trainee with no prior exposure to the software was recruited
to also analyse the images (KH). The grader was shown the software’s instruction and grading protocol,
and a single image was graded as a demonstration. The trainee then graded the same bank of undilated
images (to reflect image type most commonly found in clinical practice). The experienced grader was
not present for this analysis. Summary CRAE, CRVE and AVR values were also calculated using the
Knudtson formula for comparison. These were calculated externally to VesselMap, using the absolute
vessel measurements from each image and selecting the six largest of each type (as per the formula).
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Knudtson values were calculated from a single image (first undilated and dilated images on Visit 1) and
average vessel measurements across the sequence of 10 images from Visit 1 (undilated and dilated).
4.2.5 Statistical analysis
Statistical analysis was performed using SPSS v25.0 (IBM). Since the same population was used for dif-
ferent variables, paired sample t-tests were used to compare measurements for undilated and dilated
images, measurements from Visit 1 and Visit 2 and measurements produced from both Parr-Hubbard
and Knudtson formulae. These were also plotted graphically using Bland-Altman difference-versus-
mean plots. Coefficients of variation were used to quantify variance across the sequence of 10 images
(to demonstrate cardiac pulse cycle) and across a sequence of 10 analyses of the same image (to demon-
strate difference in vessel selection). Paired t-tests were then employed to compare the coefficients of
variation for both undilated and dilated conditions. Finally, Pearson’s correlations were used to compare
the measurements taken by the experienced and trainee graders. Significance was set at p = < 0.050.
4.3 Results
Twenty Caucasian subjects participated in the study; 9 male and 11 female. All participants were free
from cardiovascular pathology. Age ranged from 23 to 61 years (average 40.1 years ±13.7). Refractive
error ranged between +1.00 and -7.75D (MSE) (average -1.20D MSE ±2.16). Blood pressure (systolic and
diastolic) averaged 116mmHg (±11.0) and 73mmHg (±9.3) respectively, with an average beats per minute
(BPM) of 68.6 (±9.3). Of the 800 images acquired, 7were deemedungradable due to image quality. Vessel
calibre measurements were normally distributed; confirming the assumptions used in paired samples
t-test models.
4.3.1 Effect of dilation
Average undilated baseline CRAE was 178.8µm (±15.8); CRVE was 211.0µm (±15.3) and AVR was 0.85
(±0.06). Average mydriatic baseline CRAE was 176.7µm (±15.8); CRVE was 210.0µm (±17.7) and AVR
was 0.84 (±0.07). 7 images were ungradable due to image quality, six (85.71%) of which were acquired
undilated. For Visit 1, paired samples t-tests revealed a significant difference between CRAE measure-
ments taken in undilated and dilated conditions (t (19) = 2.170, 95% CI 0.07 to 4.07, p = 0.043), however
both CRVE and AVR measurements were statistically insignificant (p = >0.050). For Visit 2, there was no
significant difference between measurements taken from undilated or dilated images for CRAE, CRVE or
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AVR (p = >0.050). Bland-Altman difference-versus-mean plots show a mean bias of +2.07µm (Limits of
Agreement: ±8.38) and +1.13µm (Limits of Agreement: ±5.00) for CRAE on Visit 1 and Visit 2 respectively.
For CRVE, a mean bias of +1.02µm (Limits of Agreement: ±10.70) and +0.86µm (Limits of Agreement:
±8.27) were found on Visits 1 and 2. These are illustrated in Figure 21.
4.3.2 Cardiac pulse & small-scale temporal variations
Across a sequence of 10 images for each subject, undilated CRAE measurement range varied, on average,
by 16.19µm per individual, with an average range of 13.53µm when dilated. For CRVE, the average range
of undilated measurements was 13.38µm, and dilated range was 12.71µm. Mean coefficient of variation
for CRAE was 2.62% (±1.31; 95% CI 2.05 to 3.20) undilated, and 2.24% (±0.89; 95% CI 1.85 to 2.63) for
dilated. For CRVE, mean coefficient of variation was 1.93% (±0.88; 95% CI 1.55 to 2.32) and 1.84% (±1.00;
95% CI 1.40 to 2.28) for undilated and dilated conditions respectively. A paired samples t-test comparing
undilated and dilated coefficients of variation across an image sequence showed no significant difference
on Visit 1 for CRAE or CRVE, and only borderline significance for CRAE on Visit 2 (t (19) = 2.21, p = 0.043);
CRVE measurements for Visit 2 showed no significant difference between dilated or undilated.
4.3.3 Moderate temporal variations
When comparing results from Visit 1 and Visit 2, paired samples t-tests (for both undilated and dilated
measurements) were non-significant for all three variables; CRAE, CRVE and AVR (p = >0.050). Bland-
Altman difference-versus-mean plots (see Fig 22) for both undilated and dilated measurements demon-
strate a mean bias of -0.46µm (Limits of Agreement: ±10.21) and -1.41µm (Limits of Agreement: ±7.94) for
CRAE, and -1.62µm (Limits of Agreement: ±9.07) and -1.77µm (Limits of Agreement: ±11.49) for CRVE.
4.3.4 Image analysis and intra-image variability
4.3.4.1 Vessel selection Repeat analysis of a single image yielded an average intra-image measure-
ment range of 9.56µm and 5.55µm for CRAE (undilated and dilated), and 5.10µm and 4.19µm for CRVE
(undilated and dilated). Mean coefficient of variation for CRAE was 1.48% (±1.01; 95% CI 1.04 to 1.92)
(undilated) and 0.92% (±0.56; 95% CI 0.68 to 1.17) (dilated), and for CRVE was 0.70% (±0.45; 95% CI 0.50
to 0.89) (undilated) and 0.57% (±0.38; 95% CI 0.40 to 0.74) (dilated). A paired samples t-test between
undilated and dilated coefficients of variation was significant for CRAE (t (19) = 2.58, p = 0.018) but
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Figure 21: Bland-Altman difference-versus-mean plots showing the bias between CRAE and CRVE meas-
urements taken from images when subjects are either undilated or dilated for Visit 1 (upper panel) and
Visit 2 (lower panel). CRAE results are recorded in red, and CRVE in blue. In both graphs, note the mean





































Mean Vessel Calibre (Visit 1 & Visit 2)









































Mean Vessel Calibre (Visit 1 & Visit 2)







Figure 22: Bland-Altman difference-versus-mean plots showing the mean bias between CRAE and CRVE
measurements taken of subjects on Visit 1 and Visit 2. Results are shown for both undilated (upper panel)
and dilated (lower panel) conditions. CRAE results are shown in red, and CRVE in blue. Mean bias is
denoted by longer dashes, and upper and lower limits of agreement (LoA) shown by smaller dashes.
Note the near-coincident lower limits of agreement for CRAE (-10.67µm) and CRVE (-10.69µm) on the
upper panel.
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4.3.4.2 Formulae Using Knudtson formulae and comparing with the original Parr-Hubbard meas-
ures produced by VesselMap, paired t-tests revealed highly significant differences for all measures (p =
<0.001); CRAE, CRVE and AVR across condition types (undilated, dilated, single image, average across
image sequence). When the difference in calculations (Parr-Hubbard versus Knudtson) for each sub-
ject was compared to the number of vessels included in their Parr-Hubbard calculation, there was no
significant correlation between number of arteries and CRAE or AVR (p = >0.050), however there was
a significant correlation between the number of veins selected and difference in AVR between the two
formulae (p = <0.003 in all conditions), which is summarised in Table 20.
Single Image
Undilated Dilated
CRAE CRVE AVR CRAE CRVE AVR
Arteries 0.096 -0.076 0.191 0.041 -0.88 0.076(n.s.) (n.s.) (n.s.) (n.s.) (n.s.) (n.s.)
Veins 0.531 -0.145 0.692 0.445 -0.132 0.678(0.016) (n.s.) (0.001) (0.050) (n.s.) (0.001)
10-Image Average
Undilated Dilated
CRAE CRVE AVR CRAE CRVE AVR
Arteries 0.197 -0.029 0.228 0.005 -0.075 0.008(n.s.) (n.s.) (n.s.) (n.s.) (n.s.) (n.s.)
Veins 0.526 -0.144 0.632 0.493 -0.092 0.778(0.017) (n.s.) (0.003) (0.027) (n.s.) (<0.001)
Table 20: Pearson correlations between difference in vessel calibre (depending on formulae applied) and
number of vessels included. Significance shown in parentheses. Values in italics are non-significant (p
= >0.050).
Comparison of the two formulae (Parr-Hubbard and Knudtson), based on measurements taken from
undilated photographs (Visit 1) is demonstrated graphically in the Bland-Altman plot in Figure 23.
4.3.4.3 Observers There was a strong correlation for measurements taken by an experienced grader
and trainee. Pearson correlations (r) were similar for all three measurements; 0.87 (CRAE), 0.87 (CRVE)
and 0.84 (AVR). Bland-Altman difference-versus-mean plots for experienced grader versus trainee meas-
urements demonstrate a mean bias of +5.03µm (Limits of Agreement: ±19.10), +6.13µm (Limits of Agree-
ment: ±14.71), and -0.002 (Limits of Agreement: ±0.01) for CRAE, CRVE and AVR respectively. These are
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Figure 23: Bland-Altman difference-versus-mean plots showing the mean bias between undilated CRAE
andCRVEmeasurements generated by the original Parr-Hubbard and revisedKnudtson formulae. CRAE
results are shown in red, and CRVE in blue. Mean bias is denoted by longer dashes, and upper and lower
limits of agreement (LoA) shown by smaller dashes. Note that vessel measurements (artery and vein)
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Figure 24: Bland-Altman difference-versus-mean plots showing the mean bias between CRAE and CRVE
(upper panel) and AVR (lower panel) measurements taken by an experienced grader and a trainee. CRAE
results are shown in red, CRVE in blue and AVR in green. Mean bias is denoted by longer dashes, and
upper and lower limits of agreement (LoA) shown by smaller dashes.
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4.4 Discussion
Retinal imaging is becoming a routine element of an eye examination in the UK, and since pharmaco-
logical dilation is not typically performed without prior indication, it is important to establish whether
image analysis techniques are as robust without mydriasis. Much of the research around retinal ves-
sel calibres was performed under mydriasis, and indeed the manufacturer’s recommended protocol for
image analysis software suggests patients be dilated. To this end, image quality, and by extension accur-
acy of vessel calibre measurements, needs to be maximised to give as little variation as possible. Paired
samples t-tests highlight that both CRVE and AVR are not significantly influenced by the presence or
absence of pharmacological dilation. For CRAE, there appeared to be a significant difference in meas-
urements on Visit 1 but not on Visit 2. Difference-versus-mean plots for undilated vs. dilated (Figure 21)
show on both days however that CRAE has narrower spacing of limits of agreement than CRVE (±8.35µm
vs. ±10.70µm respectively for Visit 1). Whilst there was a slight increase in the mean bias for CRAE
(+2.07µm) compared to CRVE (+1.02µm), consideration then needs to be made for what is considered
to be clinically significant over statistically significant. A similar (slightly larger) level of agreement has
been demonstrated by photographing the same retinae on different cameras, where CRAE had a mean
bias of +0.17µm (Limits of Agreement: ±10.15) and CRVE a mean bias of -2.32µm (Limits of Agreement:
±11.76)[244]. The difference shown to be statistically significant easily fall within the variation demon-
strated by multiple imaging under the same conditions, where variation for an individual averaged a
range of 16.19µm. Interestingly, the spacing of the Limits of Agreement is considerably less than those
reported in a large-scale study comparing the agreement between two other measurement platforms
(SIVA and VAMPIRE)[193]. Whilst the cohort used here is much smaller, a cross-platform comparison
including VesselMap is required to further explore this difference.
Variation across a sequence of images taken in quick succession should be considered to determ-
ine whether a single image (and subsequent vessel measurement) is sufficient in clinical practice (for
instance, multiple readings are required for non-contact tonometry). Few studies have looked at the
variation of vessel measurements across a sequence of isolated images, with most studies instead look-
ing at video recordings, such as those taken with the Dynamic Vessel Analyzer (DVA, Imedos Systems,
Jena)[239, 245]. A study using photographs from a similar number of subjects (n = 32) by Von Hanno et
al. found a very similar level of change in vessel diameter change for CRVE (1.7% over 6 images with
prior exposure to light); however they found there was an insignificant change in CRAE[240]. The very
low coefficient of variation across a sequence, in the region of 3%, is additional evidence to support the
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continued use of a single photograph for analysis. Even when taking the single-most largest recorded
vessel in the present study (CRVE: 272µm; Subject PM), a 3% variation (±8.16µm) in individual vessel
measurement still falls within the limits of agreement demonstrated in the Bland-Altman plots above.
These findings support the work of Fuchs et al. who demonstrated that blood pressure at the time of
image acquisition does not have a transient impact on vessel calibre[246].
A difference in vessel selection for arteries and veins could possibly explain the difference in signi-
ficance levels for their measurements. A study into reproducibility of vessel calibre measurements from
images taken on different (non-mydriatic) cameras also reported a more significant variation in CRVE
measurements compared to CRAE[244]. This would be contrary to the theory that veins are easier for
a software algorithm to define because of the greater colour contrast between the deoxygenated blood
column and surrounding pigmented retina[169].
4.4.1 Study limitations
It should be noted that the cohort used was exclusively Caucasian, thus a multi-ethnic sample needs to
be considered in order to establish whether these relationships exist consistently before these findings
can be considered definitive and used in practice. Anatomical differences in vessel architecture are
unlikely, however the role of retinal pigmentation and subsequent contrast with retinal vessels seen with
varying ethnicities may influence measurement accuracy and consistency. A subsequent study should
also explore the role played by iris pigmentation, to identify whether greater variability exists on an
ethnicity basis or more locally in terms of levels of ocular pigmentation.
Additionally, the present study only examined those free from pathology (both systemic and local
to the ocular circulation). Pathologies affecting the vasculature may impact on the variability of meas-
urements, particularly in cases of endothelial dysfunction. Targeted methodological studies which run
a similar experiment with pathological samples will establish whether the limits of clinical significance
described above are the same even in diseased vessels.
Imedos (the developers of VesselMap) do not offer a structured training program in order to use their
software (by contrast, SIVA host a several weeks long training course in Singapore for those wishing to
use their software) which makes definition of an ‘experienced’ grader difficult. This could have been
mitigated with more rigorous assessment of the trial bank of images analysed by the grader (it should be
noted that the study by Neubauer and colleagues adopted a similar approach to train graders; selecting
an arbitrary bank of >100 unrelated images to analyse[187]). Comparison (by means of a paired samples t-
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test) of vessel calibre measurements from the first images within the sample bank to measurements from
the same images following completion of the entire training bank to statistically demonstrate whether
any measurable learning effect exists would have been a simple solution to this problem. It should be
noted, however, that the results from intra-image analysis go some way in demonstrating that there is
very little (0.57-1.48% coefficient of variation) difference in the calibres measured in an image when the
same vessels are selected multiple times. Another advantage of adopting the Parr-Hubbard approach is
that all vessels measuring >40µm are selected within the measurement annulus, eliminating the need
for a subjective selection of the six largest vessels, leaving just the variation within the software analysis
package to impact on the final measured calibre.
4.4.2 Conclusion
Despite the lack of ethnic diversity amongst the present sample, the population used is otherwise reflect-
ive of that encountered in routine optometric practice. A range of ages, refractive errors and pupil sizes
(although not measured beyond checking they were above the minimum required diameter) demon-
strates the versatility of this approach when applied to the consulting room. Further work will need to
be undertaken to explore whether the presence of cardiovascular disease has a significant impact upon
these findings. Such studies are potentially more difficult to undertake in optometric practice, as they
require recruited subjects to present specifically as part of the study; in the present case, on multiple
occasions. However, it forms a positive method of patient retention since they are having a greater level
of interaction with the practice and their clinician, Overall patient interest and satisfaction after taking
part in the present study was, anecdotally, high as they felt a positive return from partaking in research
about their own eye examinations.
VesselMap applies the Parr-Hubbard formulae vessel measurements, however more recent publica-
tions have applied revised formulae proposed by Knudtson et al.[114]. Manual calculation with the revised
formulae revealed altered vessel calibres in the same region as those originally outlined in Knudtson et
al.’s paper. The authors reported changes in calculated CRAE (-19.7µm) and CRVE (+12.6µm); these were
of a similar magnitude in the present study for both CRAE (-27.7µm) and CRVE (+18.3µm). This bi-
directional change would result in an overall lower AVR, more in line with the classically accepted 0.67
or 23
[87, 88, 31].
It has been shown that, for a Caucasian sample, free from cardiovascular disease, static retinal ves-
sel analysis can be easily performed in clinical practice, without the need for pharmacological dilation
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(unless otherwise indicated) or the need for multiple images. Furthermore, aside from improved image
quality, there does not appear to be a significant impact on measured retinal vessel calibre with the use
of dilating agents. The use of a single image to obtain measurements also improves it’s clinical applic-
ation; negating the need for averaging of multiple measurements which does not lend itself to a busy
clinic environment. The robustness of measurements acquired several days apart also adds strength to
the measurements taken and suggests that they are representative of the subject’s retinal microcircu-
lation at the time of examination. The repeatability of analysis software has also been independently
confirmed, demonstrating it’s clinical utility regardless of grader experience. In summary, the study’s
findings suggest that objective retinal vessel analysis can be performed in clinic to produce results com-
parable with those acquired in more rigorous laboratory-based conditions.
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5 Correlations Between Retinal Blood Vessel Calibre and Cardi-
ovascular Metrics Observed in Optometric Practice
5.1 Introduction
Cardiovascular disease is a multifaceted problem; both through aetiology and pathophysiology. It can-
not always be determined through a single measurement (such as blood pressure) and the whole pa-
tient case needs to be considered. This includes both physical characteristics; such as height, weight,
blood pressure, cholesterol levels etc., but also lifestyle characteristics such as diet, level of exercise and
smoking status. This has been reflected in the development of cardiovascular risk calculators, since they
employ a combination of measured data (such as blood pressure, blood cholesterol, heigh and weight)
and anecdotal data (such as intake of fruit and vegetables and level of exercise)[247, 248]. This is leading
patient care away from isolated measures, since even measurements such as Body Mass Index (BMI)
have been shown to lack specificity and sensitivity when quantifying levels of obesity alone[249]. The
correlations between cardiovascular pathologies and retinal blood vessels have been documented pre-
viously (see Chapter 2 (Associations of Retinal Vessel Calibre with Cardiovascular Disease: A Systematic
Literature Review)), and whilst retinal vessel health should be recorded as part of a routine eye exam-
ination, there is currently no clinical management guidance on how this can be performed to the same
standard (i.e. objective retinal vessel analysis) as shown in the literature[250]. No research currently exists
to demonstrate the utilisation of objective retinal vessel analysis in routine clinical practice despite it’s
acknowledgement as a future direction of research[89]. In addition to the identification of cardiovascu-
lar correlations, it has been shown that the techniques involved in objective retinal vessel analysis can
be performed in practice with similar levels of repeatability (see Chapter 4 (Repeatability and Variability
in Objective Static Retinal Vessel Calibre Measurement)). It then needs to be determined whether the
technique yields findings similar to those reported in the literature when performed in clinical prac-
tice. Since no management guidelines currently exist, benchmarks established for three cardiovascular
pathologies (hypertension, diabetes mellitus and stroke) will be used in line with the previous literature
review. Additionally, multi-variable modelling (analogous to the QRISK calculation) will be performed
to explore any inter-correlations of cardiovascular metrics and retinal vessel calibre, and an attempt
will be made to apply intervention criteria (or ‘cut off’ values) to measurements taken in order to high-




For detailed methodological information see Chapter 3 (Materials & Methods). Cross-sectional parti-
cipants were recruited throughout the study course, with data from their baseline visit being used. All
participants were recruited in optometric practice. Exclusion criteria was limited to those not covered
by the ethical approval (i.e. minors and those unable to give informed consent) and those with signific-
ant media opacities resulting in poor quality and ungradeable photographs, even with pharmacological
dilation. Briefly, the baseline visit involved collecting data regarding health, family history and lifestyle;
refractive status; ocular health; and cardiovascular measures.
5.2.1 Patient selection
Patients were enrolled prospectively between October 2015 and September 2018 as they attended for
routine eye examinations. Inclusion criteria was at least one photographable eye (with or without the
aid of dilation), the ability to record systemic blood pressure and completion of an eye examination (plus
additional cardiovascular-related questions). Exclusion criteria was limited to those subjects not covered
by ethical approval (i.e. minors and vulnerable adults) (see Appendix Appendix 1. Ethical Approval).
5.2.2 Patient Health History
In line with both College of Optometrists guidelines on history and symptom collection, and also util-
ising questions featured in both the Mayo Clinic and QRISK cardiovascular health risk calculators, pa-
tients reported anecdotally their general health, including present medication, diagnosed conditions
(and whether they were being treated) and any conditions currently undiagnosed but borderline or un-
der investigation[251, 247, 248]. Family history was also exploredwith additional emphasis on cardiovascular
health and occurrence of any cardiovascular events, especially in younger family members. Participants
were asked lifestyle questions, including past or present smoking status, average weekly alcohol intake
(approximate number of units), daily diet (approximate amount of both saturated fats and portions of
fruit and vegetables per day, on a scale of ‘Few’ (≤1), ‘Some’ (2-4) or ‘A lot’ (≥5), daily caffeine intake
(1-2 cups, 3-5 cups, >5 cups) and weekly exercise (Nil; <75 minutes vigorous/<150 minutes moderate; >75
minutes vigorous/>150minutesmoderate). Anecdotal height and weight were also recorded. Examples of




All participants underwent a routine objective refraction (static retinoscopy) followed by subjective re-
fraction by an experienced optometrist (CF). In cases of severe amblyopia or reduced vision or other
instances where a balance lens was prescribed, refraction was recorded as the objective refraction ob-
tained. Previous refractive status for participants having undergone refractive surgery (laser refractive
surgery, cataract/clear lens extraction etc.,) was also noted.
5.2.4 Ocular health
Routine undilated (except in cases of poor fundal view) ophthalmoscopic examination was performed
on all participants using a slit lamp biomicroscope and 78D condensing lens. Fundus photographs were
then obtained after pupil diameter had recovered sufficiently following ophthalmoscopy. 45°, full colour
disc- and macular centred fundus photographs were obtained using a Topcon 3D Maestro. Non-contact
IOP was measured with a calibrated Pulsair 3000 obtaining three readings per eye.
5.2.5 Cardiovascular measures
Digital sphygmomanometry was performed with the subject seated at the end of the examination, with
timehaving elapsed following non-contact IOP recording particularly (approximately 5minutes) to allow
blood pressure of subjects disliking this procedure to return to normal. Subjects were instructed to
remove thick sleeves and to remain still and quiet during measurement. The cuff was applied level to
the heart and three readings were taken, with a minute interval between each. The average of the final
two readings was then used in analysis. If there was a difference of ≥10mmHg between readings, further
readings were taken until three within this range were obtained. Heart rate (in BPM) was also recorded.
Finger-tip pulse oximetry was obtained from the index finger of the right hand; applied for 30 seconds
and a reading taken when measurement had stabilised.
5.2.6 Cardiovascular risk and ARIC-derived cut-offs
Cardiovascular risk calculations were determined using both the Mayo Clinic’s 30-Year Heart Disease
Risk Calculator and the QRISK2 calculator. The latter was employed rather than the newest for two
reasons; firstly NICE guidelines have not been updated to incorporate this newer algorithm so clin-
ical management will still be based upon the results obtained with QRISK2, and secondly because the







Table 21: ARIC AVR quintiles as used for quantifying risk of incident stroke.
included in the analysis. NICE state that primary threshold for prevention of cardiovascular disease is
for QRISK2 calculations of 10% or greater[227]. Thus, 10% can be considered the cut-off for significant
risk of cardiovascular disease.
No intervention criteria exists for retinal vessel calibres, either for arteries and vein measurements,
or combined AVR. The ARIC study stratified their cohort (n = 10,358) by AVR quintiles, reporting risk
ratios between upper and lower quintiles (quintile cut-offs unpublished, obtained direct from original
statistician, shown in Table 21 (D.Couper, personal communication, July 2nd, 2019))[92]. Exclusion criteria
for deriving quintiles was a positive history of stroke prior to the third ARIC visit (when the retinal
photographs were obtained, see Table 10 (Summary of population-based studies included in review)). The
ARIC study reported an 18% increased risk of stroke with subjects in the lowest quintile AVR when
compared to the uppermost. In the absence of official classification criteria for vessel measurements,
the use of a significant cardiovascular event (i.e. stroke) as calculated by the original study serves as an
initial benchmark. This is a similar approach to the reports generated with VesselMap, however those
incorporate unpublished data from a German cohort to account for age (see Appendix 6. VesselMap
Report; enlargement in Figure 25).
5.2.7 Image acquisition and analysis
All images were exported both in full colour (for vessel reference) and red-free (for measurement) in
uncompressed TIFF files. Images were then imported into VesselMap v3.0 for analysis. Analysis was
performed by an experienced grader (CF), having practiced on a bank of >150 images prior to analysis.
Images were batch analysed at time points several months after image acquisition with no access to
patient notes.
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Figure 25: Enlargement of VesselMap report describing ARIC-based quintiles.
5.2.8 Statistical analysis
Statistical analysis was performed using SPSS v25.0 (IBM). Given that some degree of vessel measure-
ment variability has been demonstrated previously (see Chapter 4.3, Repeatability and Variability in Ob-
jective Static Retinal Vessel Calibre Measurement: Results), inter-eye (OU) averages were used when
drawing comparisons with systemic parameters. In order to use this approach, cases of isolated patho-
logy which may bias one eye’s measurements (both local pathology such as central retinal vein oc-
clusion (CRVO) and systemic pathology such as carotid artery stenosis) were excluded from the ana-
lysis, and a paired samples t-test performed on the remaining data to demonstrate agreement between
both eyes. To identify variables for inclusion in analysis, correlation matrices were employed, with a
minimum significance set at <p = 0.050. For statistical models including refractive error (i.e. MSE)
as a co-variable, one randomly selected eye was chosen for each subject (given the strong correlation
between refractive error/ocular magnification and absolute vessel calibre measurements shown in the
literature[252, 209, 208, 85, 179]). Normality of data distribution was established through Levene’s test for Ho-
mogenity of Variance. A one-way ANOVA was used to determine whether vessel calibre (CRAE, CRVE
and AVR) was significantly different between each NICE hypertension classification. A post-hoc Tukey’s
Honestly Significant Difference (HSD) test was used to explore the extent of calibre differences with
increasing blood pressure category. Forward stepwise linear regression was used to construct models
identifying variables which correlated most strongly with vessel calibre. Independent t-tests were used
to explore differences between upper and lower ARIC-derived quintiles (since the cut-off values are de-
rived from a separate population, data from the present subjects can be considered parametric provided
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Variable n Mean (SD) Minimum Maximum
Gender: Female [male] 166 [104] – – –
Age (years) 270 58.33 (± 15.60) 16 93
Blood pressure: Systolic (mmHg) 270 130.81 (± 19.45) 87.00 189.00
Blood pressure: Diastolic (mmHg) 270 81.78 (± 12.13) 52.00 117.00
Height (m) 269 1.72 (± 0.06) 1.55 1.93
Weight (kg) 269 75.60 (± 10.55) 44.00 114.30
BMI (kg/m2) 269 25.46 (± 3.38) 17.63 37.32
OU CRAE (µm) 251 172.31 (± 18.16) 118.44 234.31
OU CRVE (µm) 251 201.39 (± 18.58) 152.11 268.93
OU AVR 251 0.86 (± 0.07) 0.70 1.05
QRISK2 10-year risk (%) 246 12.71 (± 12.05) <1.00 62.70
Mayo Clinic 30-year risk (%) 242 24.58 (± 17.77) <1.00 85.00
Right MSE (D) 269 -0.33 (± 2.35) -10.13 +6.38
Left MSE (D) 269 -0.25 (± 2.26) -9.50 +6.75
Table 22: Summary of cross-sectional participant data, showing variables (with units in parentheses),
number of included participants (n), mean, standard deviation (SD) and minimum and maximum val-
ues.
they are normally distributed).
5.3 Results
A total of 270 subjects were included in the cross-sectional analysis. Summary data is shown in Table 22.
Mean participant agewas 58.3 ±15.6 years (range 16 - 93), and therewere 166 females included in the study
(104 males). Mean systolic blood pressure was 130.81mmHg ±19.45 (range: 87.00 - 189.00mmHg), and
diastolic was 81.78mmHg ±12.13 (range: 52.00 - 117.00mmHg). Mean BMI was 25.46 ±3.38 (range: 17.63
- 37.32). Mean inter-eye average (OU) retinal vessel measurements were 172.31 ±18.16 (CRAE), 201.39
±18.58 (CRVE) and 0.86 ±0.07 (AVR). Calculated QRISK 10-year cardiovascular risk was, on average,
12.71% ±12.05 whilst Mayo Clinic 30-year cardiovascular risk was 24.58% ±17.77. Mean right and left MSE
were -0.33 ±2.35 (range: -10.13 - +6.38) and -0.25 ±2.26 (range: -9.50 - +6.75) respectively.
Paired sample t-tests were performed between measurements from right and left eyes (on subjects
with calibre measurements for both eyes only). There was no significant difference between eyes for
CRAE, CRVE or AVR (p = >0.050). Bland-Altman difference-versus-mean plots for right and left eye
measurements demonstrate a mean bias of -0.33µm (Limits of Agreement: ±23.17), -0.51µm (Limits of
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Agreement: ±22.45), and +0.0009 (Limits of Agreement: ±0.12) for CRAE, CRVE and AVR respectively.
These are shown below in Figure 26. As such, all subsequent analyses employed inter-eye average (OU)
measurements of CRAE, CRVE and AVR.
5.3.1 Hypertension and NICE-based blood pressure classification
All 270 subjects were included in blood pressure-based analysis, including those with existing cardiovas-
cular disease (hypertension, diabetes mellitus, etc.). Within the 270 included for analysis, 66 subjects
were already diagnosed with hypertension. Breakdown of characteristics when grouped by NICE hyper-
tension classification is shown in Table 23. Distribution of blood pressure classification, stratified by
present or absent hypertensive diagnosis is shown in Table 24. Of the 66 diagnosed hypertensives, 32
(48.48%) presented with blood pressure classified as Stage I hypertension or greater. Only 12 subjects
(18.18%) had blood pressure comparable to normotension. When stratified by NICE Guideline classific-
ation for blood pressure, one-way ANOVA was highly significant (p = <0.001) for CRAE and AVR. There
was no significant (p = > 0.050) correlation with CRVE. Levene’s Homogeneity of Variance was non-
significant (p = >0.050) for all variables prior to stratification (CRAE, CRVE, AVR). Table 25 summaries
these results. A second one-way ANOVA was run using only the first 4 classification categories due to
the very small sample size for ‘Severe hypertension’ (n = 6); there was no change in overall significance
for any vessel measurement (p = <0.001), however the value of F increased by approximately an order of
2.00 for each parameter. Post-hoc Tukey’s showed a greater difference in CRAE and AVR when there was
a larger difference between NICE hypertension classification groups. On average, CRAE was +16.41µm
greater for Grade I (normotensive) participants compared to Grade IV (Stage II hypertensives), with AVR
being 0.07 lower in Grade I compared to Grade IV. The progressive decrease in CRAE with increasing
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Figure 26: Bland-Altman difference-versus-mean plots showing the mean bias between baseline CRAE
and CRVE (upper panel) and AVR (lower panel) measurements from right and left eyes. CRAE results
are shown in red, CRVE in blue and AVR in green. Mean bias is denoted by longer dashes, and upper





















































































































































































































































































































































































































































































































































































































































































Normotension Pre- hypertension ≥Stage I hypertension
Dx’d Undx’d Dx’d Undx’d Dx’d Undx’d
BPsyst 270 66 12 78 22 73 32 53
BPdiast 27 90 22 66 17 48
Table 24: Baseline blood pressure categorised by hypertensive status. ‘Dx’d’ = diagnosed. ‘Undx’d’ =
undiagnosed.
Variable F Significance
OU CRAE 8.56 <0.001
(11.20) (<0.001)
OU CRVE 0.49 0.747
(0.43) (0.730)
OU AVR 12.39 <0.001
(16.42) (<0.001)
Table 25: One-way ANOVA for retinal vessel calibre and NICE Guideline hypertensive classification,
showing CRAE, CRVE and AVR for inter-eye average measurements (OU). Values in parentheses for
one-way ANOVA using only first four categories for comparison, due to small sample size (6) for fifth
category: Severe hypertension. Values in italics are non-significant (p = >0.050).
Difference in classification
1-2 1-3 1-4 1-5
OU CRAE 5.21 14.95 16.41 12.01
OU CRVE 2.17 3.72 2.12 8.76




3 Stage I hypertension
4 Stage II hypertension
5 Severe hypertension
Table 26: Post-hoc Tukey’s HSD demonstrating the increasing degree of calibre difference (CRAE,
CRVE and AVR) with increasing NICE Guideline hypertension classification. Values in italics are non-
significant (p = >0.050).
Forward stepwise linear regression using data from one randomly selected eye for each subject pro-
duced three models which correlated CRAE with age, refractive error and systolic blood pressure, sum-
marised in Table 27. Age alone accounted for 15.5% of the total variance (p = <0.001), and this almost
doubles with the inclusion of refractive error (R2 27.1%, p = <0.001). Systolic blood pressure accounts for
a further 4% of variance, however inclusion of this variable reduces the overall prediction confidence (F





















Figure 27: Mean CRAE (in µm) when stratified by NICE hypertension classification. Red circles graphic-
ally demonstrate a reduction in artery calibre with increasing hypertension classification [not to scale].
Note the slight increase in artery calibre noticed in the uppermost category.
and level of exercise. Similarly, forward stepwise linear regression produced three models correlating
CRVE with age, refractive error and smoking status (also summarised in Table 27). Age alone accounted
for 10.5% of overall variability (p = <0.001). With the inclusion of MSE, this model accounted for 22.8%
of total variance (p = <0.001). The addition of smoking status into Model 3 accounts for 24.9% of total
variance, however reduces the prediction confidence from F = 35.6 to F = 26.6. Excluded variables were
systolic blood pressure, weight and alcohol intake.
5.3.2 Diabetes mellitus and retinopathy risk
Twenty-five (9.26%) subjects from the cohort reported having DM (Type I: 16; Type II: 9; summarised in
Table 28). Persons with DM ranged from 16 to 87 years (mean: 59.8 years ±18.15), with mean duration
of Type I DM being 14.25 years ±9.88 and Type II DM was 5.29 years ±3.61. Due to a small sample size,
statistical interpretation of these findings will be limited. Mean age of subjects with Type I DM was over
a decade less than those with Type II DM (55.44 years vs. 67.56), with mean age of the remaining cohort
sitting in between the two (58.18 years). CRAE was slightly reduced in Type II DM compared to both
Type I DM and Non-DM subjects. When compared to the non-diabetic cohort, CRVE was slightly raised
in the Type I DM sub-group, whereas it was reduced amongst those with Type II DM. AVR appeared to
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CRAE R2 F Significance
Model 1 (Age) 15.5% 44.6 <0.001
Model 2 (Age + MSE) 27.1% 44.9 <0.001
Model 3 (Age + MSE + BPsyst) 31.2% 36.5 <0.001
CRVE R2 F Significance
Model 1 (Age) 10.5% 28.5 <0.001
Model 2 (Age + MSE) 22.8% 35.6 <0.001
Model 3 (Age + MSE + smoking) 24.9% 26.6 <0.001
Table 27: Forward stepwise linear regression correlating cross-sectional cardiovascular variables with
vessel calibre.
remain similar across all three categories, although was slightly reduced in Type II DM (-0.03). There was
a substantial increase in calculated QRISK risk amongst those with diabetes. Type I DM QRISK was, on
average, double that of the non-DM sub-group (22.19% vs. 11.67%). There was an even larger shift seen
amongst those with Type II DM (29.13%). This increase in QRISK was reflected by an equal increase
in calculated Heart Age for both groups when compared to those where DM was not present. Mean
blood pressure, both systolic and diastolic, was consistent across all three groups. Reported HbA1c was
higher amongst those with Type I DM (73.09mmol/mol) than Type II DM (48.93mmol/mol). Calculated
RetinaRisk, i.e. the risk of developing sight threatening (proliferative) retinopathy in 1 and 5 years was
greater amongst those with Type I DM than those with Type II (5 year risk 7.65% vs. 4.25%). Incidence of
co-morbidity amongst those with DM (as shown in Table 29) was greater (8 of 9 subjects) amongst those
with Type II DM, compared to those with Type I DM (12 of 16). For both types, this was predominantly
hypertension and hyperlipidaemia.
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Table 28: Descriptive statistics of patients with diabetes mellitus. ‘DM-I’ = Type I diabetes mellitus;
‘DM-II’ = Type II diabetes mellitus; ‘Non-DM’ = non-diabetic.
Hypertension Hyperlipidaemia Other Nil
DM-I ( /16) 7 6 6 4
DM-II ( /9) 4 5 2 1
Table 29: Co-morbidity within subjects with diabetes mellitus.
5.3.3 Cardiovascular risk and ARIC-based stratification
Of the cross-sectional cohort, 125 subjects fell within the age range included in the original ARIC study
(51-70 years). Five subjects were excluded from analysis as they did not have vessel data due to image
quality, leaving 120 for the subsequent analysis. These subjects were stratified according to ARIC-derived
AVR quintiles. This is shown graphically in Figures 28 and 29; for the whole study cohort and that falling
within the same age range as the original ARIC study. Normal distribution was confirmed through nor-
mal quantile-quantile plots and Kolmogorov-Smirnov testing for each variable (blood pressure (systolic
and diastolic), CRAE, CRVE, AVR, QRISK, Mayo Clinic 30-year Risk). Pulse oximetry correlations were
insignificant (p = >0.050). Independent t-tests were run on the each variable for the two groups (upper
and lower quintiles) (see Table 31). Levene’s Test for Equality of Variance showed that for all significant t-
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test results, equal variance could be assumed. For those variables with non-normal distribution (QRISK
Risk Ratio, Mayo Clinic Controlled 30-year Risk and NICE hypertension classification), Mann-Whitney
U-tests were performed instead (see Table 32). Significant differences between upper and lower quin-
tiles were found in a number of cardiovascular metrics. Blood pressure, both systolic and diastolic, was
found to be increased in subjects falling in the lower quintile compared to the upper (+18.44mmHg (±
5.08) systolic; +9.17mmHg (± 3.50) diastolic). On average, this makes participants in the lower quintile of
AVR data one NICE hypertension classification grade higher than the upper quintile. QRISK scores were
4.40% (± 2.16) greater in the lowest quintile. Mean QRISK for the upper quintile was 9.88% (± 4.89),
whilst the lower quintile was 14.28% (± 7.34). This finding was also observed, albeit to a greater extent
between the quintiles, with Mayo Clinic 30-year risk calculations (17.14% (± 6.32)). Upper AVR quintile
for Mayo Clinic 30-year risk averaged 19.21% (± 16.67), whilst lower quintile had a mean of 36.35% (±
21.17). Whilst AVR is derived from both CRAE and CRVE, independent t-tests showed opposite changes
in the different vessel types; CRAE was found to be decreased in the lower quintile (-26.05µm (± 5.31)),
whilst CRVE was found to be increased (+19.59µm (± 5.73)); an overall reduction in AVR was found in
the lowest quintile compared the highest (-0.21 (± 0.01)). Mann-Whitney U-tests showed a significant
difference in both QRISK Risk Ratio (U = 44.5, p = 0.001) and NICE hypertension classification (U = 60.0,
p = 0.001), but no significant difference in Mayo Clinic Controlled 30-year Risk.
5.4 Discussion
5.4.1 Hypertension and NICE-based blood pressure classification
Blood pressure has been shown to have a robust inverse correlation with retinal artery calibre. Histor-
ically this was reported through a reduction in AVR (employing the erroneous assumption that venular
calibre remains unchanged), although latterly this has been more specifically driven towards the arter-
ies in isolation (CRAE). One-way ANOVA confirms both of these findings; that there is a reduction in
CRAE and AVR with increased blood pressure. It is perhaps interesting to observe that there seemed to
be an apparent increase in CRAE for those subjects in the highest NICE classification category (Figure
27). Of the six subjects in this category, only 2 had received a formal diagnosis of hypertension (although
one of these was not taking their medication). The magnitude of blood pressure is perhaps indicative
of significant cardiovascular compromise. Whilst not directly comparable, it has been shown that, for
advanced hypertensives, a loss in autoregulation results in increased arteriolar lumenal diameter in the








































Cross-sectional inter-eye average Arterio-Venous Ratios (Whole ARIC cohort quintiles)
Figure 28: Scatterplot of AVRs for cross-sectional cohort with reference ARIC-based quintiles overlaid.









































Cross-sectional inter-eye average Arterio-Venous Ratios (ARIC cohort stroke-based quintiles)
Figure 29: Scatterplot of AVRs for ARIC-equivalent age range only (51-70 years) and ARIC-based quintiles
of CVD event (stroke) overlaid. Quintile cut-offs displayed above each line.
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n 125 17 19
Gender: Female [Male] 72 [48] 10 [7] 12 [7]
Age (years) 59.59 (± 6.04) 60.59 (± 6.12) 61.37 (± 6.38)
BPsyst (mmHg) 134.44 (± 18.72) 150.65 (± 13.85) 132.21 (± 16.33)
BPdiast (mmHg) 85.23 (± 11.30) 91.65 (± 2.25) 82.47 (± 11.45)
BPM 68.34 (± 9.56) 67.31 (± 9.44) 69.68 (± 9.23)
Height (m) 1.772 (± 0.05) 1.73 (± 0.06) 1.72 (± 0.04)
Weight (kg) 77.10 (± 10.35) 79.38 (± 12.19) 72.85 (± 10.97)
BMI (kg/m2) 25.93 (± 3.31) 26.50 (± 3.58) 24.67 (± 3.23)
CRAE (µm) 170.60 (± 15.24) 152.62 (± 13.24) 178.66 (± 17.95)
CRVE (µm) 201.30 (± 16.41) 207.82 (± 17.54) 188.23 (± 16.78)
AVR 0.85 (± 0.07) 0.73 (± 0.02) 0.95 (0.03)
QRISK calculation (%) 10.77 (± 7.18) 14.28 (± 7.34) 9.87 (± 4.89)
QRISK Risk Ratio 1.48 (± 0.81) 1.99 (± 0.91) 1.24 (± 0.39)
QRISK Heart Age (years) 63.77 (± 8.10) 68.50 (± 6.76) 64.18 (± 7.44)
Mayo Clinic 30-year
Risk (%)
28.36 (± 19.04) 36.35 (± 21.17) 19.21 (± 16.67)
Mayo Clinic 30-year
Controlled Risk (%)
16.90 (± 11.43) 16.88 (± 13.84) 11.47 (± 11.20)
NICE hypertension
classification
2.48 (± 1.02) 3.35 (± 0.61) 2.26 (± 1.10)
Table 30: Descriptive data for included cohort based on ARIC age range (51-70 years); split into whole
cohort, upper and lower quintiles. Original ARIC quintile cut-offs shown in parentheses.
Variable Mean Difference (SE) Significance (p)
BPsyst 18.44 (± 5.08) 0.001
BPdiast 9.17 (± 3.50) 0.013
CRAE -26.05 (± 5.31) <0.001
CRVE 19.59 (± 5.73) 0.002
AVR -0.21 (± 0.01) <0.001
QRISK calculation 4.40 (± 2.16) 0.050
Mayo Clinic 30-year Risk 17.14 (± 6.32) 0.010
Table 31: Independent t-tests comparing subjects falling into the upper and lowerARIC-derived quintiles.
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Variable Test Statistic (U) Significance
QRISK Risk Ratio 44.5 0.001
Mayo Clinic Controlled 30-year Risk 131.0 0.346
NICE hypertension classification 60.0 0.001
Table 32: Mann-Whitney U-test comparing subjects falling into upper and lower ARIC-derived quintiles
(for those parameters not deemed to be normally distributed in either or both categories). Values in italics
are non-significant (p = >0.050).
Variable Lower AVR quintile Upper AVR quintile
Diagnosed Undiagnosed Diagnosed Undiagnosed
n 10 7 4 15
Mean BPsyst 148.00 (± 10.92) 155.00 (± 15.53) 137.00 (± 18.45) 131.00 (± 14.69)
Mean BPdiast 93.00 (± 10.29) 90.00 (± 6.56) 83.00 (± 12.09) 82.00 (± 6.61)
≤ Pre-hypertensive
(Grade III) 1 1 3 11
≥ Stage I hypertensive
(Grade IV) 9 6 1 4
QRISK 13 (± 7.16) 16 (± 6.68) 14 (± 4.15) 9 (± 4.57)
Table 33: Blood pressure characteristics stratified by upper and lower ARIC-derived AVR quintiles. Quin-
tiles split on basis of formal hypertension diagnosis. Note the number of undiagnosed cases with blood
pressure falling in Stage I hypertension category or above (highlighted in bold) relative to the total
number of subjects in that cohort.
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root of this finding. Alternatively, at least two of the subjects in this category reported disliking the
procedure of sphygmomanometry. White-coat hypertension is a recognised and well-documented phe-
nomenon (>20/10mmHg between clinic and average daytime ambulatory blood pressure) and may also
account for the apparent increased arterial calibre, since the blood pressure measurement will not truly
reflect actual pressure[254, 13]. Additionally, the altered light reflex within an advanced atherosclerosed
arteriole may yield spurious results during the measurement process, with incorrect selection of the vis-
ible blood column and poorer contrast with surrounding retinal tissue. Ultimately, greater numbers will
be required to investigate this finding further. Since there was a comparatively small group in the top
blood pressure category (≥180/110mmHg; n=6), exploration on whether this sample size had an effect on
the overall significance of the test revealed a persistent significance even when this uppermost category
was omitted from the test. To further explore the inverse correlation between blood pressure and CRAE
and AVR, a post-hoc Tukey’s test showed, perhaps unsurprisingly, that the effect was larger (for both
measures) when the blood pressure categories were further apart. This reinforces the linear nature that
there is a greater reduction in CRAE (and AVR) with an increased level of blood pressure. Clinically
this suggests that an optometrist should expect to see a greater reduction in artery calibre with higher
blood pressure. This is a well-known phenomenon already, however static analysis allows for a definitive
quantification of this rather than subjective ‘intuition’.
Whilst there was no significant correlation between CRVE and blood pressure, the veins are known
to be affected by other aspects of cardiovascular disease which can arise through raised blood pressure
(see below). The lack of direct correlation between CRVE and blood pressure is also a finding extensively
reported elsewhere (see Chapter 2.4.1. Association of blood pressure and retinal vessel calibre).
5.4.2 Diabetes mellitus and retinopathy risk
The relative number of subjects with DM in the study cohort (9.25%) was reasonably reflective of the
incidence of DM within the UK (6%), however for the present study it meant there were comparatively
fewer subjects in order to perform statistical analyses. General observations of the results do give some
insight however and are suggestive that the data is reflective of the different pathophysiological pro-
cesses associated with DM and DR. The mean age for Type II DM for instance was greater than both
Type I and the non-DM sub-groups, which tallies with this type of DM having a tendency to develop
in later life (when considering young-onset Type II DM as a separate pathological entity). Because of
this, the likelihood of co-morbidity increases, which is again reflected in both the raw data of co-morbid
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incidence (Table 29) and the significantly increased QRISK calculations. Given the shorter average dur-
ation of Type II DM, the slight decrease in CRAE and CRVE compared to Type I and non-DM subjects is
similar to that previously reported as being associated with ‘incident DM’; theorised as the early vascular
changes in DM (see Chapter 2.4.2 (Association of diabetes mellitus and retinal vessel calibre)). Also, the
trend continues with an increased CRVE relative to both Type II and non-DM subjects, in what could
be considered more ‘established’ cases of DM. Duration of DM is known to be a significant risk factor
for developing DR, and this is reflected in the higher estimated risk as determined by the RetinaRisk
algorithm for both 1 and 5 years. This is perhaps also influenced by the higher mean HbA1c amongst the
Type I DM subjects compared to those with Type II. HbA1c has a strong, independent positive correla-
tionwith development or progression ofDR, especially once levels rise above 48-51mmol/mol (6.5-6.8%);
and is seen in both types of DM[255, 256, 257, 258, 259]. Although a much larger diabetic sample is required,
RetinaRisk has the potential to help formulate a management plan for patients at the time of their eye
examination. Although the application is designed to be patient-facing, usage of the internal algorithm
has demonstrated a significant improvement in frequency of retinopathy assessments in individuals;
lower risk patients are seen at greater intervals than those at higher risk. In optometric practice, the
RetinaRisk application could be used in conjunction with retinal vessel calibres to formulate a manage-
ment plan and decide on the review interval for the patient. More work is required to correlate the two
in order to establish structured management and intervention pathways, but in principle the approach
would have a very useful clinical application. Whilst the cohort size is limited, the initial conclusions
appear to follow the established trends reported elsewhere. A focussed study using a much larger num-
ber of subjects with DM is required to produce more definitive statistics, but should also focus on the
sub-types of DM, since it is likely that the underlying pathological processes may have different effects
on the retinal microcirculation.
5.4.3 Cardiovascular risk and ARIC-based stratification
Whilst methods of categorising and stratifying cardiovascular risk and blood pressure exist with rel-
evant intervention criteria, no such framework currently exists for retinal vessel calibre. This reflects
their current standing in the management of patients in that the retinal vessel appearance is simply a
confirmation or incidental observation, additional to the diagnostic criteria. The conclusions from the
original ARIC study were based upon the formulae derived by Hubbard et al., and comparison to these
findings are a good initial step in defining cut-off values and intervention thresholds. As cardiovascular
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disease is a multi-faceted condition, a binary end-point was adopted to allow simpler classification of
cardiovascular risk based upon vessel calibre (i.e. incident stroke). The original ARIC study reported
that those subjects in the lowest quintile of AVR were 18% more at risk of incident stroke than those
in the uppermost quintile. This was much greater for those without pre-existing cardiovascular disease
(RR 2.85). The present study cohort indicated a similar trend when comparing other metrics from upper
and lower AVR quintiles. Blood pressure, one of the key contributors to cardiovascular risk, was found
to be elevated between the two quintiles. Both average systolic and diastolic blood pressure for the low-
est quintile (150.65mmHg / 91.65mmHg respectively) fall within NICE guidelines ‘Stage I hypertension’
classification; thus requiring intervention. Conversely, for the uppermost quintile, mean systolic and
diastolic blood pressures would both be considered ‘pre-hypertension’. A greater proportion of subjects
in the lower quintile were currently undiagnosed for hypertension, yet their blood pressure was recor-
ded above the Stage I hypertension threshold (140/90 mmHg); 6 of the seven subjects met this criteria
(85.71%), compared to only 26.67% of the upper AVR quintile cohort. This is supported by an increased
QRISK score between the quintiles. Whilst the mean difference is only 4.40%, the absolute mean values
for each quintile straddle the NICE intervention threshold of 10%. Taking only the undiagnosed cases
of hypertension, the mean QRISK score is almost double in the lower AVR quintile when compared to
the upper (16% vs. 9%).
Whilst AVR has been criticised previously for it’s lack of specificity regarding the vessel type affected,
independent t-testing showed that as well as general changes in AVR, there were bi-directional changes
in CRAE and CRVE with lower ARIC-derived AVR quintiles. A number of factors could explain this. Hy-
pertension is considered the leading modifiable risk factor associated with stroke[260, 261]. As such, those
most at risk of incident stroke will be more likely to have raised blood pressure. As mentioned previ-
ously, a strong inverse correlation exists between raised blood pressure and reduced CRAE (and AVR).
This could explain the increased incidence of Stage I and II hypertension in the lowest quintile, as well
as increased QRISK scores. Whilst the underlying pathophysiology is not understood, a positive correla-
tion between CRVE and stroke has previously been reported (see Section 2.4.3 (Association of stroke and
retinal vessel calibre)). Differences in the classification of stroke exist, with ARIC classifying as either
ischaemic or haemorrhagic (with the Rotterdam study adopting a similar stratification[158, 159]), whilst
others opt for a more general grouping of ‘stroke’[155, 262]. Arguably since an optometrist is not able to
perform the requisite investigations to determine stroke sub-type (and the clinical intervention for risk of
stroke is not dependent on type[263]) even a broad grouping of stroke is sufficient (although Wieberdink
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et al. suggest that increased CRVE is more indicative of haemorrhaging stroke, particularly in those tak-
ing anti-coagulants[159]). More recent studies investigating retinal vessel calibre and stroke have pointed
towards an, as yet, unexplained increase in CRVE with increased risk of stroke[158]. Both hypoxia and
similarities to early stages of DR progression have been suggested as possible mechanisms[158, 127]. Both
arterial narrowing and venular dilation, as reported previously in the literature as being associated with
stroke and cardiovascular risk, have been demonstrated in the present cohort in the lowest quintile of
AVR, itself associated with incident stroke.
The ARIC-derived quintiles are not perfect. Just as the Mayo Clinic Cardiovascular Risk calculations
over-estimate when compared to a locally derived formulae (QRISK), the same population-bias could
be attributed to these quintile cut-offs. Whilst AVR is less susceptible to magnification errors or overall
image size, methodological differences (such as measurement software) exist between the present study
and ARIC which could impact on the accuracy of the cut-offs. The cut-offs are also linear across the
ARIC age-range, yet natural ageing is known to affect vascular calibre, independent of ethnicity or any
pathology process[187, 264, 265, 131]. For use as a clinical decision making tool, cut-off values would need to
consider this natural ageing process (and be extended beyond the current range).
5.4.4 Study limitations
Undertaking such a study in clinical practice means that, by it’s very nature, methodological issues
may impact upon the validity of the results. As discussed in Chapter 3.3 (Sample size and patient
recruitment), to carry greater statistical weight a sample size calculation should be performed in order
to demonstrate whether the cohort used is large enough to yield meaningful results. Since the present
study is observational, and for reasons discussed in the aforementioned section, determination of a
sample size in this instance is difficult. Whilst the results found have been found to be statistically
significant (and it is therefore possible to suppose that these findings are clinically significant), it can-
not be said with absolute confidence that they are applicable to the population as a whole; only to the
cohort in the present study. However, what these results demonstrate (particularly those in smaller
sub-samples such as the diabetic cohort) is areas for future research to focus on; with a more targeted
research question, it becomes more feasible to perform a sample size calculation.
Of equal consideration is the ethnic representation of the present sample. A restricted geographic
sample is advantageous when correlating with other variables which are equally stratified by location
(i.e. QRISK), and also since if any ethnic variations do exist, when considered as one sample they have
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the potential to attenuate any ethnic-specific correlations. The lack of diversity within the sample does,
however, prevent any generalisation of findings. Correlations within the present sample, whether in
agreement or not with the established literature, cannot be expanded to relate to the entire UK popu-
lation as it does not truly reflect the genetic and ethnic diversity within it. Subsequent studies, most
likely adopting a multi-centre approach, will need to test for any geographic or ethnic variations in the
correlations reported here. Whilst a geographic element may exist, it is more likely that levels of retinal
pigmentation may indirectly influence results by enhancing (or reducing) vessel edge contrast. It is only
possible at present, therefore, to apply observed correlations to the localised Caucasian population.
Finally, with respect to calculated inter-eye average vessel calibre measurements, the impact of loc-
alised vascular pathology on these measurements needs to be fully determined. In the present study,
these effects were mitigated by simply removing the affected eye from analysis. Whilst it was demon-
strated with the present sample that there is good agreement between eyes (including those with local
pathology), the potential influence of local pathology needs to be explored to discover if there is a level
of disease severity where summary measurements are impacted by significantly different results.
5.4.5 Conclusion
Having inter-eye (OU) averages enables clinicians to explore systemic associations with the retinal vas-
culature whilst also attempting to reduce the intra-eye variations (as described in detail in Chapter 4 (Re-
peatability and Variability in Objective Static Retinal Vessel Calibre Measurement)). The cross-sectional
cohort demonstrates a good level of agreement with the existing research literature. Whilst the meth-
odology may not be as stringent as lab- and hospital-based studies, the correlations with cardiovascular
metrics (blood pressure, stroke and diabetes) reported elsewhere have been reproduced with similar ef-
fects in the present study. Finger-tip pulse oximetry was not found to be correlated significantly with
any ocular vascular parameters, and this is perhaps reflective of the limitations of the device for accurate
classification. Instead, the pulse oximeter can be used as a gross assessment of pulmonary exchange,
thus enabling elimination of this as a potential co-founder. The findings suggest that routine objective
measurement of retinal vessel calibre could be used in conjunction with blood pressure measurement
and cardiovascular risk calculations. A patient falling in the upper quintile of AVR is, on average, 4%
less at risk of a cardiovascular event compared to a patient in the uppermost quintile. There is also
a much greater incidence of potentially undiagnosed hypertension in the lowest quintile. Using both
retinal vascular calibres and dedicated algorithms to evaluated subjects with DM is also useful. Whilst
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more extensive work is required to produce statistically robust results, the present findings appear to
support those theories already established elsewhere. Despite a current lack in professional guidance
and intervention strategies based upon retinal vascular measurements, their use in clinical practice can
serve two purposes. Firstly, they enable a clinician to accurately quantify the vessels and evaluate both
arms of the circulation in relation to ocular and systemic factors. Secondly, they can serve as a reinfor-
cer for patients when management is being given, such as in cases of undiagnosed hypertension. Here
the blood pressure measurement itself is backed up with a sign of structural change which is strongly
associated with the increase in pressure. Whilst the ARIC quintile system has not been validated against
a UK-based population, it serves as a starting point from which clinicians can start to stratify their pa-
tients and make more reasoned clinical judgements based on retinal vessel calibre measurements. The
current findings suggest that it is feasible to apply cut-off values to retinal vascular measurements to
help refine individual patient management and clinical decision making.
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6 LongitudinalChanges inRetinalBloodVesselCalibreObserved
Between Routine Optometric Eye Examinations
6.1 Introduction
Following cross-sectional associations between retinal vascular calibre and both local and systemic patho-
logies, the clinical usefulness of objective vessel analysis lies in it’s application in the long-term mon-
itoring of patients. Of the studies undertaking longitudinal observation of participants (see Chapter 2
(Associations of Retinal Vessel Calibre with Cardiovascular Disease: A Systematic Literature Review)) the
average interval between visits was between 3 and 5 years, whereas patients will typically visit their op-
tometrist every 1 to 2 years. This interval could, therefore, still be considered ‘short-term’ in relation to
these studies. Since small intervals in time between image acquisition (several seconds and several days)
have been examined to demonstrate levels of repeatability for a single visit (see Chapter 4 (Repeatabil-
ity and Variability in Objective Static Retinal Vessel Calibre Measurement)), the inter-examination vessel
measurements also need to be explored. Applying the ‘single visit’ variability as a benchmark, measure-
ments and correlations falling outside of this range could point towards areas of improved detection and
diagnostic capabilities.
Previous repeatability studies have highlighted that vessel selection is a key detractor to intra- and
inter-grader reproducibility[113, 187]. Since patients in practice will be presenting usually 12 months later
for a follow-up examination, consistent vessel re-selection needs to be ensured and a method of recalling
the previous examination’s vessel selection is required.
When considering correlations between retinal vessel calibres and systemic cardiovascular health,
there are three principle metrics which can change; vessel calibre, blood pressure, and cardiovascular
risk score. Each of these variables can be measured both continuously and categorically, however it is
the latter which forms the backbone of clinical management guidelines (where applicable). Retinal ves-
sel calibre can be measured with absolute values (µm) or with an ARIC-based score. Blood pressure’s
measurement in millimetres of mercury (mmHg) can then be grouped into tension categories (hypo-,
normo- and (stage I / II / severe) hypertension) which carry different management criteria. This also
applies to cardiovascular risk score, with UK NICE guidelines referencing values from the QRISK2 calcu-
lator; specifically recommending intervention when risk exceeds 10% (a lowering of risk from previous
guidance with a 20% threshold)[227, 23].
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Metric Measurement unit Intervention
Vessel calibre µm –
Blood pressure mmHg
• Stage I (>140/90mmHg)
• Between 40 and 80yrs: Cardiovas-
cular risk > 20%[23]
Cardiovascular risk % ≥10%[227]
Table 34: Measurement and points of intervention for cardiovascular metrics. Note the current lack of
guidance regarding vessel calibre changes.
6.2 Methods
For detailed methodological information see Chapter 3 (Materials & Methods). Longitudinal parti-
cipants were recruited throughout the study course and advised to return for a routine follow-up ex-
amination in line with College of Optometrists guidance for frequency of eye examinations[266], with
data from their baseline visit being used. All participants were recruited in optometric practice. Exclu-
sion criteria was limited to those not covered by the ethical approval (i.e. minors and those unable to
give informed consent) and those with significant media opacities resulting in poor quality and ungrade-
able photographs, even with pharmacological dilation. Briefly, the baseline visit involved collecting data
regarding health, family history and lifestyle; refractive status; ocular health; and cardiovascular meas-
ures.
6.2.1 Patient Health History
In line with both College of Optometrists guidelines on history and symptom collection, and also util-
ising questions featured in both the Mayo Clinic and QRISK cardiovascular health risk calculators, pa-
tients reported anecdotally their general health, including present medication, diagnosed conditions
(and whether they were being treated) and any conditions currently undiagnosed but borderline or un-
der investigation. Family history was also explored with additional emphasis on cardiovascular health
and occurrence of any cardiovascular events, especially in younger family members. Participants were
asked lifestyle questions, including past or present smoking status, average weekly alcohol intake (ap-
proximate number of units), daily diet (approximate amount of both saturated fats and portions of fruit
and vegetables per day, on a scale of ‘Few’ (≤1), ‘Some’ (2-4) or ‘A lot’ (≥5), daily caffeine intake (1-2 cups,
3-5 cups, >5 cups) and weekly exercise (Nil; <75 minutes vigorous/<150 minutes moderate; >75 minutes
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vigorous/>150 minutes moderate). Anecdotal height and weight were also recorded. Examples of all
categories were given to participants to improve consistency of self-reporting (see Appendix 5. Patient
Questionnaire for detail).
6.2.2 Refractive status
All participants underwent a routine objective refraction (static retinoscopy) followed by subjective re-
fraction by an experienced optometrist (CF). In cases of severe amblyopia or reduced vision or other
instances where a balance lens was prescribed, refraction was recorded as the objective refraction ob-
tained. Previous refractive status for participants having undergone refractive surgery (laser refractive
surgery, cataract/clear lens extraction etc.,) was also noted.
6.2.3 Ocular health
Routine undilated (except in cases of poor fundal view) ophthalmoscopic examination was performed
on all participants using a slit lamp biomicroscope and 78D condensing lens. Fundus photographs were
then obtained after pupil diameter had recovered sufficiently following ophthalmoscopy. 45°, full colour
disc- and macular centred fundus photographs were obtained using a Topcon 3D Maestro. Non-contact
IOP was measured with a calibrated Pulsair 3000 obtaining three readings per eye.
6.2.4 Cardiovascular measures
Digital sphygmomanometry was performed with the subject seated at the end of the examination, with
time having elapsed following non-contact IOP recording (approximately 5 minutes) to allow blood
pressure of subjects disliking this procedure to return to normal. Subjects were instructed to remove
thick sleeves and to remain still and quiet during measurement. The cuff was applied level to the heart
and three readingswere taken, with aminute interval between each. The average of the final two readings
was then used in analysis. If there was a difference of ≥10mmHg between readings, further readings
were taken until three within this range were obtained. Heart rate (in BPM) was also recorded. Finger-
tip pulse oximetry was obtained from the index finger of the right hand; applied for 30 seconds and a
reading taken when measurement had stabilised.
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6.2.5 Cardiovascular Risk and ARIC-derived cut-offs
As explained previously in Section 5.2.6 (Cardiovascular risk and ARIC-derived cut-offs), in the absence
of official intervention criteria for vessel calibres, the original study from which the formulae were de-
rived and validated offers the benchmark of predicting incident stroke; itself a surrogate measure of
‘cardiovascular risk’. The absolute cut-off values for the quintiles were obtained from the study’s named
statistician, and these values were applied as the cut-offs (shown in Table 21).
6.2.6 Image analysis
All images were exported both in full colour (for vessel reference) and red-free (for measurement) in
uncompressed TIFF files. Images were then imported into VesselMap v3.0 for analysis. Analysis was
performed by an experienced grader (CF), having practiced on a bank of >150 images prior to analysis.
Images were batch analysed at time points several months after image acquisition with no access to
patient notes.
6.2.7 Statistical analysis
Statistical analysis was performed using SPSS v25.0 (IBM), however this was limited by the numbers
of participants involved. Natural drop-out of participants over the course of the study and the uneven
follow-up period, with some participants presenting much sooner than others, had a significant impact
on the final numbers included for analysis (and thus prevented any complex statistical interpretation).
There was no significant variation between right and left eye measurements, therefore inter-eye (OU)
averages were used for systemic correlations (with eyes affected by localised pathology excluded). To ex-
plore variance of vessel calibres over time, Pearson correlations were used initially to determine whether
time interval needed to be considered a co-variable (and thus necessitating the need for an ANCOVA in-
stead). Examination time interval and absolute change in vessel calibres were insignificant (p = >0.050)
for all three measures (CRAE, CRVE, AVR) in either eye. Correlations between examination interval
and vessel calibres remained insignificant even when the largest interval for each participant was used
(i.e. between initial and final visits). Bland-Altman difference-versus-mean plots were used to explore
measurement differences across examinations.
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6.3 Results
Analyses were broken down into two categories; 12 months (± 6 months) from baseline, and 24 months
(± 6 months) from baseline. 122 subjects were included in the 12 month follow-up, and 55 in the 24-
month follow-up; 11 of whom it was their first follow-up (i.e. they were not included in the 12-month
follow-up).
Of those subjects who did not return for follow-up examination, 9 were enrolled too close to the end
of data collection (i.e. <6 months). Two subjects died before they could attend follow-up appointments.
There were no statistically significant differences in characteristics between those who returned and
those who did not aside from blood pressure; both systolic (t = -2.288, p = 0.023, mean difference =
-5.53mmHg) and diastolic (t = -3.037, p = 0.003, mean difference = -4.55mmHg).
Bland-Altman plots (see Figure 30) comparing baseline and maximum interval show wider spaced
limits of agreement compared to those taken in the Methodology study (see Chapter 4), with a similar
distribution of data points. When stratified by time interval between visits (12 months ± 6 months and 24
months ± 6 months), Bland-Altman plots then show closer spaced limits of agreement across the initial
twelve-month period (CRAE LoA: ±13.74; CRVE LoA: ±15.45) compared to across the twenty four-month
period (CRAE LoA: ±20.14; CRVE LoA: ±20.36).
6.3.1 NICE-based blood pressure classification
Hypertensive status of subjects ranked by their absolute change in blood pressure are shown in Table 36.
These are further sub-classified into diagnosed hypertensives and those without. Absolute changes (in
mmHg) are shown for both systolic and diastolic blood pressure. Clinically, changes in NICE Guideline
classification are shown in Table 37 (for 12 months) and Table 38 (for 24 months). ANOVA revealed
no significant correlation between change in blood pressure (systolic or diastolic) or beats per minute
(p = >0.050) over the study course. Small sample sizes for larger changes in blood pressure prevent
robust statistical analysis being performed. For both 12- and 24-month follow-up, a greater number of
subjects had a reduction in blood pressure (systolic and diastolic) compared to an increase (65 vs. 41
for 12 months and 28 vs. 16 for 24 months respectively). There was also a large number of undiagnosed
Pre-hypertensives and Stage I hypertensives identified in both the 12-month and 24-month follow-up
(these were mixtures of both categories at baseline and/or follow-up); and this was a greater proportion
than those with diagnosed hypertension. Of the 31 subjects with hypertension diagnosed throughout
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Figure 30: Bland-Altman difference-versus-mean plots showing the mean bias between baseline CRAE
and CRVE and 12-month (upper panel) and 24-month (lower panel) follow-up. CRAE results are shown
in red andCRVE in blue. Mean bias is denoted by longer dashes, and upper and lower limits of agreement
(LoA) shown by smaller dashes. Note the near coincident 12-month upper LoA for CRAE and CRVE.
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24-months saw a similar increase. Greater numbers of diagnosed hypertensives at both 12- and 24-
month follow-up saw either a plateau or decrease in their blood pressure compared to baseline (16 and
8 respectively). With reference to NICE classification of blood pressure, only 2 subjects saw an increase
of two categories over a 12-month period (and also a 24-month period). In both cases, this saw a mean
increase of QRISK calculation of +10.60 and +9.00% for 12- and 24-months respectively. Mean QRISK
for these individuals at 12-months was 48.30% and 30.00% at 24-months (both higher than the 20%
intervention threshold). These changes were associated with a severe change in systolic blood pressure
(+45.67 and +20.50mmHg respectively) and only a mild to moderate increase in diastolic blood pressure
(+3.17 and +11.92mmHg respectively). Subjects who rose by +1 NICE category over the first 12 months had
a mild decrease in CRAE (-4.07µm ±5.99) and a slight increase in CRVE (+2.49µm ±10.25). Conversely,
over a 24-month follow-up, CRVE was seen to decrease (-5.05µm ±5.63), whilst CRAE only saw a very
small overall reduction (-0.52µm ±4.65). For those individuals who dropped by -1 NICE category similar
changes were observed. Over 12-months, CRAE decreased on average by -1.22µm ±8.18, whereas across
24-months follow-up, this same drop in category saw an average CRAE increase of +4.34µm ±4.92. Over
these same periods, CRVE saw only a mild increase in the first 12-months from baseline (+0.09µm ±8.08)
and a slightly larger increase over 24-months (+2.91µm ±5.90). For individuals whose blood pressure fell
in NICE hypertension category, there was a progressive decrease in the calculated QRISK and Heart
Age. For those who fell by a single blood pressure category, there was a -0.65% and -1.16% over 12-
and 24-months respectively. The effects were doubled for individuals falling by two NICE hypertension
categories over the same time periods (-3.27% and -3.63% respectively). Only those individuals whose
blood pressure category did not change over the 12-month review period had a mean QRISK that was less
than the 10% intervention threshold (9.45%±10.12). QRISKwas higher for those individuals with extreme
changes in blood pressure (i.e. +/- two NICE categories); with a mean baseline QRISK of 37.70% (± 8.00)
for those who rose by 2 categories, and a mean baseline QRISK of 24.57% (± 7.24) for those whose blood
pressure fell by two categories. This effect was seen at a similar magnitude for the 24-month follow-
up also (21.00% (± 6.40) and 22.57% (± 9.11) for +2 and -2 categories respectively). Real age-heart age
disparity was greatest amongst those who rose by two categories (+7.50 years) over 12-months, but was
greatest for those who fell by two categories over 24-months (+8.67 years); although the same category
for 12-month follow-up also saw a 6 year real age-heart age disparity. CRAE andCRVEwere approximately
6µm greater in those individuals who saw no change to their blood pressure classification over the initial
12-months of the study. For those individuals who were reviewed at 24 months, mean baseline CRAE
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Interval n Normotension Pre-hypertension ≥Stage I hypertension
Dx’d HT Undx’d Dx’d HT Undx’d Dx’d HT Undx’d
12 months 122 5 36 10 37 16 16
24 months 55 2 13 7 16 7 10
Table 35: Cohort sizes based on NICE hypertension classification, split between those with pre-
diagnosed hypertension (Dx’d HT) and undiagnosed (Undx’d). Data shown for both 12- and 24-month
follow-up.
and CRVE were slightly greater (by a similar amount) in the +1 category, rather than no change.
6.3.2 Diabetes mellitus and retinopathy risk
Mean baseline data is summarised in Table 39 and average changes are shown in Table 40. Nineteen
participants enrolled reported having either Type I (n = 10) or Type II (n = 9) diabetes mellitus. More
males had Type II DM compared to females (6 vs. 3). Those with Type I DM were of a younger mean
baseline age (57.40 years ±19.91 vs. 67.56 years ±11.14) and had a longer duration of the condition (13.80
years ±10.58 vs. 5.29 ±3.61) compared to Type II DM.Mean baselineHbA1cwas higher amongst thosewith
Type I DM (73.43mmol/mol ±29.52) and also increased by a greater amount over the follow-up period
(+6.70mmol/mol ±33.37). Baseline BMI was greater amongst those with Type I DM compared with Type
II (28.15 ±4.10 vs. 25.96 ±3.41); all but one subject reported ‘no change’ to their weight at subsequent
follow-up visits. There was no significant correlation between BMI and HbA1c for all diabetic patients,
or when split into Type I and Type II (p = >0.050). Systolic and diastolic blood pressure at baseline were
very similar between both groups (129.77mmHg ±17.34 vs. 131.78mmHg ±5.06 and 79.50mmHg ±12.19 vs.
83.30mmHg ±10.76 respectively). Systolic blood pressure was seen to decrease during follow-up amongst
the Type II DM cohort (-4.04mmHg ±11.27); with there being little mean change in the Type I cohort
(+0.12mmHg±16.85). Bi-directional changeswere seen in diastolic blood pressure, with Type IDMseeing
a slight increase (+2.30mmHg ±9.37) and Type II a slight decrease (-1.96mmHg ±8.25). Baseline QRISK
score was higher than the specified 10% intervention threshold, more so with Type II DM (27.36% ±12.62)
than Type I DM (21.12% ±12.02); QRISK was seen to increase in both groups, but this was also more so
amongst Type II DM (+1.46% ±3.17 vs. +0.56% ±0.66). Baseline Heart Age was lower amongst Type I
DM (73.17 years ±10.38), however there was also a greater mean baseline real age-heart age disparity
compared to Type II DM (18.00 years ±3.06 vs. 9.11 years ±6.64). Mean baseline CRAE was less (and less







Normotension Pre-hypertension ≥Stage I hypertension
Dx’d HT Undx’d Dx’d HT Undx’d Dx’d HT Undx’d
BPsyst↑ 41 10 1 11 2 14 7 6
BPdiast ↑ 46 10 2 16 4 14 4 6
BPsyst = 4 1 0 2 0 1 1 0
BPdiast = 3 0 0 1 0 2 0 0
BPsyst ↓ 65 16 2 28 9 15 5 6






Normotension Pre-hypertension ≥Stage I hypertension
Dx’d HT Undx’d Dx’d HT Undx’d Dx’d HT Undx’d
BPsyst↑ 16 2 0 4 0 6 2 4
BPdiast ↑ 15 5 0 5 3 4 1 2
BPsyst = 0 0 0 0 0 0 0 0
BPdiast = 3 0 0 2 0 1 0 0
BPsyst ↓ 28 8 2 8 3 12 3 0
BPdiast ↓ 26 5 1 15 2 2 1 4
Table 36: Hypertensive status classified by overall blood pressure change between visits (upper: 12
months from baseline; lower: 24 months from baseline). Data is split between those with pre-diagnosed
hypertension (Dx’d HT) and those without any diagnosis (Undx’d), and shows data for increases (↑),















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































both Type I and II DM saw a similar change in CRAE during follow-up (+2.64µm ±4.18 and +1.65µm ±7.16
respectively). Mean baseline CRVE was also reduced amongst those with Type II DM (195.45µm ±15.04)
by almost 10µm compared to those with Type I DM (204.70µm ±21.76). Baseline AVR was very similar
between both cohorts; 0.85 (± 0.04) and 0.83 (± 0.04) for Types I and II DM respectively. Calculated
1-year RetinaRisk at baseline was greater amongst those with Type I DM (1.49% ± 1.95). RetinaRisk was
also seen to rise by a greater amount amongst those with Type I DM compared to Type II (+1.37 ±1.50 vs.
+0.50 ±1.23). The distributions for these calculations was the same for 5-year RetinaRisk as the algorithm
simply increases them by a factor of five.
6.3.3 ARIC-based stratification and cardiovascular risk
Changes in recorded AVR over time for those subjects falling within the ARIC age-range are shown in
Figure 31. Given that follow-up time varied between subjects, with some presenting more frequently
than others, statistical analyses becomes complex and lacks the sample size to strengthen these more
elaborate tests. Those subjects in the upper and lower quintiles could be further classified by the time
point in which they featured in these categories. Subjects could either remain in the quintile for the
duration of follow-up (i.e. consistent); there could be an increase in AVR, which would lead to a rise in
quintile (NB; for those in the lowest quintile, this effectively means that they are no longer in this quin-
tile, whereas for the upper quintile this means a subject’s AVR has now entered this range); there could
be a decrease in AVR, leading to a fall in quintile, or there could be a non-linear change (“other”). The
distribution of individuals into each of these categories is shown in Table 41. Cardiovascular and retinal
vessel measurements for each upper and lower quintiles, stratified by longitudinal change category are
shown in Tables 42 and 43.
Considering each progression type (consistent, rise, fall, other) is limited due to sample size, it is
still possible to make general observations. Those AVRs in the uppermost quintile were generally more
stable (i.e. all visits measured as the uppermost quintile; 6 of 11 subjects) whilst the AVRs in the lowest
quintile had a greater number whereby the AVR increased to above the quintile cut-off during follow-
up (5 of 15 subjects). Both mean systolic and diastolic blood pressure were lower in the entire upper
quintile cohort (127.95 / 80.94mmHg), falling into the ‘pre-hypertensive’ NICE classification. This is
contrasted to the lower quintile, where mean systolic and diastolic blood pressure fell within the ‘Stage
I hypertension’ category (145.27 / 88.19mmHg). Blood pressure was highest amongst those who were





































































































































































































































































































































































































































































































































































































however both systolic and diastolic blood pressure dropped amongst these individuals on average by
-13.21 and -7.67mmHg respectively. A similar drop in blood pressure was observed amongst individuals
who were in the lowest ARIC quintile at baseline, but later rose above the cut-off during follow-up (-12.52
and -4.67mmHg respectively); this was accompanied by a slight drop in calculated QRISK (-0.32%) and
heart age (-0.20 years). There were no significant changes in pulse oximetry measurements over the 12-
or 24-month intervals in either quintile (p = >0.050).
All QRISK scores for those in the uppermost quintile were below the 10% intervention threshold sug-
gested by NICE Guidelines. The highest scores were amongst those who were consistently in the upper
quintile and those who fell below the quintile cut-off. The largest change in QRISK score for the upper
quintile was seen in those who were consistently in this category (+1.97%). Real age-heart age disparity
was greatest amongst the ‘Rise’ category in the upper quintile (+4.34 years), however this category had
the largest mean decrease throughout the duration of the study (-4.00 years). QRISK was consistently
greater than the 10% intervention threshold for the lower quintile, except for those individuals who rose
above the quintile cut-off throughout the follow-up period. Those who were consistently in the lowest
quintile had a mean QRISK score of 15.73% (compared to mean QRISK of 8.63% for those who were con-
sistently in the uppermost quintile), but it was those who’s AVR changes fell into a non-linear ‘Other’
change pattern who had the highest QRISK score (22.37%) and largest increase in QRISK across the dur-
ation of the study (+2.67%). Subjects in this category also had the highest recorded real age-heart age
disparity (+10 years), which also rose during the follow-up period (+1.33 years), albeit on the same level
as those who were consistently recorded in the lowest quintile (+1.25 years).
CRAE was greater for the upper quintile than lower (176.06 vs. 159.43µm), and was highest amongst
those individuals whowere consistently recorded as having anAVR in the uppermost quintile (183.71µm).
Conversely, the lowest mean CRAE was recorded amongst those who were consistently in the lowest
quintile (150.52µm). CRAE was seen to rise amongst those individuals whose AVR rose into the upper-
most quintile throughout the study (mean change of +2.10µm), whilst the biggest decrease in CRAE was
seen amongst individuals whose AVR fell into the lowest quintile after baseline (-5.90µm). CRVE was
seen to be lower amongst the uppermost quintile compared to the lowest (189.95 vs. 203.63µm). In
conjunction with the raised CRAE, this explains the higher overall AVR amongst this cohort. CRVE was
greatest amongst those whose AVR rose into the uppermost quintile, although this category saw the
largest overall decrease in CRVE across the follow-up (-8.27µm). CRVE was seen to increase by +8.14µm








































Longitudinal inter-eye average Arterio-Venous Ratios (ARIC cohort stroke-based quintiles)
Figure 31: Scatterplot of longitudinal changes in AVR for ARIC-equivalent age range only (51-70 years)
with ARIC-based quintiles of CVD event (stroke) overlaid. Quintile cut-offs displayed above each line.
largest for the consistent and non-linear ‘Other’ categories, being 207.19µm and 208.50µm respectively.
The largest longitudinal change over time was seen amongst the sub-group whose AVR fell below the
quintile cut-off throughout the study (+11.24µm). AVR was seen to increase amongst those who rose into
the upper quintile throughout the study (+0.03) and fell by an equal amount for those whose AVR fell
below the upper quintile cut-off as the study progressed. Consistent upper quintile individuals saw a
mean decrease of -0.01 in AVR, which was similarly seen amongst those consistently in the lowest quin-
tile (-0.02). The biggest change in AVR throughout the study was seen amongst those whose AVR fell
below the lower quintile cut-off during follow-up (-0.07), which was in contrast to those whose AVR rose
above the lowest quintile (+0.03).
6.4 Discussion
6.4.1 Hypertension and NICE-based blood pressure classification
The present study highlights the variability in blood pressure measurements over moderate time inter-
vals, with a significant number of individuals (40.98% at 12-months and 50.91% at 24-months) meas-
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Table 41: Distribution of subjects in upper and lower ARIC quintiles, based on longitudinal changes in
AVR.
uring in a different blood pressure category to that of their baseline one. Whilst a number of factors
would also need to be considered, including the time of readings and a detailed analysis of the patient’s
cardiovascular health to identify any asymptomatic changes, this supports the argument that optomet-
rists can assist in the management of patients through regular recording of blood pressure. This is also
highlighted by the high proportion of subjects meeting the NICE hypertension classification, but are
currently undiagnosed. Of the 89 subjects seen at the 12-month review (of a total of 122), only 16 (18%)
registered a blood pressure within the ‘normotensive’ classification range. Of those whose blood pres-
sure was higher than this, half fell into the ‘Stage I hypertension’ classification or higher. Sub-analysis
of these groups could potentially highlight morphological changes observed in the retinal vasculature,
although greater numbers are required to account for the variable duration of the diagnosed hypertens-
ives to whom they would be compared (since overall duration of hypertension and intervention will both
influence this group).
Interestingly, for those individuals who rose by oneNICE category over 24months saw amean change
in systolic blood pressure of 20.00mmHg (± 8.46). Whilst this change itself is similar to the interval
between some NICE categories, it should be noted that which categories individuals rose between has
not been factored for. Whilst the mean change is similar to those individuals who rose by 2 categories
(+20.00 vs. +20.50mmHg), and indeed baseline mean measurement are similar (116.87 (±15.24) vs. 118.33
(±1.00) mmHg respectively), there is increased variability in those who only changed by one category, as
demonstrated by the increased standard deviation. Despite this consideration, it can be supposed that
a number of those subjects who rose by one category are actually close to the threshold for a further
category increase, and thus the number of those rising by two categories may not be fully reflective of
the cardiovascular changes observed.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































pressure beyond those who saw a reduction in blood pressure category (i.e. their blood pressure was
higher at baseline than follow-up) were observed to have a slightly reduced baseline CRAE compared to
those whose blood pressure remained stable throughout. A limitation of the current study is that stable
blood pressure as defined by NICE classification categories does not account for those with persistent
hypertension, whether or not it is being treated. Due to the cohort size, splitting the categories down to
number of changes around each classification criteria would result in extremely small numbers, further
weakening any statistical arguments.
6.4.2 Diabetes mellitus and retinopathy risk
Both mean baseline age and duration of DM were reflective of the different pathogeneses of Type I and
II DM. Those with Type I were generally younger (with a mean difference from Type II DM of 10.16 years)
and had a longer duration of the condition, thus increasing the age gap at diagnosis. The larger number
of males with Type II DM is in line with reported incidence rates and a suggested higher susceptibility
(particularly at lower BMI) which is also observed in the present cohort[267]. The increased duration of
Type I DM, alongwith higher BMI, could also be reflected in the higherQRISK calculation for this cohort.
Prolonged disease duration, with potential decreased responsiveness to treatment, could account for an
impaired cardiovascular system and also be related to the increased BMI of these subjects. This is further
demonstrated by the increased real age-heart age disparity amongst these subjects; almost double that
of the Type II cohort. Previous epidemiological studies have shown duration of DM to be a significant
risk factor for further development of cardiovascular disease, with DM onset >10 years prior comparable
to a past history of heart attack and increased mortality[268, 269, 270]. Increased DM duration, HbA1c and
BMI are all considered to be independent risk factors for developing diabetic retinopathy[161, 271, 272, 273].
These are all reflected in the RetinaRisk calculations (which includes the duration and HbA1c); however
the algorithm does not account for BMI. It could therefore be considered supportive evidence of the
independent link between BMI and risk of DR development/progression that the RetinaRisk calculation
is indeed higher in the subjects with a higher mean BMI, despite no individual correlation between BMI
and HbA1c. Baseline retinal vessel measurements were not dissimilar to the rest of the cohort (see Table
44).
Consideration must be given, however, to the large non-diabetic cohort versus the relatively small
diabetic ones, plus the wide age-range and co-morbid nature of these groups; all of which have not been
accounted for. The relative narrowing of CRAE and CRVE amongst those with Type II DM compared to
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n CRAE CRVE AVR
Type I DM 10 175.06 (± 21.37) 204.70 (± 21.76) 0.85 (± 0.04)
Type II DM 9 161.31 (± 10.17) 195.45 (± 15.04) 0.83 (± 0.04)
Non-DM 245 172.43 (± 18.06) 201.16 (±18.10) 0.86 (±0.07)
Table 44: Baseline retinal vessel data for both diabetic and non-diabetic cohorts.
Type I could reflect the earlier microvascular alterations described in Chapter 2, Associations of Retinal
Vessel Calibre with Cardiovascular Disease: A Systematic Literature Review (see Section 2.4.2. Associ-
ation of diabetesmellitus and retinal vessel calibre) particularly given the much shorter duration amongst
this group. However, it could equally be explained by physiological differences observed in older sub-
jects, since the mean age of those with Type II DM at baseline was a decade greater than that of Type I.
In order to determine true changes observed in relation to pathologies such as DM, an accurate method
of accounting for what could be considered ‘natural ageing’ also needs to be employed. At present, the
changes observed, however significant, still fall below the threshold of measurement error and would
thus be considered clinically insignificant at this stage.
6.4.3 Cardiovascular risk and ARIC-based stratification
In the absence of official values relating to retinal vessel calibre (either individual CRAE / CRVE or an
aggregate such as AVR), the use of values based on the original study whereby the formulae used were
derived and tested offers a starting point for stratification. Whilst this is based on an AVR and doesn’t
give as much detail for the arteries and veins independently, it has the advantage of supporting evidence
in a larger cohort. The associations seen with this approach in the present cohort cross-sectionally has
good agreement with those reported by the ARIC study and elsewhere (see Section 5.4.3 Cardiovascular
risk and ARIC-based stratification). A number of these trends have been observed longitudinally also.
Blood pressure was lower in the upper quintile category, with the majority of individuals registering as
‘pre-hypertensive’, in contrast to the lowest quintile were individuals were ‘Stage I hypertension’. This is
in agreement with the established correlation between raised blood pressure and risk of stroke. Inter-
estingly, those individuals who were in the uppermost quintile at baseline, but proceeded to drop below
the cut-off (i.e. ‘fall’) had a mean blood pressure in the ‘Stage I category’ which saw a subsequent drop
to the ‘Pre-hypertensive’ category over the same time course. Whilst cohort numbers are small for this
category (n = 2), the conjunction of change in ARIC quintile and significant drop in blood pressure may
warrant further investigation into cardiovascular status. All subjects who rose to a higher ARIC quin-
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tile throughout the study saw a decrease in blood pressure, systolic more than diastolic. These changes
were, on average, greater than 10mmHg (although the standard deviations are also relatively high, as
a result of small cohort numbers), i.e. the changes would see a down-grading of the individuals’ NICE
blood pressure classification. This is echoed by decreases in calculated QRISK for these subjects, and in
the case of the lower quintile, bringing those individuals closer to the 10% intervention cut-off. There
is an opposite increase in QRISK for both those individuals who either fell a quintile throughout the
study, and those who remained consistently in the same quintile throughout. This poses the question
whether the changes observed in QRISK calculation are of a magnitude to reflect a clinical change in
the individual (i.e. the ‘Fall’ categories) or whether this is associated with natural ageing (i.e. the ‘con-
sistent’ categories). Again, both greater numbers and a more specific array of cardiovascular measures
(including blood samples and less reliance on anecdotal reporting from patients) would be required to
further investigate this point. Calculated Heart Age, also derived through the QRISK algorithm, changed
to different extents depending on quintile category. Those consistently in the uppermost AVR quintile
saw a 2-year increase in their Heart Age over the course of the study; however this was very similar to
their actual baseline age (61.83 vs. 61.33 years respectively). Those whose AVR rose into the top ARIC
quintile over the course of the study saw, on average, a 4-year reduction to their calculated Heart Age,
which was 4 years above their actual age at baseline (therefore, when factoring in the duration of the
follow-up, their final Heart Age would, on average, be less than their real age, implying a greater level
of cardiovascular health). There was a much greater real age-heart age disparity amongst individuals
in the lowest ARIC quintile; suggesting poorer cardiovascular health. Those who were consistently in
the lowest quintile had, on average, a Heart Age 4.75 years greater than their actual age. The greatest
disparity was, however, amongst those individuals who’s AVR had a non-linear change across the course
of the study (i.e. their AVR was intermittently graded as being in the lowest quintile). This was again
limited to a small sample size (n = 3), however it suggests an interesting sub-group warranting further
attention. This group had the highest QRISK scores (22.37%) and also the most variable blood pres-
sure at baseline (systolic blood pressure: 150.33 (± 18.46) mmHg). This was not reflected in their retinal
blood vessel measurements, which did not alter hugely from the other categories in this quintile. This
is perhaps unsurprising, since changes to the microcirculation are likely to not be as turbulent as other
cardiovascular metrics in the given timescale.
CRAE was markedly reduced in the lowest quintile (150.52µm ± 5.26) compared to the uppermost

















Figure 32: Summary flowchart for interpretation of vessel changes. A colour fundus photograph is ana-
lysed and the AVR produced and supplemented with blood pressure (BP) data and a QRISK cardiovascu-
lar risk calculation. If changes in AVR are not observed, individual vessel changes (CRAE and CRVE) are
prompted to fully exclude any vessel-specific calibre alterations. The decision to monitor or intervene /
manage is then instigated.
AVRs by which the groups were stratified) with CRVE. In the lowest quintile CRVE was slightly wider
(207.19µm ± 8.84) compared to the uppermost quintile (191.40µm ± 15.98). The greater standard devi-
ation should also be noted for CRVE which, despite the greater contrast with the background retina,
appears to be a common finding in retinal vessel measurement repeatability and accuracy. The differ-
ence in individual vessel width suggests that arterial narrowing plays a greater role in the stratification by
AVR compared to CRVE. This is supported by the significant difference in mean blood pressure readings
across the two quintile extremes. Whilst the present study is limited by sample size, the good agreement
of blood pressure, QRISK, Heart Age with changes in retinal vessel parameters (particularly CRAE and
AVR), suggests that there is merit in stratifying patients by a pre-defined cut-off value for AVR. The use
of AVR can precede any vessel-specific observations, as summarised in Figure 32.
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6.4.4 Study limitations
The most significant limitation of the present study is the lack of patient retention within the sample.
Availability to see the same optometrist, responsiveness of patients to reminder letters, and general
patient movement meant that there was a severe drop in the number of repeat visits included in the
study. This was further compounded by the less than regular nature at which patients present for a
‘routine’ eye examination, which is more sporadic than the recommended review interval. Some patients
presented earlier or later than their allocated review appointment (for instance with a subjective change
in vision, or simply wishing to replace existing spectacles) which meant that follow-up time was not
confined to fixed intervals of 12 or 24 months. Combined with the lack of consistent review, this resulted
in a greatly diminished sample for subsequent analysis.
Just as with the limitations outlined in Chapter 5.4.4, the issue of patient drop-out is doubly affected
by the lack of adequate sample size (as determined through a sample size calculation; see Chapter 3.3
(Sample size and patient recruitment)). Similar to the cross-sectional study, significant findings and
trends reported within this chapter at least serve to highlight areas which will require future study of
a more focussed design. For instance, observing a sample of patients with significant cardiovascular
risk profiles and whether changes can be detected amongst that sample depending on whether their
risk profile improves, worsens or plateaus. Particularly if vessel calibres and AVRs are to have inter-
vention guidelines in-line with established metrics like QRISK, longitudinal data is very important for
subsequent visit management. Such studies would need to be undertaken alongside observation of a
comparative ‘healthy’ sample to determine whether normal physiological ageing of vessels results in
clinically significant changes to measured calibres. As with the previous cross-sectional study, general-
isation of findings with the present cohort is restricted to the localised Caucasian population and further
work is needed to discover any regional variance in findings.
6.4.5 Conclusion
Whilst cross-sectional correlations are readily demonstrated and replicated in a clinical practice set-
ting by objective retinal vessel analysis (see Chapter 5 Correlations Between Retinal Blood Vessel Calibre
and Cardiovascular Metrics Observed in Optometric Practice), it appears that these correlations do not
fluctuate over moderate time intervals (i.e. 12 - 24 months); an interval which could be considered the
average inter-examination period in routine practice. Stability and consistency of findings at this level
is key both in the cases of known pathology and physiological ‘good health’. Microvascular changes have
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generally been observed over extended periods (such as 5 or even 10 year intervals), which is suggest-
ive of more gradual remodelling. This would support the lack of clear trend(s) observed in the present
cohort. Consistency in vessel calibre measurements across this time scale then allows for clinically sig-
nificant changes to be highlighted and managed accordingly. It should also be noted that preference is
placed upon the term ‘consistency’ in measurements, since ‘stability’ has an indirect implication against
the activity of any pathological process. The present study’s findings have been hampered most sig-
nificantly by small numbers. Robustness of statistical analysis requires greater numbers and so future
longitudinal studies should focus on increased participant numbers. Sub-division of cohorts into dis-
tinct pathology groups (hypertension, Type I diabetes mellitus, etc.) will then allow for identification of
condition-specific changes. It should also be noted that this approach is not able to account for changes
which occur for part of the inter-examination period, such as bouts of altered exercise levels or periods
of dieting. Above all, work to identify (and ultimately account for) physiological ageing of the retinal
microcirculation in the absence of disease is paramount. Just as limits of error have been identified from
a number of sources at a single visit (see Section 4.4 Discussion), extrapolation of these limits needs to
be made for longitudinal observation.
Clinically, this longitudinal study observed a lack of variation in vessel calibre despite blood pres-
sure changes, which suggests that the structural change either precedes the rise in blood pressure, or
is happening at too slow (or too little) extent to be detected by this current approach. With reference
to the extensive pool of literature correlating reduced CRAE with increased blood pressure (see Section
2.4.1. Association of blood pressure and retinal vessel calibre), when quoting change in blood pressure in
the order of +10mmHg, an average CRAE change was reported as -3-4µm; suggesting that an increase
in blood pressure with a magnitude of +40mmHg would need to be required in order to cause a calibre
change with enough clinical significance to fall outside the current limits of error. The present study also
highlights the continued agreement of blood pressure, QRISK and stratification of patients by AVR. A
clinician can therefore use AVR as an initial marker for change, before focussing on more vessel specific
changes.
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7 Incorporation of Retinal Blood Vessel Calibre Measurements
into Multi-Disciplinary Patient Care
7.1 Introduction
Multi-disciplinary care is being heralded as a possible future solution to the currently over-burdened
general practitioner (GP) based model of healthcare. It has been identified that with the current num-
ber of new GPs there will be a shortfall in provision of services for the population[274]. Annually, there
are over 300 million GP consultations (compared to 23 million A&E presentations), despite funding for
the latter increasing twice as fast over the same period[275, 276]. In an effort to tackle this, a number
of approaches are being taken to promote multi-disciplinary care; utilising other competent health-
care providers to work collaboratively for a patient. This is in addition to the NHS aim to provide an
additional 10,000 staff into GP practices by 2021, with half of those being doctors and the remaining con-
sisting of other healthcare providers such as pharmacists and nurse practitioners[277]. An independent
report by the King’s Fund identified the need (and ability to integrate) multi-disciplinary patient care
and that it was a viable and worthwhile solution to meet the ever-increasing financial burdens upon the
NHS[278]. Over the last few years, the NHS, in collaboration with the National Association of Primary
Care (NAPC) proposed the primary care home concept which focuses heavily on a localised healthcare
network[279]. The combination of primary, secondary and tertiary care aims to bring a wealth of expert-
ise and clinical skill to improve the management of patients, but also ease the burden on current go-to
healthcare environments such as GP surgeries and accident and emergency. Whilst the Optical Confed-
eration, an organisation representing a number of professional bodies within UK optometry, are listed
as an associate of the NAPC, there is currently limited interaction of optometrists in the ‘general’ care
of patients[276]. Minor Eye Conditions Schemes (MECS) exist on a regional basis and act as a buffer to
prevent less serious eye complaints from arriving in ophthalmology accident and emergency. Although
there is currently limited data, the use of MECS-based schemes has been shown to generally reduce the
number of first-time and follow-up attendees at hospital ophthalmology departments[280]. MECS-based
care could be considered ‘later’ within the pathological process, since the patient is symptomatic upon
presentation which implies that a process has already been underway prior to this point. Relating this to
cardiovascular health, the events which would render the patient symptomatic (such as stroke or heart
attack) would firstly not involve the optometrist, but more significantly, pose a life-threatening risk to
the patient. The cost implications of such an event are also much greater than if prophylactic inter-
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vention were offered at an earlier point. A local scheme in the West Midlands has developed over the
past few years to partially address this point. The Healthy Living Optician scheme in Dudley involves
optometric practices providing health checks such as blood glucose and cholesterol levels, but also life-
style management including weight loss and smoking cessation[281]. The scheme has yet to be rolled
out nationally, but it demonstrates the ability to develop and integrate such a scheme. The Mayo Clinic
Heart Disease Risk Calculator calculates 30-year risk of a cardiovascular event also provides a Controlled-
Risk Factor grade; the 30-year risk if the modifiable (i.e. lifestyle) parameters were improved. From the
cross-sectional population described in Chapter 5, Correlations Between Retinal Blood Vessel Calibre and
Cardiovascular Metrics Observed in Optometric Practice, the modifiable risk was, on average, 11.30% less
than their ‘current’ risk. Whilst not directly comparable, the QRISK calculator also provides a score for a
‘healthy individual’ of the same age, gender and ethnicity. Since this includes the presence (or absence)
of pathology, it is not strictly the same as modifiable risk, but it gives some indication as to the dispar-
ity between what the individual’s present cardiovascular risk is compared to an age-matched healthy
individual.
7.2 Hypertension
Management of newly-diagnosed cases of hypertension is increasingly being delegated to other health-
care practitioners within a GP’s practice. 73% of practices in a UK-based study reported changes to their
hypertension management structure between 2011-16, with more responsibility placed upon nurses and
healthcare assistants[17]. In this same study there was increased interest in a pharmacist-led hyperten-
sion clinic (19 of 117 practices), suggesting an appetite for shared-care beyond the GP’s practice. The
present studies have shown that optometrists are capable of recording structural microvascular differ-
ences observed in those with hypertension, in line with that reported elsewhere. Short-term structural
changes have been reported with commencement of anti-hypertensive treatment[282]. Further studies
need to demonstrate whether these changes are observable in practice with the current methodology
(Hughes et al’s study employed length-to-diameter ratio (LDR) to quantify arterial narrowing), but the
finding suggests a possible role for optometrists in the co-management of recently diagnosed hypertens-
ives. It has also been shown that dietary advice (adopting the Dietary Approaches to Stop Hypertension
(DASH) approach) to normotensive UK adults was both well-tolerated but also resulted in a reduction in
blood pressure[283]. Interestingly, mean pre-intervention blood pressure was 122.0/82.8mmHg which is
actually considered ‘pre-hypertensive’ under NICE Guidelines, however this reduced to 117.4/78.9mmHg
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following 30 days on the DASH diet.
7.2.1 Retinal vessel calibres and current hypertension intervention guidelines
Cross-sectionally, it has been shown that retinal vessel calibres (specifically arterial calibres) are strongly
correlated with increasing blood pressure. This correlation appears to be unaffected by the cardiac cycle
as measurements do not change significantly across a rapid sequence of images, and is supported by
work elsewhere which suggests transient fluctuations in BP throughout the day also do not impact
on retinal vessel calibre correlations[246]. Despite retinal arterial narrowing and increasing blood pres-
sure being correlated for over 150 years, there is no clinical management guideline at present which
includes this link, and it is simply a supplementary finding, or there is simply a suggestion that the
patient will get their blood pressure checked by the GP. With over-burdened GP practices, an appet-
ite for multi-disciplinary care with regards to hypertension has been demonstrated with other primary
care professionals (pharmacists) suggested as a possible option for easing the workload of GPs[17]. As
an alternative, optometrist-led hypertension clinics would have the added benefit of supplementing
blood pressure measurements with structural measurements of the microcirculation (i.e. CRAE). This
presents significant advantages over the conventional method of simply measuring blood pressure. In
addition, the present cross-sectional study has highlighted a significant proportion of potentially un-
diagnosed hypertensives (62.35% of all those with a blood pressure considered as ‘Stage I hypertension’
or higher), as well as an even larger proportion of pre-hypertensives (76.84%)) (see Section 5.3.1. Res-
ults: Hypertension and NICE-based blood pressure classification). This is a finding reported previously
when optometrists have measured blood pressure in practice, with a similar percentage (67%) also be-
ing undiagnosed[18]. With hypertension being predominantly asymptomatic, the benefit of incorpor-
ating routine hypertensive monitoring into optometric care (over other primary care providers such as
pharmacists) is the routine nature with which patients present. The NHS run their Health Check ser-
vice, which screens patients aged between 40 and 74 years for early signs of cardiovascular disease. This
scheme, whilst adopting a proactive approach, is not all-encompassing. Patients are invited to attend
screening; between 2012 and 2017 this amounted to over 11.5 million invitations[284]. On average, only
44.7% of those invited attended. The rate of non-attendance was much worse in the younger age bracket,
with a yearly average of 207,797 persons aged 40-49 attending for their health check, with 650,001 not at-
tending. This is in contrast to those aged 60-69 years, where average for attendance and non-attendance
over the same period were 266,376 and 225,878 respectively. The NHS have not yet published data to
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demonstrate how successful the Health Check programme has been at identifying those patients who
would otherwise have gone undiagnosed, but whatever the success rate the attendance suggests that
over half of England’s population within the eligible age-range have gone unchecked. As such, screen-
ing as part of an annual (or biennial) eye examination has the additional benefit of potentially detecting
hypertensive changes, both through physical examination of the retinal microcirculation (via objective
measurement independent of clinician experience) and measurement of blood pressure. It is difficult
to determine the overlap of non-attenders for a Health Check appointment and those presenting for
a routine eye examination, but since Health Check is available to those of a presbyopic age, there is a
significant chance that they may present in practice for a routine eye examination, even if for a one-off
visit. Just as changes in IOP, whilst within the NICE Guidelines ‘optimum’ range, can still indicate (pre-
)glaucomatous changes for that individual, the same can be said for a pre-hypertensive patient. It is only
through having a catalogue of readings of successive visits that any gradual changes may be detected. For
instance, a patient who is considered hypotensive could have a large increase in blood pressure and still
remain within the ‘normotensive’ classification despite their change being significant and potentially
warranting a cardiovascular examination. This particular instance would greatly benefit from regular
measurement of blood pressure and review of those values by an optometrist in conjunction with an ex-
amination of their retinal microcirculation. Given the number of co-variables which may (or may not)
influence retinal vascular calibre, it becomes difficult to attempt to provide an optimum value under
which all measurements of CRAE should be considered at risk. Rather, an intuitive approach would
need to be taken, considering both previous measurements of vessel calibre, blood pressure and the pa-
tients’ general health and well-being. However, further studies observing patients over extended periods
in an attempt to emulate the large cohort studies that have reviewed subjects after 5 or 10 years, would
potentially allow practitioners to begin to discriminate between pathological and physiological changes
in vessel calibre. At present it is possible to correlate blood pressure and vessel calibre cross-sectionally,
and whilst it is unlikely to set an absolute change in vessel calibre (i.e. reduction in CRAE) suggestive of
incipient hypertension without accompanying blood pressure measurements, it will be perfectly feasible
to develop a structured intervention and management profile which incorporates retinal vessel calibre
changes. The NHS has proposed that the introduction of more clinician pharmacists into GP practices
who can help monitor and intervene earlier with common-yet-severe conditions such as hypertension is
one way that multi-disciplinary care can ease the burden on GPs[275]. An additional proposition to this
should be the use of optometrists for the routine screening of those individuals not currently attending
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GP practices, and are therefore not going to access this service.
7.3 Diabetes mellitus
Individualised care regimes based on risk calculations have been shown to decrease the number of
review appointments in low-risk cases and conversely increase appointment frequency for high-risk
cases amongst diabetic patients[233, 230, 231, 232]. Of all the pathologies associated with cardiovascular dis-
ease, DM has the strongest multi-disciplinary links incorporating optometric care; from diagnosis and
monitoring through to outcome-based patient management. It has recently been shown that incor-
porating retinal vessel parameters (including CRAE and CRVE) greatly improved the classification of
CVD risk when included alongside conventional biomarkers such as estimated Glomerular Filtration
Rate (eGFR) and high-sensitivity C-reactive protein (hsCRP) by between 17.0-19.1% (Net Reclassification
Improvement)[285]. At present in the UK, those with DM are screened routinely by the Diabetic Eye
Screening (DES) Programme on an annual basis (or more frequently as appropriate)[286]. The defin-
ing criteria for evaluating images omits any reference to vessel calibre (subjective or objective), despite
the documented evidence of calibre changes in diabetes[287]. Individualised review periods based on
algorithms have been shown to reduce screening frequency by up to 61%, a benefit for both the patient
and the health service. These algorithms have since been incorporated into the RetinaRisk app, and have
the ability to highlight patients considered ‘at risk’ for DR progression. As a patient group, those with
DM are benefiting from a further evaluation of DR status by presenting for routine eye examinations in
between DES visits. Since visits to DES are primarily concerned with evaluating DR, the additional CVD
risk factors can be evaluated by the optometrist and actioned accordingly.
7.3.1 Retinal vessel calibres and current diabetes mellitus intervention guidelines
Algorithm-based risk calculators such as RetinaRisk can be refined as additional factors are identified.
Since it has been shown that retinal vascular signs (in conjunction with established biomarkers of DM)
improve the calculation of CVD risk, further work into retinal vessel calibre changes in DM is required
to explore this relationship further. Whilst it is possible to quantify other vessel properties (including
tortuosity, branching angle and fractal dimension), none have gained such widespread application as
calibre measurements suggesting this characteristic be the initial site of attention for further refinement
of risk calculations[288]. The use of specialist risk calculators like RetinaRisk (although designed for
the patient) can be used in practice by an optometrist to help determine follow-up and recall periods
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for diabetic patients to minimise risk of retinopathy going undetected. Greater distinction also needs
to be made in order to reflect the underlying subtype of DM, particularly to reflect the recognition
of young-onset Type II DM as a pathological process distinct from the classic ‘age-onset’ Type II DM.
Further improvements in the classification of DM subtypes may also help to explain the sometimes
conflicting findings observed in diabetic cohorts. A number of deep learning programmes using artificial
intelligence (AI) have been used on DM and DR datasets with promising results[289, 290, 291]. Similar to
the NHS’s defining criteria of DR, there is no accounting specifically for vessel calibre with AI, although
since the system works on a pixel-by-pixel approach and detects local changes, it may be that calibre is
inadvertently being incorporated into these models. The present defining criteria for DR still features
subjective elements and the inclusion of definitive measurements has the potential to further identify at
risk patients, and also document changes to (and stabilisation of) the microvasculature longitudinally.
As with hypertension, the definition of optimum calibres is unlikely, especially given the multiple co-
morbidities associated with DM, but clinically significant changes to vessel calibre can be identified and
correlated with existing measures of DM, with subsequent inclusion into DR defining (and intervention)
criteria.
7.4 Cardiovascular risk
The risks associated with cardiovascular disease can be broadly split into two categories; those which
are pathological and those which are modifiable. Pathological risk factors include genetic predisposi-
tion, co-morbidity, height (if considering BMI-based calculations of risk) etc., and whilst they cannot
be altered they need to be considered when determining an individual’s risk. Modifiable risk factors are
those which equally important in risk calculations, but their impact can be, to some extent, controlled
or mitigated by the individual’s lifestyle. This includes diet, alcohol and caffeine intake, smoking status
(or exposure to passive smoke) and amount of exercise. These are all integrated into general risk calcula-
tions, since pathologies of the cardiovascular system are so diverse it would not be practical to establish
individual risk for each element of CVD. At a primary care level, identification of those at most risk is
key since the modifiable risk factors for each form of CVD are generally the same, and early intervention
is key.
170
7.4.1 Retinal vessel calibres and current cardiovascular risk intervention guidelines
In order to reflect the geographic consideration built into the present QRISK algorithms, studies of ret-
inal vascular calibre could benefit from a multi-centre approach to investigate whether retinal vessel
trends are equally variable depending on location also. The use of multiple clinics across the UK would
provide a greater number of subjects, but also reflect this geographic (and socio-economic) diversity
which has been accounted for in QRISK. Just as QRISK has been shown to have a greater accuracy than
Framingham-based calculations, the same could be the case when using the ARIC-derived AVR cut-off
values for stratifying risk. Whilst these values have been shown to support findings based on cardiovas-
cular risk alone, there is undoubtedly room for refinement in those values; particularly to reflect the
multiple variables which can impact upon cardiovascular risk. As such, it may well be that a tailored
approach of intervention or cut-off values is required, with a QRISK-style algorithm requiring input of
certain metrics to derive the values (such as age, gender, smoking status, medical history etc.). Since
these are shared variables between both retinal vessel assessment and QRISK calculation, a simple solu-
tion would be the development of a combined platform which generates both values for an individual
simultaneously.
Many of the large cohort studies covered in the literature review have integrated a battery of blood
tests (particularly cholesterol, HbA1c and c-reactive protein) into their methodology to evaluate cell-
specific correlations with cardiovascular pathology and retinal vessel diameter. The most recent figures
available from the NHS (for the year 2015-16) show that the unit cost for phlebotomy is £3 per patient,
with additional haematology costs of a further £3[292]. Whilst a low unit cost, the combined total spend
on those two services cost the NHS £145,471,320.00 in that year alone. Taking the number of potentially
undiagnosed hypertensives detected in the present study as an example, there are potential merits in
optometrists also performing such routine blood work on patients whom may be identified as ‘at risk’
through combined QRISK and retinal vessel assessment (blanket screening would be not be financially
viable). However, the additional costs of such an expansion to the clinical remit of an optometrist would
be significant (education and training, indemnity insurance, and also clinic preparation to provide sterile
environments for sample collection and handling; plus clinical waste disposal). As such, further work to
explore whether such detail would provide clinically useful information needs to be undertaken, if only
to demonstrate that correct signposting to the appropriate medical practitioner (i.e. GP) to perform
these additional tests is sufficient. Alternatively, regional blood specialists in optometry may provide an
intermediate solution if there was significant demand. The use of finger-tip pulse oximetry has shown
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that tests can be used to give a gross overview of patient health, but their lack of correlation to any retinal
vascular measurements suggests limited application.
7.5 Implementation into clinical practice
Implementation requires the purchase of the necessary equipment. In this instance, vessel analysis is
more of an adjunct to fundus photography, rather than the incorporation of an entirely new examin-
ation. In order to build vessel analysis into practice, the principle investment will be in the analysis
software. VesselMap is a one-off cost of £10,000 (iFlexis is significantly cheaper at £3,000, although this
only covers a three-year period). Using the present enrolled cohort (n = 270), it would take 3 years at a
charge of £12.35 per patient to fully recoup this expenditure. By means of a worked example, the practice
involved in the present study saw, on average, 12 patients per day. Extending this over a 5-day week for
48 working weeks in a year results in an average patient load of 2,880. Assuming a similar age distribu-
tion to the enrolled cohort, 74.1% (n = 200) fall into the NHS Health Check age bracket (40 - 74 years).
Spreading the (significant) cost of implementation (i.e. software purchase, since accurate blood pres-
sure monitors are relatively inexpensive) across these patients (n = 2,134), a single charge of £4.69 per
patient would cover the cost of implementation within a single year. The practice used for the present
study employs a 45-minute eye examination time, which renders integration of such a technique relat-
ively straightforward as there is sufficient time with each patient. Faster-paced clinics, operating on a
25- or even 20-minute appointment schedule may find such implementation difficult; however, even by
extending each appointment by 5 minutes to obtain accurate blood pressure readings would still result
in a greater number of patients seen and thus a faster return on recouping costs of implementation.
Since the cost of implementation is a single payment (the software is not fixed-term licence), additional
charges would simply be remunerating the clinician for the (additional) service provided. The increased
risk of litigation due to additional tests and management options is negligible provided clinicians are
adequately trained. The Association for Optometrists (who provide a medico-legal protection for a sig-
nificant proportion of the UK optometric workforce) have already stated that provided optometrists are
suitably trained and registered, they will extend cover to include the measurement of systemic blood
pressure in the consulting room[293].
As has been shown in Chapter 4 (Repeatability and Variability in Objective Static Retinal Vessel Cal-
ibre Measurement), there is very good agreement between an experienced and novice grader. Although
further study is required, this suggests that vessel selection and analysis could be delegated to an ad-
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equately trained optical assistant or ophthalmic photographer. This would then mean that the image
and accompanying vessel data could be recalled by the optometrist without having to use clinic time.
Interpretation of the data would need to incorporate the additional information obtained throughout
the eye examination. By obtaining blood pressure, this information can be used in it’s own right and
also when combined with data from history and symptoms to calculate a QRISK value. As demonstrated
in Chapter 5. Correlations Between Retinal Blood Vessel Calibre and Cardiovascular Metrics Observed
in Optometric Practice, use of AVR quintiles can highlight those patients at greater cardiovascular risk.
Once these patients have been identified, attention can be drawn to the measurements to the vessel
types specifically (arteries and veins). Here, the optometrist can check individual vessel measurements
to identify any of clinical significance (i.e. which fall outside the values of ‘internal noise’ as determined
in Chapter 4. Repeatability and Variability in Objective Static Retinal Vessel Calibre Measurement).
This, combined with knowledge obtained from both Chapters2 (Associations of Retinal Vessel Calibre
with Cardiovascular Disease: A Systematic Literature Review) and 5 (Correlations Between Retinal Blood
Vessel Calibre and Cardiovascular Metrics Observed in Optometric Practice), it can then be determined
which arm of the retinal microcirculation has experienced a calibre change, and a number of potential
influencing factors considered.
Two worked examples of possible pathways are displayed in Figure 33. In the first example, AVR
is highlighted as being in the lowest ARIC quintile, and the change is then identified as a reduction
in CRAE (when compared to the previous examination). Blood pressure is measured (and found to
be slightly elevated, although still considered as ‘pre-hypertensive’), and QRISK is calculated to be less
than the 10% intervention threshold. As a result the GP need only be notified, and the patient could be
monitored in practice by the optometrist (with appropriate lifestyle advice as is suitable for borderline
hypertensives). In the second example, the same increase in BP is noted, but here vessel changes are
instead due to a CRVE increase, and an increased QRISK profile suggests intervention is required (and
that anatomical changes are perhaps not solely due to raised blood pressure). The result is that the GP
is requested to do a cardiovascular work-up in order to attempt to identify the possible cause. These
two examples demonstrate the diagnostic usefulness of vessel calibre measurement (and the retention
of AVR as an overall indicator), but also how they can help to stratify other clinical measures such as
blood pressure. This has the potential to streamline the referral process as well as reduce GP chair-
time to manage pre-hypertensives, which the Healthy Living Optician Scheme has demonstrated can be

























































































































































































































































































































































































Fundamental to the uptake of objective retinal vessel analysis into clinical practice is the clinical
guidance provided by the College of Optometrists. Currently, guidelines advocate the use of subjective
analysis (AVR) and descriptions. Implementation of objective retinal vessel analysis into clinical guid-
ance would require a revision of the current standards. In doing so there are two avenues which need to
be considered. Firstly, the evidence base demonstrating the applicability and clinical utility of the tech-
nology would need to be increased from clinic-based data. The data presented within this thesis forms
the first step in this, however further validation across imaging modalities and diverse populations will
add weight to the argument to incorporate this approach into clinical guidance. Secondly there is a need
to both educate and address the concerns of optometrists and clinicians. Despite it’s well-documented
drawbacks, the AVR is deeply ingrained in the optometrists’ toolkit. To move away from this requires
(re-)education of clinicians to improve their understanding of cardiovascular physiology in order to in-
terpret the findings of objective analysis. A general awareness of disease processes and how different
vessel types are affected is a key element to this interpretation. There would also need to be a move
towards educating clinicians to take blood pressure routinely and starting to consider systemic health
and cardiovascular risk, but also to be comfortable with understanding the results and developing a
management plan. This would extend to raising awareness across healthcare disciplines (particularly
GPs) about the scope of practice of optometrists and how their continued monitoring of patients’ ret-
inal microcirculation (in conjunction with systemic biomarkers) can feed into multi-disciplinary care.
Aligning any changes to optometric clinical management guidelines with pre-existing pathways such as
NICE Guidelines and the use of the QRISK algorithms will not only aid cross-disciplinary interaction
and understanding, but also reinforce the level of competence in increased optometric involvement.
7.6 Conclusion
Whilst there is inconclusive evidence regarding the use of different vessel analysis platforms, further
work needs to be undertaken to determine the levels of agreement between platforms. If clinical guid-
ance is to be based upon retinal vessel measurements, the reproducibility of those measurements needs
to be consistent across platforms, and if this is not the case, a standardised procedure (including ap-
proved platforms and protocols) needs to be devised. A pilot study focussing on image fixation high-
lights this need, since spurious results can result simply from using a macular-centred image rather than
a disc-centred one[294]. Consideration for changing camera systems also needs to be made. As instru-
ments improve, or even as CCD chips within existing setups are replaced, a method of cross-system
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calibration needs to be developed in order to allow sequential images acquired on different systems
to be compared. A reference image or grating of known dimensions that can be imaged through both
fundus camera systems could yield individualised system-to-system correction factors which would al-
low historical images to be analysed and the measurements remain comparable. This would require
high accuracy production methods since measurements are on a micrometre level, but it is an essential
consideration for application in clinical practice. Instruments are not replaced frequently, so such a
calibration process could be provided by the company supplying the analysis software.
Further work is required to document physiological changes in retinal vasculature. This allows for
age-related corrections (or considerations) to measurements taken over time in practice. Discernment
between pathological and physiological changes to vessel calibre could then potentially be made. Large
cohort studies such as those outlined in Chapter 2. Associations of Retinal Vessel Calibre with Cardi-
ovascular Disease: A Systematic Literature Review will generally quote baseline retinal vessel measure-
ments. Whilst this can provide detail for both cross-sectional and longitudinal observations, it does
not provide any clarity over the rate at which individual vessel measurements change over time. Since
practice-based settings have been shown to produce comparable results in this thesis, studies which
would follow patients for a number of years and track those changes individually are much more suited
to being undertaken in optometric practice.
This thesis has highlighted issues with current practice guidelines surrounding retinal blood ves-
sel assessment and identified a potential replacement strategy; objective retinal vessel analysis. This
alternative has a wealth of literature supporting it’s use and application in research. The method has
been shown to be as repeatable and reproducible in a clinical practice setting as the original research
settings, particularly with undilated patients (as is routine in UK optometric practice). Correlations
already established in the literature have also been reproduced cross-sectionally (particularly between
hypertension and cardiovascular risk), and shown to be relatively static over the standard 12-24 month
eye examination interval. This has been accompanied by growing evidence that optometrists should be
taking greater consideration of patients’ overall cardiovascular health and risk status, and the assess-
ment of the retinal microcirculation is greatly improved with the addition of simple measures such as
systemic blood pressure and QRISK calculations. The routine nature of eye examinations offers a fant-
astic opportunity to not only identify a significant number of previously undiagnosed hypertensives, but
also to monitor patients non-invasively over time and thus ease the burden upon GPs practices. With
this initial groundwork completed it has been shown that objective retinal vessel analysis is capable of
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making the transition from a predominantly research-based setting and move across into routine screen-
ing and monitoring of patients. There is also the opportunity for a wealth of research to be conducted
within clinical practice focussing on particular sub-groups within the population to better our under-
standing of the retinal microcirculation. Objective retinal vessel analysis has an enormous potential to
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Evaluation of objective versus subjective techniques for retinal blood vessel 
analysis 
Patient volunteer information sheet 
 
Lead researchers: Christian French MOptom (Hons), MCOptom 




We would like to invite you to take part in a research study. Before you decide whether to take part, we would 
like to explain to you why the research is being done and also what it will involve for you. One of the team will 
go through the sheets with you and answer any questions that you should have. This should take a few 
minutes. Please feel free to speak to anyone about the study. 
Please feel free to ask any questions if something is not clear. 
 
What is the study about? 
A lot of health information can be gained from studying the eyes, particularly the retina. It allows for non-
invasive viewing of the blood vessels, which is not possible anywhere else in the human body. Traditionally, 
this was done with a special torch, the ophthalmoscope. Technology, however, has advanced beyond this, to 
allow us to take photographs and even take 3D scans of the retinal layers. With these images we are able to 
perform digital analysis to give much more accurate measurements of the blood vessels. This study then hopes 
to investigate: 
1. How does computer-performed vessel analysis compare to an optometrist looking at the blood vessels 
themselves? Are the measurements that the computer makes repeatable and reliable? 
 
2. How do the blood vessel measurements compare to the patient’s general health? Are the 
measurements able to pick up subtle changes before they would normally be seen? This would mean 
medical treatment could be provided earlier and so reduce potential damage caused to the eye and 
the body. 
 
Figure 35: Patient Information Sheet
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3. Do the results from (1) and (2) mean we should change the existing national practice guidelines to 
ensure this technology is used across the country? 
 
So with the study, we hope to show that by using a computer to analyse your retinal photographs, we will get 
much more accurate measurements, but also be able to link this to your general health. This means if there 
are any changes, we can provide healthcare earlier and much more effectively. If our study is successful, we 
will be able to update the guidelines of practice, which would mean that optometrists across the country 
would be using this technology to help their patients. 
 
Do I have to take part? 
Whilst we would really appreciate your time and participation in the study, there is no obligation to take part 
in this study. Even if you initially consent to take part but change your mind at a later date, you are perfectly 
entitled to withdraw yourself and your data from the study. This will in no way affect the level of treatment 
and care that you will receive on subsequent visits to the practice. 
 
Why do you need me in the study? 
Every person is different; from gender and age to their lifestyle and genetic background. The more people that 
are included in the study means that we will have a better range of data and be able to make our findings 
much more accurate and certain. We hope to recruit 500 people into the study. 
 
What will I need to do? 
Because we hope for the results of this study to improve future eye examinations performed across the 
country, the ‘extras’ being performed today are to be kept to a minimum. It will still be a full comprehensive 
eye examination that you receive, but we shall take photographs of the back of your eyes, check your blood 
pressure you for and may also have to put some dilating eye drops in. The dilating drops ensure that we can 
get good quality, clear photographs of the back of your eyes. However, this will only be necessary if we cannot 





Page 3 of 5 
Patient information sheet - Version 1.1 – 15.09.2015 
If I need to have the drops, what do I need to know about them? 
The drops are the standard drops that are used by optometrists, called Tropicamide 0.5%. These drops only 
affect your eyes and do so by making your pupil get larger. This means that your vision can be blurry for around 
six hours afterwards and you can be sensitive to lights. They take about twenty minutes to work after they 
have been put in your eyes and their effect wears off after several hours. Although they can be a little 
uncomfortable when they are first put into your eyes, this wears off very quickly (within a minute). We strongly 
advise against driving in this time. If you have driven today that is not a problem, we can simply book you in 
for another time to do the photographs and do the other tests today. There are no long-term after effects of 
the drops. 
 
Will you be using my personal records? 
Your eye examination record, which will include information about your general, eye and family health history, 
will still only be accessible by your optometrist. The information that we will need to use for the study will be 
made anonymous so that we are able to use it without the worry that you can be identified by it. We may 
need to refer to specific details (such as your age or an existing health condition) but there will be no personal 
identifiers included (such as name or address). Only the lead researchers will have access to the list which 
links the personal records to the study data and it will never be published. 
 
Are there any risks by taking part in the study? 
No. The study is what we call an ‘observational study’, which means that we do not interfere with our subjects, 
we simply use the data that we would be taking normally (and possibly take some extra readings, such as 
blood pressure). 
 
What are the benefits of taking part in the study? 
On a personal level, you will be having a thorough eye examination that will be supplemented by an in-depth 
analysis of your retinal photographs and scans which has the potential to highlight any illnesses or changes 
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By taking part you will also be helping to advance the profession of optometry across the UK (and possibly 
worldwide) and allow for eyecare providers across the country to expand and improve the level of care that 
they offer the public. This will allow for earlier and more accurate diagnoses and treatment. 
 
Who has reviewed the study? 
Aston University’s ethical approval committee has approved the study. Their primary concerns are not the 
research, but the safety, rights and welfare of subjects taking part in the study. They have also approved all 
written information about this study (including this information sheet and accompanying consent form). 
 
Who is funding the study? 
The study has partly been funded by the College of Optometrists in London. They are in charge of the 
education of all optometrists in the UK and any optometrist working in the UK must have passed their exams 
(shown by having the letters MCOptom or FCOptom) and they also set out the guidelines for the way in which 
optometrists are expected to work. 
 
What will happen with the information collected? 
The (anonymous) data will be analysed and presented in a final report which shall be published. Findings will 
also be published in research articles in scientific journals that are used across the globe. We will be more than 
happy to discuss the outcome of the study with you at a convenient time and send a copy of any articles that 
we may publish if you so wish. 
 
Will I get any documents or paperwork to keep? 
You will be given a copy of this information sheet, along with a signed copy of your consent form. Please 
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So in a nutshell, what does the study need from me? 
The study is looking at blood vessel analysis and trying to improve the way that it is performed. Subjects taking 
part will have: 
 a comprehensive eye examination – including vision, eye health and eye pressure check 
 photographs taken of the back of the eyes 
 blood pressure measured 
The data collected will be made anonymous and used in a collection of data to allow us to look for trends and 
assess the validity of this new technique. 
 
What if I have further questions, today or at a later date? 
Contact either Christian French or Rebekka Heitmar, both of whom will gladly assist with any questions. 
  
Christian French (Davis Optometrists) Telephone: 01858 462061 [Market Harborough practice] 
       
 Dr Rebekka Heitmar (Aston University) ] 
       
 
Should, for any reason, you wish to make a complaint please contact the practice manager for Davis 
Optometrists who is not involved in the study and so will be able to resolve matters in an unbiased fashion. 
The practice manager, , can be contacted on the details below: 
 
  (Davis Optometrists) Telephone: 01536 512792 [Kettering practice] 
       
 
We hope that you will be able to take part in the study, and thank you in advance for your time. 
Fig. 9 contd
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Patient volunteer consent form - Version 1.1 - 15.09.2015 [As per NRES template Version 3.6.1, March 2011] 
Evaluation of objective versus subjective retinal blood vessel analysis 
Patient volunteer consent form 
 
Patient Name: _______________________________________ 
 
Investigator Name: _______________________________________ 
 
Please read each statement carefully and initial in the box provided. 
 
1. I confirm that I have read the Patient information leaflet (Version 1.1 – dated 15.09.2015) 
for the above study. I have had the opportunity to consider the information, ask questions 
and had them answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving a reason and without my optometric care or legal rights being affected. 
 
3. I understand the relevant sections of my medical notes and data collected during the 
study may be looked at by members of the research team, regulatory authorities or the 
NHS Trust where it is relevant to my taking part in this research. I give my permission for 
these individuals to have access to my records. 
 
4. I agree to my GP being informed of my participation in the study. 
 
 
5. I agree to take part in the above study. 
 
_______________________________    _________________ ___:___ 
Signature of the patient           Date: day/month/year       Time: hr:min 
 
_______________________________    _________________ ___:___ 
Signature of the consent taker    Date: day/month/year       Time: hr:min 
 
 
[When completed: 1 for participant, 1 for researcher site file, 1 (original) to be kept in clinical record] 
Figure 36: Patient Consent Form
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11 Appendix 4. Patient Record Card
REF NO: D.O.B.: 
EYE EXAM SUPPLEMENTARY TESTS OTHER: 
BOS  INFORMATION SHEET GIVEN CONSENT FORM SIGNED 








ROUTINE ENROLMENT SPECIAL INTEREST (SPECIFY): 
G.H. 
EVALUATION OF OBJECTIVE VERSUS SUBJECTIVE TECHNIQUES 





TIME: ( ) 
PULSE 
OXIMETRY 
DM (T1 / T2) HT Chol. 
Cardiac Renal Hepatic Resp. Blood 
MI TIA Cor. bypass Stent Ab. aortic aneur. Periph. art dis. 
F.Hx DM (T1 / T2) HT Chol. 
Cardiac Renal Hepatic Resp. Blood 
MI TIA Cor. bypass Stent Ab. aortic aneur. Periph. art dis. 
Lifestyle: Smoke? Alcohol? Caffeine? 
Sat. fat Veg. 




PRESSURE TIME: ( ) 
MEAN SPHERE 
EQUIVALENT 
Figure 37: Patient Record Card
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12 Appendix 5. Patient Questionnaire
 
 Page 1 of 4  
Medical History Questionnaire - Version 1.0 – 11.02.2015 
Evaluation of objective versus subjective retinal blood vessel analysis 
Medical History Questionnaire 
Please answer all of the questions below. If you are unsure of what to put for any section, please leave it blank 
and speak with a member of the research team. If you are unsure of any dates, please write an approximate. 
 
Name: __________________________________ D.O.B.: ___ / ___ / ___ Age: ____ 
Today’s date: ___ / ___ / ___  Record No. (For Admin use only): ________________ 
 
Refractive Status:   
Emmetrope   Low Myope (< -3.00 MSE)  Low Hypermetrope (< +3.00 MSE) 
 
    High Myope (> -3.00 MSE)  High Hypermetrope (> +3.00 MSE) 
 
Ocular Pathology:  (Write ‘R’ (right); ‘L’ (left); ‘U’ (both) in the box) 
Glaucoma   Cataract    Amblyopia 
 
Macular Degeneration (Wet) Macular Degeneration (Dry) Diabetic Retinopathy 
 
Hypertensive Retinopathy  Other: _______________________________ 
 
Ocular Surgery:  (Write ‘R’ (right); ‘L’ (left); ‘U’ (both) in the box) 
Cataract extraction (Date: ______________ ) Laser refractive surgery (Date: __________________ )
   






Figure 38: Patient Questionnaire
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 Page 2 of 4  
Medical History Questionnaire - Version 1.0 – 11.02.2015 
General (cardiovascular) Health:  (Include even if taking medication for) 
Diabetes - Type I / Type II (please circle)  Diagnosed: __________________ 
Hypertension (High blood pressure)  Diagnosed: __________________ 
Hyperlipidaemia (High cholesterol)   Diagnosed: __________________ 
Cardiac / heart problems    Diagnosed: __________________ 
Renal / kidney problems    Diagnosed: __________________ 
Hepatic / liver problems    Diagnosed: __________________ 
Blood disorder (Specify: ____________________ ) Diagnosed: __________________ 
Lung disease / COPD / Emphysema   Diagnosed: __________________ 
Sleep apnoea     Diagnosed: __________________ 
History of myocardial infarction (heart attack) Date: __________________ 
History of cerebrovascular accident (stroke)  Date: __________________ 
History of vascular surgery (heart surgery, stent etc.) Date: __________________ 



















 Page 3 of 4  
Medical History Questionnaire - Version 1.0 – 11.02.2015 
Habits: 
Smoker  Started: ______________________ Quit: ______________________ 
 
Alcohol   Approx. units per week: _______ (1pt beer / 1 glass wine = 2.3 units; 1 spirit = 1 unit) 
 
Caffeine  Cups of coffee per day: _______  Cups of tea per day: _______ 
 
Social: 
Occupation: ______________________________________ (Current / Retired) 
Exercise (types and duration per week): ________________________________________________________________ 
 
Family History: 
Diabetes - Type I / Type II (please circle)  Relative(s): ___________________________________ 
Hypertension (High blood pressure)  Relative(s): ___________________________________ 
Hyperlipidaemia (High cholesterol)   Relative(s): ___________________________________ 
Cardiac / heart problems    Relative(s): ___________________________________ 
 
Father Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Mother Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Brother Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Brother Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Brother Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Sister Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Sister Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Sister Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Child Age: _____ Alive / Deceased  Cause of death: ____________________________________ 
Child Age: _____ Alive / Deceased  Cause of death: ____________________________________ 




 Page 4 of 4  
Medical History Questionnaire - Version 1.0 – 11.02.2015 
Symptoms:  (Please tick any which you experience) 
 
Chest discomfort   Shortness of breath  Irregular / rapid heart beat 
 
Fainting / blackouts  Breathing problems at night Palpitations 
 
Light headedness   Leg / arm pain with exertion Hand pain with cold exposure 
 
Easy bruising / bleeding 
 
Many thanks for filling in this questionnaire. Please remember that this information is confidential 
and will be fully anonymised before any analysis takes place. 
 
Date   Amendment / Addition      Initial 
Fig. 12 contd
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13 Appendix 6. VesselMap Report
Static Vessel Analysis
Comment:
VM2: V3.60.1.2, CT: FF450/FF450p + VC2.5/KY-F70/KF-F75 Mono (V2.30)
The diagram is a statistical appraisement helper for the 
comparison of the individual examination result with the 
reference data of the  ARIC study  "amongst others: 
Wong TY et al: Retinal microvascular abnormalities and 
incident stroke: The Atherosclerosis Risc in Communities 
Studie. Lancet 2001; 258:1134-1140" and
on the Munich normal data study 2006 respectively.




































Academy of Life and Health Sciences, Aston University




Figure 39: Sample report generated by VesselMap v3.0 (Imedos Systems, Jena)
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14 Appendix 7. Poster Presentation: BCOVS (2015)
C : British Congress of Optometry and Visual Science (BCOVS)
D : 7th / 8th September, 2015
V : City University, London, UK
T : Evidence-based practice: How do we assess retinal vessels in practice?
Abstract
This prospective study will evaluate the current methods used in practice to assess retinal blood
vessels (primarily the subjective-based arteriole-venule ratio (AVR) which has been shown to have a
number of limitations) alongside newer, objective techniques. Objective analysis has been used in clin-
ical research for approximately 20 years, though it has yet to be used routinely in optometric practice.
There is a wealth of academic literature that advocates the use of objective vessel analysis, particularly
Central Retinal Artery/Vein Equivalents (CRAE and CRVE), including links with various cardiovascular
diseases.
This study will examine 300 patients seen in independent practice for routine eye examinations
over a course of several visits. Alongside ’routine’ procedures such as ophthalmoscopy (including sub-
jective vessel assessment) and fundus photography/OCT, supplementary data will be obtained from
patients; including blood pressure. Data analysis of photographs obtained will produce objective ves-
sel analysis results. This will concentrate on generating CRAE and CRVE values. These can also be
used in generating an objective AVR, allowing a direct comparison between subjective and objective
AVRs for the same patient.
Despite still using a subjective measure for vessel analysis, optometric practice has the capacity
to integrate advanced retinal vessel analysis, and this will hopefully aid clinical decision making; for
example monitoring/detecting changes due to systemic pathologies. By accompanying vessel analysis
with supplementary data such as blood pressure, medication and general health, it will hopefully be
shown that these additional measures provide an extra level of efficiency and accuracy for optometrists
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15 Appendix 8. Poster Presentation & Rapid Fire Oral Presenta-
tion: EVER (2016)
C : European Association for Vision and Eye Research (EVER)
D : 5th-8th October, 2016
V : Acropolis Convention Centre, Nice, France
T : Static Retinal Vessel Analysis in Routine Optometric Practice
Abstract
Title: Static Retinal Vessel Analysis in Routine Optometric Practice
Purpose: To evaluate the use of objective retinal vessel calibre measurements in optometric prac-
tice and its utility in clinical decision making.
Methods: A sub-sample [n=56] was extracted from a prospective study including patients booked
for routine eye examinations in optometric practice. All participants underwent a standard exam-
ination including subjective refraction and slit lamp biomicroscopy. Undilated fundus photography
and/or optical coherence tomography (OCT) was also performed. Optic nerve-centred (camera angle:
50 degrees), red-free photographs were analysed using VesselMap software (Imedos, Germany) to give
objective vessel calibre measurements (central retinal artery and vein equivalents (CRAE / CRVE)).
Results: Mean age of the cohort was 56 years (range: 21-82yrs; consisting of 32 women and 24
men). Univariate analysis showed a significant association between systolic blood pressure and CRAE
which was lost in multivariate analysis (p=0.02). Stepwise forward multiple regression analysis found
age to be significantly, negatively associated with CRAE (CRAE: 157au (SD ±20); β=-0.54; p<0.001) and
CRVE (β=-0.56; p<0.001), whereas BMI was positively associated with CRVE (198au (SD ±20) au; β=1.84;
p=0.005) only. Two patients were measured twice: on initial presentation, one with a significant retinal
haemorrhage and one with unilateral papilloedema; both showed normalisation of vessel diameters on
follow up.
Conclusions: Participants with the largest CRVE had the highest BMI and/or were diabetic. Cross-
sectional results from this sample are in agreement with results published from large cohort studies,
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including the negative association with age and CRAE. Retinal vessel calibres can help provide in-
formation on a patient’s vascular system and systemic health, and therefore be a useful tool to refine
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16 Appendix 9. Poster Presentation & Rapid Fire Oral Presenta-
tion: EVER (2017)
C : European Association for Vision and Eye Research (EVER)
D : 27th-30th September, 2017
V : Acropolis Convention Centre, Nice, France
T : Cross-sectional Static Retinal Vessel Analysis in Routine Optometric Practice
Abstract
Title: Cross-sectional Static Retinal Vessel Analysis in Routine Optometric Practice
Purpose: To demonstrate the clinical significance of objective static retinal vessel analysis when
utilised in routine optometric practice.
Methods: A cross-sectional sample of patients seen in routine UK optometric practice [n=225]
underwent a standard eye examination including subjective refraction and slit-lamp biomicroscopy.
Undilated, optic nerve-centred fundus photographs were obtained (camera angle: 50 degrees). Red-
free photographs were analysed using iFlexis software (Vito, Belgium) to give objective retinal vessel
calibre measurements (central retinal artery/vein equivalents; CRAE/CRVE), as described by Knudtson
et al.
Results: The mean age of the cohort was 59 years (range: 16-90 years ±15) and comprised of 137
women and 88 men. BMI ranged between 17.6 – 37.3 kg/m2. Average systolic blood pressure was
131mmHg ±20 and diastolic blood pressure was 82mmHg ±12. Refractive error (MSE) ranged from -
10.00 to +7.00D. Mean CRAE was found to be 143AU ±17, CRVE was 210AU ±22, with the ratio of the two
(AVR) averaging 0.68 ± 0.07. When compared, there was significant agreement between right and left
eyes (P<0.001), however this only accounted for around half of the agreement (r2 = 0.42 (CRAE); 0.50
(CRVE). Bland-Altman plots demonstrate good agreement between eyes but with widely spaced limits
of agreement. Stepwise forward multiple regression analysis found a significant (p<0.0001) correlation
between CRAE and age and MSE; and between CRVE and age, MSE and BMI.
Conclusions: Correlation between right and left eyes demonstrates that one eye does not fully
account for the observations in the other when performing static retinal vessel analysis. Established
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associations between age and both aspects of the retinal circulation are confirmed. The effect of re-
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17 Appendix 10. Poster Presentation: ARVO (2018)
C : Association for Research in Vision and Ophthalmology (ARVO)
D : 29th April-3rd May, 2018
V : Hawaii Convention Centre, Honolulu, Hawaii
T : Do Static Retinal Vessel Diameters Compliment Cardiovascular Risk Calculations?
Abstract
Title: Do Static Retinal Vessel Diameters Compliment Cardiovascular Risk Calculations?
Purpose: Online cardiovascular risk calculators are freely available to input known health metrics
and determine the likelihood of developing a cardiovascular incident in the future. Static retinal vessel
measurements are known to change as a result of cardiovascular disease. A cross-sectional study was
performed to establish whether vessel calibre compliments these risk calculations.
Methods: 263 subjects were enrolled from routine optometric practice in the UK. As well as a com-
prehensive eye examination (including refraction and fundus examination), OCT and fundus photo-
graphs were acquired, as well as blood pressure. A full history of general health, family history and life-
style questions (including smoking status, diet and exercise) were also collected. Red-free, 50-degree,
optic nerve head centred photographs were analysed using semi-automated retinal analysis software.
Cardiovascular risk was calculated with the Mayo Clinic’s online 30-year risk calculator.
Results: Overall average age was 58.5 years (range: 16-93), males (n=104) 58.8 (SD) and for females
(n=159) 58.3 (SD). BMI ranged from 17.6 to 37.3, with male and female averages of 26.2 and 24.6. Mean
30-year cardiovascular risk was 27.5%, and higher in men (Males: 36.3%; Females: 22.1%; p=<0.001).
The was no gender difference in retinal vessel calibres (CRAE and CRVE (p=<0.001)). In univariate
analysis however, reduced CRAE correlated with increased 30-year risk (R=-0.26; p=0.004), in females
only. BMI was linked with increased 30-year risk and CRVE (R=0.52 (p=<0.001); R=0.19 (p=0.017) re-
spectively). In a stepwise forward multiple regression model significance was retained for BMI and age
in men only.
Conclusions: Whilst there aremultiple relationships between retinal vessel calibres and individual
cardiovascular risk factors (BMI, age, gender, etc.) this relationship is lost in some multivariate models
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accounting for these risk factors. Nonetheless, the present study highlights the value of retinal vessel
calibres for their potential to refine existing cardiovascular risk stratification and how individual risk
factors are strongly linked to vessel calibre changes which can potentially impact on the development
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18 Appendix 11. Poster Presentation: ARVO (2019)
C : Association for Research in Vision and Ophthalmology (ARVO)
D : 28th April-2nd May, 2019
V : Vancouver Convention Centre, Vancouver, Canada
T : Repeatability of Static Retinal Vessel Analysis in a clinical practice setting
Abstract
Title: Repeatability of Static Retinal Vessel Analysis in a clinical practice setting
Purpose: Static objective retinal blood vessel analysis is widely used in research yet hasn’t transitioned
into clinical practice. Reduced retinal artery and vein calibres have been associated with hypertension,
diabetes and coronary heart disease-related deaths. Findings like this suggest retinal vessel calibre
measurements have great potential as a clinical screening and monitoring tool. Despite strong evid-
ence of repeatability in a research setting, there is little evidence to demonstrate that this approach is
equally robust in a clinic (where conditions could be considered sub-optimal; e.g. undilated patients).
Methods: 20 subjects had 10 retinal images captured in quick succession (both undilated and
dilated with Tropicamide 0.5%) on Day One with a Topcon 3D Maestro and were then re-imaged seven
days later. Central Retinal Artery and Vein Equivalents (CRAE and CRVE) and Arterio-Venous Ra-
tios (AVR) were calculated for each image using VesselMap v3.0 (Imedos Systems, Jena). Intra-image
measurement variance was also calculated through multiple vessel analysis for a single image of each
subject.
Results: Mean age was 40 years ±14, with 11 females and 9 males. Overall average MSE was -
1.20D (±2.22D). No subjects had existing cardiovascular disease. Average undilated baseline CRAE was
178.8µm (±15.8); CRVE was 211.0µm (±15.3) and AVR was 0.85 (±0.06). Average mydriatic baseline CRAE
was 176.7µm (±15.8); CRVE was 210.0µm (±17.7) and AVR was 0.84 (±0.07). Both dilated and undilated
measurements for CRAE and CRVE were compared in a Bland-Altman plot, with a bias of +2.07µm
and +1.01µm respectively. Repeated measures ANOVA did not reveal a statistical significance between
measurements taken on Day One or Day Seven, either dilated or undilated (p=>0.05).
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Conclusions: It has been demonstrated that there is no significant difference in measurements
taken from images acquired with or without the use of mydriatics. Furthermore successive image cap-
ture showed a negligible effect induced by the cardiac pulse cycle. Finally, short-term time intervals
(one week) did not impact significantly on retinal vessel measurements. In summary, it has been
shown that vessel analyses conducted on images (both dilated and undilated) acquired in clinic with





 Page removed for copyright restrictions. 
  
19 Appendix 12. Publication: Associations of retinal vessel cal-
ibre with cardiovascular disease: A systematic literature re-
view (2017)
J : Optometry in Practice
D (V :I , ): 2017 (18:3, 155-170)
A : Christian JD French; Rebekka Heitmar
T : Associations of retinal vessel calibre with cardiovascular disease: A systematic literature review
Abstract
Optometrists have to examine the retina and its vasculature as part of a standard eye examination.
Added to this, a thorough history and symptoms at the beginning of an examination will include both
general health and family health history. All of these factors can highlight potential risks or issues with
the cardiovascular system, but are optometrists making full use of the technology available to them
in the investigation of cardiovascular disease (CVD)? Since the Atherosclerosis Risk in Communities
(ARIC) study first published the use of objective formulae to determine static retinal vessel calibre,
there has been a wealth of literature produced on the subject (Hubbard et al. 1999). The use of the
Parr–Hubbard, and latterly Knudtson, formulae has all but become the gold standard when measuring
retinal vessel calibre. Objective retinal vessel analysis is not currently performed in UK optometric
practice, principally since there is no research demonstrating its suitability. Since optometrists are
primary healthcare clinicians, detecting and monitoring systemic health changes, as well as ocular
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